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Abstract 
 
Objectives: This project seeks to reduce duplication of effort in finding data 
for NHS healthcare quality indicators, to resolve issues identified in previous 
efforts to develop quality-monitoring ontologies and to identify areas for future 
computer-interpretable quality indicator development for the United Kingdom’s 
Department of Health and National Health Service (NHS). Outcomes will 
include  specification of inclusion and exclusion criteria for a set of healthcare 
quality indicators, along with categorisation beyond screening and prevention 
and identification of levels of indicator relationships 
 
Methodology: Following an exploration of potential methods for ontology 
development, Methontology was the method chosen to develop the ontology.  
This involved a conceptual analysis to inform the development of an ontology 
for a 2009 set of healthcare quality indicators made available on the NHS 
Information Centre website. Indicators were categorised by NHS Dimension, 
NHS-specified clinical pathway and by United States Institute of Medicine 
purpose. Relationships between indicators were identified, as well as an initial 
set of inclusion and exclusion criteria. Protégé 3.4.1 was the platform used to 
develop a pilot ontology.  
 
Results: NHS quality indicators that share some of the same criteria were 
made searchable, along with broader and narrower related criteria. Up to six 
layers of inclusion and exclusion criteria were specified and incorporated into 
the ontology. Search capabilities were created for indicators originating from 
the same source and from more than one source, along with indicators 
assigned to specific care pathways. It was shown that indicators have 
purposes other than prevention and screening, rendering Arden Syntax, 
intended for computer-interpretable guidelines and previously tested on a 
specialised set of healthcare quality indicators, unsuitable for a large, diverse 
set of quality indicators. A large number, 222, of quality indicators with 
different purposes justified the development of a separate ontology. 
 
Conclusions: This ontology could reduce duplication of effort in finding data 
for NHS healthcare quality indicators. There is potential to link to components 
of queries currently in use in the NHS, as an interim step away from the need 
to develop separate queries for each indicator. Areas for future computer-
interpretable quality indicator development include resolving Electronic Health 
Record compatibility issues and improved indicator metadata quality. The 
ontology could be useful to NHS indicator developers, NHS data extractors 
and vendors of electronic health records who supply to the NHS.  
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Chapter 1 - Introduction 
 
This chapter covers the background for the research, including brief 
overviews of the concept of quality of healthcare, clinical practice guidelines, 
quality indicators and ontologies.  Motivation for the research will follow the 
background, including issues with quality indicators in the National Health 
Service (NHS) and a platform to address some of these issues. The chapter 
will conclude with the hypothesis and objectives for this research and an 
outline of the thesis. 
 
1.1 Background  
 
1.1.2 Concept of Quality of Health Care 
 
‘Quality of Health Care’ is a broad concept, described in the National Library 
of Medicine’s Medical Subject Headings (MeSH) as “The levels of excellence 
which characterize the health service or health care provided based on 
accepted standards of quality.”  ‘Quality indicators, Health Care’, is more 
narrowly defined as involving measurable criteria. Introduced in 1998, it sits 
below the heading, ‘Quality of Health Care’ in the MeSH Tree Structure. The 
subject headings, ‘Risk Adjustment’ and ‘Standard of Care’ are narrower 
headings within ‘Quality Indicators, Health Care’. 
 
There are fourteen subject headings in MeSH that contain the word ‘quality’, 
with ninety-five additional headings having the word ‘quality’ in the scope 
notes.  ‘Quality of Health Care’, introduced in 1968, sits in more than one 
branch of the MeSH Tree Structure and has many narrower headings, 
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including ‘Guideline Adherence’.  Appendix 1 shows the Tree Structure for 
‘Quality of Health Care’. The hierarchical Tree Structure has branches 
stemming from sixteen categories. The Tree Structure helps to conceptualise 
different aspects of healthcare quality, with narrower and same level 
components. ‘Clinical Practice Guidelines’ (‘Guidelines as Topic’) and ‘Quality 
Indicators, Health Care’ are two related aspects of healthcare quality. 
  
1.1.3 Clinical Practice Guidelines 
 
In 1992, The United States (US) Institute of Medicine published a highly cited 
report, defining clinical practice guidelines (CPGs) as "systematically 
developed statements to assist practitioners and patient decisions about 
appropriate health care for specific circumstances" (Field and Lohr 1992). 
Guidelines may be developed at local, regional, national, or international 
levels (Woolf et al. 1999, Ollenschlager et al. 2004). A major goal of CPGs is 
to improve patient outcomes.  
CPGs can also be used to:  
• Address inconsistencies in quality of health care 
• Assist with health care policy development  
• Foster professional consensus and fellowship  
Drawbacks of CPGs include:  
• Inapplicability to some individual patients  
• Possible misinterpretation  
• Poorly written guidelines   
• Outdated guidelines 
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• Clinicians may resent outside interference with their decision-making 
• Lack of access to or awareness of appropriate CPGs 
• Lack of resources for implementation 
 
Clinical guidelines are sometimes confused with clinical pathways, consensus 
statements, or protocols. “A protocol is a set of systematically developed 
statements specifying the roles and dependencies between planned activities 
as part of a plan” (Román 2007). A consensus statement is (NICE 2013) “A 
statement based on the collective views of a body of experts.“ This may or 
may not be incorporated into a CPG. 
 
1.1.4 Quality Indicators 
 
Quality indicators are designed to assess changes in quality of health care.  
Campbell et al. (2002) state that indicators describe the structure, process or 
outcomes of care.  Quality indicators differ from CPGs in that CPGs are 
designed to assist with clinical decision-making.  While CPGs are intended to 
improve patient outcomes, quality indicators measure health care outcomes. 
Quality indicators also assist with assessing the effectiveness of quality 
improvement programmes, pay for performance and public accountability 
(Institute of Medicine 2006). Table 1.1 (Walter et al. 2004) shows the 
difference between CPGs and quality indicators (or performance measures). 
 
Characteristics Practice Guidelines Performance Measures 
Definition Sources of 
recommendation to be 
applied prudently based on 
clinical experience 
Quantitative tools (eg, rates, 
percentages) that indicate 
performance related to a 
specific process or outcome 
Intention Consolidate information to 
reduce gaps between 
scientific knowledge 
and clinical practice 
Measure the quality of 
medical care 
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Language Flexible: acknowledge the 
“gray zone” of uncertain 
appropriateness 
Rigid: provide specific criteria 
for which practices are “right” 
and “wrong” 
Complexity Acknowledge medical 
complexity and patient 
preferences 
Simplistic algorithms that 
provide clear scoring 
instructions for processes 
that can be measured 
practically 
Accountability Advisory Mandatory: assign penalties 
or rewards based on 
performance 
Table 1.1. Characteristics of Practice Guidelines vs Performance 
Measures (Walter et al. 2004) 
 
EHR data accuracy, completeness and comparability are factors that may 
interfere with successful measurement of quality (Chan et al. 2010). 
Variations in health care settings, populations served, health conditions, data 
elements and EHR systems are some of the challenges in developing quality 
indicators. Failure to assess illness severity of the population audited for 
adherence, failure to distinguish screening from diagnostic procedures and 
lack of accounting for patient preferences or clinician judgment when scoring 
performance measures can also interfere with successful application of quality 
indicators (Walter et al. 2004). O’Connor and Neumann (2006) point out that 
the cost of incapacity benefits should sometimes be factored into 
measurement of outcomes. Quality indicators will be explored further in 
Chapter 2. 
 
1.1.5 Ontologies 
 
“Ontology” is defined in a general dictionary as “a branch of philosophy 
concerned with the nature of being [b]y ‘the nature of being’ “ (Allen 2007). 
The field of Health Informatics has embraced this term as a system for 
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organising concepts. An ontology is an “explicit specification of a 
conceptualization” (Gruber 1993b).  
 
Ontologies differ from relational databases in that they are more flexible (Klein 
et al. 2001), with the ability to expand, and have less constraints on data 
structures (Gruber 2009, Horrocks (2008). Ontologies focus on possibilities, 
while relational databases concentrate on definite structures. This makes 
ontologies more suitable for linking data from different sources (Gruber 2009). 
 
A practical way to explain biomedical ontologies is to examine some of their 
functions. Functions of ontologies have been portrayed in different ways 
(Bodenreider 2008, Rubin et al. 2008), some of which appear to be arbitrary.  
Controlled vocabularies and the facilitation of data exchange are examples of 
functions of ontologies. Ontologies will be further explored in Chapter 2. 
 
1.2 Motivation 
1.2.1 Need for Improvement in Healthcare Quality Monitoring 
 
In the United Kingdom’s National Health Service, quality indicators are 
frequently measured electronically by using queries and data extraction, with 
very little support of conceptually modelled ontologies that may help to 
facilitate quality monitoring. NHS Trusts must supply data to show whether 
they are complying with NHS quality indicators. Electronic Health Record 
vendors should consider elements of healthcare quality indicators when 
designing or making changes to EHRs. RAND Europe (2012) has noted that 
interoperability interfered with the success of the UK Department of Health’s 
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2009-2012 integrated care pilots. Improved access to the quality indicators 
themselves, along with components of the indicators, may improve 
interoperability and data extraction. 
 
It has been shown that queries do not always adequately translate the quality 
indicators (Morris et al. 2004). Mabotuwana and Warren (2010) explain that 
relying on individual queries complicates the addition of new criteria to quality 
indicators. Baker et al. (2007) found that the use of queries increased the 
number of false positives for exclusion criteria. Benin et al. (2011) found that 
relying on clinical coding to measure quality indicators is less reliable than a 
more iterative process. Persell et al. (2010) explain that automated data 
capture may miss clinical detail. They recommend the inclusion of exceptions 
to quality indicators in the recording of normal clinical workflow. Chan et al. 
(2010) advocate for research into attributes of quality indicators to support 
electronic health record compatibility. 
 
1.2.2 Relationship between Clinical Practice Guidelines and Quality 
Indicators 
 
As discussed in section 1.1.5, ontologies are useful for linking data from 
different sources (Gruber 2009). While much research has been published on 
ontologies for computer-interpretable guidelines (Wang et al 2002, Wang et al 
2003, Shahar et al 2004, Bernstein and Anderson 2008, White and Roudsari 
2011, Peleg 2011), research related to computer-interpretable quality 
indicators has lagged behind. Useful ontology research for computer-
interpretable quality indicators could identify attributes and facilitate tailoring of 
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queries by identifying relationships between indicators and their component 
parts. 
 
Quality indicators and clinical practice guidelines are part of a set of health 
care quality tools intended to improve health care. There are many similarities 
between quality indicators and clinical practice guidelines, often involving 
physical measurements and time-sensitive data. Quality indicators are 
frequently derived from clinical practice guidelines (Mertz 2009, Kotter 2012). 
As quality indicators are increasingly used to evaluate clinical practice, it is 
useful to determine whether the application of guideline modelling ontologies 
may facilitate the development of computer-interpretable quality indicators 
(Jenders 2008).  Additionally, it may be useful to develop a separate ontology 
for quality indicators. 
 
Arden Syntax, a precursor to GLIF, an ontology developed for clinical practice 
guidelines, has been somewhat successfully applied to a small, specific set of 
quality indicators (Jenders 2008). There is room for improvement in the 
ontology and in testing on a larger, more diverse set of indicators. This is, in 
part, due to Arden Syntax’s having been designed to support computer-
interpretable screening and prevention guidelines, rather than other guideline 
categories  (Ohno-Machado et al. 1998). Although many quality indicators are 
based on clinical practice guidelines, a diverse set of healthcare quality 
indicators is likely to cover more categories than just screening and 
prevention and will show whether a more flexible ontology is warranted.   
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1.2.3 Benefits of Ontology Development 
 
Finding commonalities, such as organisational structure (eg, Next Stage 
Review pathway), process (eg, screening and prevention) and hierarchical 
relationships, among a large set of quality indicators can reduce the time and 
effort needed to find data for the quality indicators. Integration of inclusion and 
exclusion criteria into an ontology will resolve a semantics issue previously 
identified with respect to computerisation of quality indicators (Surján et al. 
2006, Baker et al. 2007, Persell et al. 2010).  
 
NHS Trusts will be able to use this ontology to reduce administrative time 
required to identify relevant quality indicators for specific departments. 
Because quality indicators come from different sources, duplication of effort is 
often required to find indicators specific to clinical areas.  Access to 
commonalities between different types of indicators, such as age groups, 
previous history of a clinical condition or test results relevant to a range of 
clinical conditions may speed the quality monitoring process and enable 
tailored queries to extract data for quality indicators. Identification of layers of 
inclusion and exclusion criteria will also facilitate tailored queries and reduce 
duplication of effort finding data. Patient data that should be excluded from 
indicator reporting will be easier to identify, as will patient data which should 
be included in indicator reporting. Instead of browsing through lists of quality 
indicators, issued by different government entities, Trusts will be able to 
identify related indicators and indicator components, thus reducing effort in 
the quality-monitoring process. Organisations that develop queries for NHS 
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quality indicators will be able to separate components of queries and code or 
otherwise relate the components to relevant components of indicators. 
 
This ontology should be used to inform the development of metadata for 
future sets of healthcare quality indicators. The ontology will allow for 
specification of inclusion and exclusion criteria and specification of 
relationships between indicators, along with specification beyond screening 
and prevention. The ontology can serve as a guide for EHR and quality 
indicator developers, highlighting information that is either vital to include in 
health records or warning indicator developers that indicators need to be 
worded in such a way that facilitates data extraction. This document-centric  
approach (Sonnenberg and Hagerty 2006) is useful in that it does not require 
EHR compatibility. It is instead intended as a stage toward EHR compatibility. 
 
1.2.4 Development Platform  
 
Protégé, a freely available ontology development platform, has been selected 
to create the ontology. Protégé is used to describe concepts, including their 
properties, attributes and constraints (Noy and Tu 2003). Instances of the 
concepts are identified after the concepts, properties, attributes and 
constraints have been initially specified, with revision taking place as needed 
throughout the development process. In Protégé 3.4.1, the version of Protégé 
chosen for this ontology, concepts are specified as ‘classes’ and properties 
are specified as ‘slots’. Classes may have subclasses and slots may have 
subslots, with subclasses and subslots inheriting the properties or attributes of 
their parent versions.  
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Protégé 3.4.1 is frames-based, with tabs to differentiate work areas for 
classes; slots; instances; forms to enter instances; and queries. Buttons and 
widgets can be used to manipulate the classes, slots, forms and queries. 
Further information on ontology development platforms is available in section 
2.4.3.5 Ontology Development Platforms. 
 
1.2.5 Motivation Summary 
 
This project will facilitate computer-interpretable quality indicators by 
specifying an initial set of inclusion and exclusion criteria from a large, diverse 
set of quality indicators (NHS Information Centre 2009a) from an ontology 
development perspective.  The project will list the indicators by Institute of 
Medicine category (Field and Lohr 1992), investigating whether certain 
categories of quality indicators warrant specific capabilities in an ontology. 
Specification of relationships is an integral part of ontology conceptualisation 
and development. This research project may therefore contribute to closing 
the research gap regarding interoperability in ontology development for health 
care quality monitoring by exploring attributes of and relationships between 
health care quality indicators.  The literature review will also serve as a 
contribution to the field of health informatics by exploring quality monitoring 
via electronic health records. 
 
 
1.3  Hypothesis and Objectives 
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1.3.1 Hypothesis 
 
The hypothesis of this research is that the conceptualisation stage of ontology 
development for a large set of health care quality indicators can facilitate 
specification of inclusion and exclusion criteria, along with categorisation 
beyond screening and prevention and identify levels of indicator relationships. 
Stated as two research questions, this translates to: 
1) What attributes of health care quality indicators influence the development 
of an ontology that emphasises specification of inclusion and exclusion 
criteria, along with specification beyond screening and prevention? 
2) What relationships between health care quality indicators identify 
complexity of indicator relationships? 
  
1.3.2 Objectives  
 
1. To identify relationships in a large, diverse set of quality indicators  
2. To identify layers of inclusion and exclusion criteria for a large, diverse 
set of quality indicators  
3. To determine the attributes of quality indicators most suited to ontology 
coverage 
4. To determine whether there any features of quality indicators that do 
not need an ontology to facilitate quality-monitoring 
5. To develop a preliminary ontology for a large, diverse set of quality 
indicators 
 
Justification for the first and second objectives appear in section 2.6.3.5, 
Challenges for Computer-Interpretable Quality Indicators, in the literature 
review. Established approaches for developing computer-interpretable quality 
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indicators will be covered in section 2.6.3, Computer-Interpretable Quality 
Indicators, in the literature review, with notable features described in Chapter 
6. The third and fourth objectives are justified in sections 1.2.1, Need for 
Improvement in Healthcare Quality Monitoring, 2.6.3.5, Challenges for 
Computer-Interpretable Quality Indicators, and 2.7, Summary, of the literature 
review, respectively, and in section 3.2.3, Conceptualisation, of the 
Methodology chapter. 
 
1.3.3 Outline of the Thesis 
 
Chapter 2 will offer a review of the literature related to the concept of quality, 
clinical practice guidelines and quality indicators, with respect to computer 
interpretability and ontologies.  The search strategy and statements will be 
introduced, along with the objectives for the review.  The concept of health 
care quality will be explored. An overview will be provided of clinical practice 
guidelines and the use of ontologies to facilitate their computer interpretability. 
The development and use of quality indicators will be detailed, along with use 
of ontologies to facilitate their computer interpretability. Popular methods for 
developing ontologies will be identified, along with the reason for the chosen 
method.  Procedures for evaluating ontologies will be described, with relevant 
evaluative strategies selected for application to this research. 
 
Chapter 3 will describe the method for this project, explaining how it was 
applied.  Chapters 4 and 5 will describe the results of the project.  A 
discussion and analysis will follow in Chapter 6.  Chapter 7 will offer 
conclusions and Chapter 8 will provide recommendations for further research. 
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1.4 Summary 
 
This chapter has explored the background and motivation for this research, 
giving brief overviews of the concept of quality, clinical practice guidelines, 
quality indicators and ontologies. It has also presented the hypothesis and 
objectives, followed by an outline of the thesis. The next chapter will 
summarise the literature review leading to this project.  
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Chapter 2 Review of the Literature 
 
2.1 Objectives 
 
The objectives for this literature review were: 
1) To assess whether developing an ontology for health care quality 
indicators will make a significant contribution to health informatics 
research; 
2) To provide an overview of research on the development of ontologies 
for computer-interpretable guidelines; 
3) To provide an overview of research on the development of ontologies 
for health care quality indicators; 
4) To provide background information on clinical practice guidelines, 
quality indicators and ontologies; 
5) To assess approaches to ontology development; 
6) To explore methods for evaluating ontologies. 
 
 
2.2 Search Strategy  
  
A review was conducted in 2012, to identify articles with the concepts of: 
 
1) Health Care Quality Indicators 
2) Clinical Practice Guidelines 
3) Computer Interpretability 
4) Ontologies 
Database searches in PubMed, CINAHL, Cochrane, and Web of Science 
were supplemented by hand-searches of reference lists of the selected 
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articles.  The MeSH terms used to search for the concepts of computer-
interpretability and healthcare quality indicators were: Medical Records 
Systems, Computerized AND Quality Indicators, Health Care. ‘Ontologies’ 
was not a MeSH term at the time of the search and is currently limited in 
scope to biological ontologies. The concept of ontologies was entered as a 
truncated key word (ontolog*) and covered, in part, by the MeSH term, 
Medical Records Systems, Computerized. An additional search was 
conducted in City University’s library catalogue, for general books on 
ontologies, using the Subject word ‘ontologies’.  
 
The 2012 review followed a 2009 search of the same databases, which 
included the concept of clinical practice guidelines. The MEDLINE search 
statement was: 
("quality assurance, health care"[Mesh] OR “quality control” OR audit 
OR "Guideline Adherence"[Mesh] OR compliance OR reminder 
systems[mesh] OR reminders) AND ("Medical Records Systems, 
Computerized"[Mesh]) OR EMR’s OR “Electronic Medical Records” OR 
EPR’s OR “Electronic Patient Record*” OR EHR's OR “Electronic Health 
Records” OR “clinical coding” OR "forms and records control"[mesh]) 
AND ("Vocabulary, Controlled"[Mesh] OR ontolog* OR thesaur*) AND 
(“practice guidelines as topic”[Mesh] OR “clinical practice guidelines” 
OR cpgs). 
 
 
The Related Articles search link was used in PubMed for relevant articles.  
The US National Center for Biomedical Ontology, DAML (DARPA Agent 
Markup Language) Library and OpenClinical websites were browsed, with 
relevant external links or references noted (Wynden et al. 2010, Peleg et al. 
2004a). Information selected from non-permanent resources, eg, web sites, 
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was verified, where possible, in permanent resources.  Where this was not 
possible, it was noted as such. 
 
PubMed searches were stored in NCBI’s database and set to send updates. 
Articles published in languages other than English were excluded. When an 
author or group of authors had published more than one article on 
substantially the same topic, the most recent article was selected. Primary 
literature was reviewed as a priority, with grey literature included if it met all 
other criteria. Review articles and commentary were marked for background 
reading.  
 
The authors of relevant articles were searched under a ‘Cited Articles’ search 
in Web of Science and/or Google Scholar for follow-up articles by the original 
first author.  Information selected from non-permanent resources, eg, web 
sites, was verified, where possible, in permanent resources.  Where this was 
not possible, it was noted as such. 
 
PICO (Patient or Population; Intervention; Comparison; Outcome) is one 
framework commonly used to help clinical researchers to create answerable 
clinical questions. PICO works well for identifying clinical questions. It does 
not always work well in specifying non-clinical questions. The question for the 
2012  literature search could be stated as: “How are ontologies being used to 
improve computer interpretability of health care quality indicators?” The 
question for the 2009 literature search could be stated as: “How are 
ontologies being used to facilitate audit of clinical practice guidelines via 
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electronic health records?” These are not clinical questions and do not fit well 
in the PICO framework. 
2.2.1 Inclusion/Exclusion Criteria 
 
Because ontologies are a relatively new area in the field of health informatics 
and opinions vary as to what constitutes an ontology in this field (Jones et 
al.1998, Bodenreider 2008, Rubin et al. 2008, Horrocks 2008, Klein et al. 
2001, Grabar et al. 2012), articles were selected from the 2012 results if their 
titles or abstracts focused on the development of computer-interpretable 
healthcare quality indicators or an ontology for healthcare quality indicators. 
Titles and abstracts of the 2009 results were reviewed regarding the 
inclusion/exclusion criteria of whether the article was about using ontologies 
to facilitate assessment of compliance with clinical practice guidelines via 
electronic health records. Articles about single reminder systems were 
excluded, as clinical practice guidelines tend to be multi-faceted. When an 
author or group of authors had published more than one article on 
substantially the same topic, the most recent article was selected. Articles for 
the literature review for this thesis were ranked by the number of the following 
concepts that they covered: Health Care Quality Indicators, Clinical Practice 
Guidelines, Computer Interpretability, and Ontologies. The next sections will 
cover the concepts of Quality of Healthcare; Ontologies, including approaches 
to development and evaluation; Clinical Practice Guidelines, including 
computer-interpretable guidelines; and Quality Indicators, including computer-
interpretable quality indicators. 
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2.3 Quality of Healthcare 
 
2.3.1 Definition   
 
In a classic article, Donabedian (1966) describes quality as little more than a 
value judgement. He goes on to define healthcare quality as “a reflection of 
values and goals current in the medical care system and in the larger society 
of which it is a part.”  
 
 
2.3.2 Brief History 
 
The Hippocratic Oath (translated by North 2002) demonstrates the dedication 
of physicians to quality of practice.  The existence of doctors for members of 
the public has been documented from the fifth century, BC. These posts, 
granted on a competitive basis, show that quality of care was a consideration, 
though selection was largely based on public reputation. Contracts for health 
care provided by physicians provides a picture of commitment to health care 
quality during Medieval times (Sistrunk 1993).  There was as yet no 
systematic method of evaluating the quality of health care. Medical schools 
and universities became recognised as a formal route to clinical competency 
in the twelfth and thirteenth centuries.  
 
In the early eighteenth century, Francis Clifton published “The state of 
physick, ancient and modern, briefly considered with a plan for the 
improvement of it” (Tröhler 2011). This was one of the first calls for the 
medical community to use numbers to assess the quality of health care. 
Tables of results of small pox inoculations were circulated in 1722.  
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In 1803, Sir Thomas Percival attempted to persuade colleagues of the 
benefits of establishing a hospital registrar to improve the quality of care.  
Although his fellow English physicians were not convinced, his work informed 
the American Medical Association’s (AMA) 1847 first Principles of Medical 
Ethics. During the 1850’s, Florence Nightengale collected data to improve 
clinical outcomes. She developed a model hospital statistical form to collate 
data and statistics (Darr 2007). 
 
In the early nineteenth century, a Boston surgeon, Earnest Codman, began 
organising conferences focusing on discussions of morbidity and mortality, 
leading to the concept of outcomes management in patient care (Darr 2007). 
The American College of Surgeons’ Hospital Standardization Program, 
established in 1917, included a requirement to keep medical records of 
patient care (Luce et al. 1994). This programme led to the 1952 formation of 
the Joint Commission on Accreditation of Hospitals, a collaboration between 
the American College of Surgeons, the American College of Physicians, the 
American Hospital Association, the AMA, and the Canadian Medical 
Association. 
 
During the 1920’s, Walter Shrewhart developed a technique called ‘Statistical 
Process Control’, the precursor to Continuous Quality Improvement (Darr 
2007), popular in the 1980’s.  Shrewhart’s technique emphasized consistency 
and similarity.  The concept of continuous quality improvement has been 
recycled under various euphemisms ever since. 
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2.4  Ontologies  
 
2.4.1 Definition  
 
The definition of ontologies has not stabilised in the field of Health Informatics. 
This is, perhaps, due to its newness to the field. Gruber (1993b) describes an 
ontology as a “specification of a representational vocabulary for a shared 
domain of discourse — definitions of classes, relations, functions, and other 
objects” and also as “an explicit specification of a conceptualisation” (Gruber 
1993b).  Guarino and Giaretta (1995) describe the meaning of ontology as 
“vague” and identify seven interpretations. Other than original use of the term 
“ontology” in the field of philosophy, the differences relate to semantic versus 
syntax interpretations, formal versus informal interpretations, and 
interpretations of logic, theory, specification and conceptualisation. 
 
Jones et al. (1998) define an ontology as a ‘domain model’. Klein et al. (2001) 
further state that “ontologies provide a shared and common understanding of 
a domain that can be communicated between people and heterogeneous and 
distributed application systems.“ Bodenreider (2008) uses the terms 
‘ontologies’ and ‘terminology’ interchangeably, though does not rule out other 
types of ontologies. Grabar et al. (2012) explore varying interpretations of the 
meaning of ‘terminology’ and ‘ontologies’ and suggests that they are part of a 
continuum. Rubin et al. (2008) describe ontologies in a similar manner to the 
description of a relational database; as the “specifications of the entities, their 
attributes and relationships among the entities in a domain of discourse. 
Horrocks (2008) explains that an ontology is “ a model of some aspect of the 
world and introduces vocabulary relevant to domain”, often including names 
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for classes and noting relationships, …it “specifies intended meaning of 
vocabulary, typically formalized using a suitable logic, …and consists of two 
parts (axioms describing the structure of the model and facts, describing 
some concrete situation)”.  While these definitions have similarities, often 
involving representational descriptions of a domain, they may be confused 
with the description of a relational database. 
 
Horrocks (2008) distinguishes between ontologies and relational databases 
by explaining that relational databases present a ‘closed world’ view, with 
missing information considered invalid, while ontologies offer an ‘open world’ 
view, with missing information interpreted as unknown and possibly valid. 
Ontologies are more flexible than relational databases and therefore more 
suited to linking data from different sources (Gruber 2009).  Horrocks also 
notes that ontologies are capable of making inferences (reasoning). Horrocks’ 
interpretation may conflict with those that include terminologies, as 
terminologies are not known for their ability to reason. In a guide used to 
support learning Protégé, used in this research, Noy and McGuiness ([2002]) 
acknowledge that there are contradicting definitions of ontologies in the 
published literature.  They go on to state: 
“For the purposes of this guide, an ontology is a formal explicit description of 
concepts in a domain of discourse (classes (sometimes called 
concepts)), properties of each concept describing various features and 
attributes of the concept (slots (sometimes called roles or 
properties)), and restrictions on slots (facets (sometimes called role 
restrictions)). An ontology, together with a set of individual instances 
of classes, constitutes a knowledge base. In reality, there is a fine line 
where the ontology ends and the knowledge base begins. (Noy and 
McGuiness [2002]).” 
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2.4.1.1 Two Functions of Ontologies related to Quality in Health 
Informatics 
 
Ontologies serve different functions in Health Informatics. Examples of the 
functions of terminologies and facilitation of data exchange among 
applications are given in this section. Terminologies are emphasised because 
they have a much longer history. 
2.4.1.1.1 Terminologies  
 
Terminologies may serve different purposes. Medical reference terminologies 
are used to organise complex clinical concepts. The Systematized 
Nomenclature of Medicine-Clinical Terms (SNOMED CT) is an example of a 
reference terminology (Kanter et al. 2008).  Medical interface terminologies 
are more narrowly intended to support digital recording of or access to 
patient-related information. Daniel-Le Bozac et al. (2009) describe the 
importance of interface terminologies in clinical statements and the need for 
interface terminologies to map to reference terminologies. Classification 
systems, such as ICD-10 and CPT are used for secondary purposes, eg, 
reimbursement and public health reporting. They can then sometimes be 
mapped to other terminologies or classification systems (American Medical 
Informatics Association and American Health Information Management 
Association Terminology and Classification Policy Task Force [2006]). There 
is conflicting literature on types of terminologies (Daniel-Le Bozec et al. 2007, 
American Medical Informatics Association (AMIA) and American Health 
Information Management Association (AHIMA) Terminology and Classification 
Policy Task Force 2006). Daniel-Le Bozec et al. (2007), describe the 
International Classification of Diseases as a reference terminology, while the 
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AMIA and AHIMA Terminology and Classification Policy Task Force (2006) 
distinguish between terminologies and classification systems, explains that 
classification systems, including ICD, are more general and lack the clinical 
detail of terminologies.  
 
2.4.1.1.2 Facilitating Data Exchange Among Applications 
 
Ontologies can be used to facilitate data exchange among applications, such 
as computerised clinical practice guidelines and electronic health records. 
Ontologies are useful to facilitate data exchange because they can be used to 
describe data from different sources. Figure 2.1 shows an example of data 
exchange among applications. The domain ontology and upper ontology link 
to HL7 and an external database, enabling communication between different 
systems. Upper ontologies are very broad categories (eg, Thing) which can 
cross domains. Upper ontologies are not always shown as separate from 
domain ontologies. 
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Figure 2.1: This is an example of how ontologies can facilitate data 
exchange among applications (Correndo and Terrenziani 2004). 
 
2.4.2 Brief History 
 
In the 17th century, an effort to compile accurate health statistics became 
known as “the Bills of Mortality.” Health authorities in London used a standard 
list of about 200 causes of death, to organise data. The list was later 
integrated into the International Classification of Diseases (ICD), now 
maintained by the World Health Organization. Linnaeus also began 
formalising the biological relations among species (Bodenreider 2008). 
 
  
2.4.3 Approaches to Ontology Development 
 
Jones et al. (1998) describes two approaches to ontology development: 
stage-based and evolving. Unless otherwise stated, steps in stage-based 
approaches are not repeated. TOVE (Toronto Virtual Enterprise) and 
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Enterprise are two established examples of the stage-based approach. 
Evolving approaches are more flexible, allowing for repetition of steps and 
with less emphasis placed on order of steps. Methontology and IDEF5 are two 
popular examples of the evolving approach.  
 
2.4.3.1 Stage-based Approaches 
2.4.3.1.1 TOVE 
 
TOVE (Toronto Virtual Enterprise) involves 6 stages (Jones et al.1998): 
“(1) motivating scenarios: the start point is a set of problems encountered in a 
particular enterprise, which are often in the form of story problems or 
examples. 
(2) informal competency questions: requirements of the ontology, based on 
the motivating scenario, described as informal questions that an 
ontology must be able to answer; this phase acts as an evaluation on 
the ontological commitments made in the previous stage. 
(3) terminology specification: the objects, attributes and relations of the 
ontology are formally specified (usually in first order logic). 
(4) formal competency questions: the requirements of the ontology are 
formalised in terms of the formally defined terminology…. 
(5) axiom specification: axioms that specify the definition of terms and 
constraints on their interpretations are given in first-order logic, guided 
by the formal competency questions as the axioms must be necessary 
and sufficient to express the competency questions and their solutions.  
(6) completeness theorems: an evaluation stage which assesses the 
competency of the ontology by defining the conditions under which the 
solutions to the competency questions are complete.” 
 
TOVE is implemented with C++ and Prolog (Bullinger 2008). It is intended to 
support deductive reasoning in distributed enterprise models (Fox 1992). 
2.4.3.1.2 Enterprise 
 
The Enterprise model involves 4 stages (Jones et al.1998): 
“(1) identify purpose: determines the level of formality at which the ontology 
should be described.  
(2) identify scope: a “Specification” is produced which fully outlines the range 
of information that the ontology must characterise. This may be done 
using motivating scenarios and informal competency questions, as in 
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TOVE or by “brainstorming and trimming” i.e. produce a list of 
potentially relevant concepts and delete irrelevant entries and 
synonyms. 
(3) formalisation: create the “Code”, formal definitions and axioms of terms in 
the Specification. 
(4) formal evaluation: the criteria used may be general, …, or specific to a 
particular ontology, such as checking against purpose or competency 
questions. This stage may cause a revision of the outputs of stages 2 
and 3.” 
 
The Enterprise model focuses on people and their interactions, and on 
organisations (Dietz 2006). 
2.4.3.2 Evolving Approaches 
2.4.3.2.1  Methontology 
 
The nine components of Methontology are: specification, knowledge 
acquisition, conceptualisation, integration, formalisation, implementation, 
evaluation, documentation, and maintenance.  Knowledge acquisition, 
evaluation, and documentation are applied throughout each component. The 
components are further explained as follows: 
Specification involves explaining the intended use of the ontology, along with 
the intended audience, and scope of terms to be represented.  
Knowledge Acquisition takes place during the specification process and 
may continue during other processes. Knowledge Acquisition often involves 
literature reviews and interviews.  
Conceptualisation is the informal representation of domain terms in the form 
of concepts, instances, verbs, relations, and properties. 
Formalisation uses frames-oriented or description logic systems to model the 
ontology. 
Integration attempts to address a common standard for ontologies, by 
incorporating definitions from other ontologies. 
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Implementation occurs when the ontology is translated into a formal 
language. 
Evaluation involves assessing the ontology for completeness, consistency 
and redundancy. 
Documentation entails the selection and organisation of documents 
produced during the entire process. 
Maintenance is the continued assessment and development of the ontology, 
in line with the specification. 
Methontology supports ontology development at the conceptual level, with 
less focus on the implementation or post-development level (Semantic Web 
2012). 
 
2.4.3.2.2 IDEF5 
 
IDEF5 (Integrated Definition for Ontology Description Capture Method) has 5 
components (Jones et al.1998): 
“(1) organising and scoping: establishes the purpose, viewpoint, and context 
for the ontology development project. The purpose statement provides 
a set of “completion criteria” for the ontology, including objectives and 
requirements. The scope defines the boundaries of the ontology and 
specifies parts of the systems that must be included or excluded. 
(2) data collection: the raw data needed for ontology development is acquired 
using typical KA [Knowledge Acquisition] techniques, such as protocol 
analysis and expert interview. 
(3) data analysis: the ontology is extracted from the results of data collection. 
First, the objects of interest in the domain are listed, followed by 
identification of objects on the boundaries of the ontology. Next, 
internal systems within the boundary of the description can be 
identified. 
(4) initial ontology development: a preliminary ontology is developed, which 
contains proto-concepts i.e. initial descriptions of kinds, relations and 
properties. 
(5) ontology refinement and validation: the proto-concepts are iteratively 
refined and tested. This is essentially a deductive validation procedure 
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as ontology structures are “instantiated” with actual data, and the result 
of the instantiation is compared with the ontology structure. 
 
IDEF5 uses both graphical and structured text languages (Grover 2000). IDEF 
is most commonly used for US military projects (KBSI [2000]). 
 
2.4.3.3 Comparison of Approaches to Ontology Development 
 
There are many similarities between the different approaches to ontology 
development described in this chapter, including specification of terms and 
their definitions. All of the approaches have evaluative components. The 
Stage-based approaches are more proscriptive, with known scenarios and 
requirements established towards the beginning of the ontology development. 
TOVE is problem-based, while Enterprise emphasises the essence or 
intention of an organisation, rather than its structure. Like TOVE, the 
Enterprise model is intended to support enterprise organisations.  The 
Enterprise model allows more flexibility in developing the specification, as 
brainstorming is acceptable. The Enterprise model also allows more flexibility 
in evaluation, as the criteria may be general or specific to the ontology (eg, 
competency questions). TOVE requires two types of competency questions: 
formal and informal.  
 
The Evolving approaches are suitable for developing ontologies when 
scenarios and requirements are not necessarily known. Both Methontology 
and IDEF5 involve knowledge acquisition, which is not a component of the 
Stage-based approaches. Methontology appears more thorough than IDEF5, 
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involving documentation and maintenance. Both Methontology and IDEF5 
allow for overlap and repetition of steps. 
 
2.4.3.4 Justification of Use of Methontology 
 
The decision to use a modified version of an evolving prototype methodology, 
Methontology, was informed by Jones’ et al. (1998) seminal review of 
methods for ontology development. Jones et al. note that while stage-based 
approaches are useful when requirements are clear at the outset, an evolving 
prototype, such as Methontology, allows more flexibility in development. The 
disparate nature of different clinical areas covered by the selected set of 
quality indicators, coupled with the potentially different nature of quality 
indicators from different sources, meant flexibility was crucial to the 
development of the proposed ontology. Methontology is also suitable for non-
expert ontologists (Fernandez-Lopez et al.1999) and is described as the most 
2.4.4 mature methodology of several reviewed by Corcho et al. (2003).  Stage-
based approaches, such as TOVE, would not work for an undefined model, 
with unknown components and attributes.  
 
2.4.3.5 Ontology Development Platforms 
 
While ontologies are encoded using expression languages, such as OWL 
(Web Ontology Language) and OBO (Open Biomedical Ontologies) (Popescu 
and Xu 2009), they are generally developed with the aid of editorial tools. 
Denny (2004a) compared ninety-six ontology editors, assessing categories 
such as features and limitations, base language, availability via the Internet 
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and the ability to perform consistency checks. Two features he did not assess 
were cost and ease of use for new ontology developers, important 
considerations for this project. He singles out Protégé in a benchmarking 
sense, to illustrate that ontology editor features are still evolving, and refers to 
it as a very capable tool (Denny 2004b). He suggests that it may be useful to 
use more than one ontology development tool, depending on features needed 
to develop the ontology, and that suitable ontology development tools may 
very, depending on the chosen domain. He acknowledges a collective desire 
for ontology editors that are easy to use, for non-expert ontology developers.   
 
Many ontology editors lack long term availability and support. The WC3 
(World Wide Web Consortium) (WC3 2014) lists ten ontology editors, 
including Protégé, NeOntoolkit, SWOOP, Neologism, TopBraid Composer, 
Vitro, Knoodl, Anzo for Excel, OWLGrEd, and Fluent Editor. Of these ten 
editors, SWOOP and Knoodl are no longer available at the URLs shown on 
the WC3 website. Protégé is by far the most popular of the freely available 
ontology editors (Keramaris 2014). 
 
2.4.3.5.1 Justification of Selection of Protégé 3.4.1 
 
Protégé is a well known ontology editor, popular with academic and business 
developers (Stanford Center for Biomedical Informatics Research.2014a). The 
availablility of educational and supporting information, including a user 
discussion group, contributed to the decision to use Protégé for this project. 
Popescu and Xu (2009) recommend Protégé, due to its free availability and its 
being noted in OWL tutorials. Learning about ontologies through frames-
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based tutorials (Sachs 2006, Stanford Center for Biomedical Informatics 
Research 2014c) influenced the decision to use a frames-based version of 
Protégé.  
 
Protégé 3.4.1 and Protégé 4.0 rc1 were the most recent versions at the time 
of downloading the software. Protégé 4, intended for ontology development 
using OWL and not frames-based, was very new at the time and lacked 
support and training materials. A review of version histories (Stanford Center 
for Biomedical Informatics Research 2014b) for Protégé 3 and 4 shows a lack 
of stability in their versions, with many releases within a short time. Protégé 
3.4.1 was the most stable recent frames-based version of Protégé available at 
the time and did not require the use of encoding to create an ontology.  
 
Protégé 3.4.1 utilises an object-oriented way of thinking, where properties are 
subordinate to classes and are modelled in terms of A has Property P. More 
recent versions of Protégé do not use slots and are more abstract, with 
properties being modelled independently of classes, but applied to domains 
and ranges (eg, a Domain of medication, a range of Disease). While the 
newer versions allow more flexibility, Protégé 3.4.1 is easier to learn. 
 
2.4.4  Evaluation of Ontologies 
 
As of 2004, there was no common methodology for evaluating ontologies 
(Gomez-Perez 2004). Rogers (2006) reviewed literature on quality assurance 
for ontologies and found four broad criteria for evaluation: philosophical 
validity, compliance with meta-ontological commitments, 'content correctness', 
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and fitness for purpose. These criteria were not applied all at the same time to 
any one ontology reviewed by Rogers, repeating the conclusion of Gomez-
Perez. Rogers commented that a perfect ontology might not be desirable, due 
to the increased likelihood of being overly complex. Five common evaluation 
criteria seemingly appropriate for biomedical ontologies, though also not 
necessarily consistently applied (Gruber 1993a) are: 
1) Consistency 
2) Completeness 
3) Expandability 
4) Conciseness 
5) Sensitiveness 
Consistency can be assessed by whether contradicting conclusions may be 
reached following the input of valid data. An ontology can be considered 
semantically complete (Gomez-Perez 1996) if: 
“(1) All that is supposed to be in the ontology is explicitly set out in it, 
or can be inferred using other definitions and axioms. 
(2) Each definition is complete. Semantic completeness of a definition 
refers to the degree to which the definitions in a user-
independent ontology cover the equivalent concepts in the real 
world. We determine the completeness of a definition by 
figuring out:  
a) what information the definition defines or does not explicitly define 
about the world; and  
 b) for all the information that is not explicitly defined, but 
required, we check if it can be inferred using other axioms and 
definitions. If it can be inferred, the definition is complete. 
Otherwise, it is incomplete.” 
 
An ontology is concise if it does not contain explicit redundancies and does 
not contain useless information. Expandability can be determined by the 
feasibility of adding new definitions to the ontology without interfering with the 
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other definitions. Sensitiveness refers to the impact of any changes to a 
definition after it has become linked to already-defined properties. 
 
Noy and Tu (2003) describe the development of ‘competency questions’ as 
part of the ontology design process. Competency questions are intended to 
test whether the ontology fulfills its intended purpose.  The types of questions 
that the ontology seeks to answer are shown in Chapter 5: Results: 
Evaluation (Section 5.6).  
 
Statistical metrics identify baseline information for the ontology, enabling 
others to compare ontology characteristics. These metrics may also be used 
to identify potential modelling deficiencies and/or completeness of the 
ontology. A class with only one direct subclass may be a sign of a modelling 
problem or that the ontology is not complete. More than a dozen subclasses 
for a given class indicate that additional intermediate categories may be 
necessary (Noy and McGuiness [2002]). Recommended metrics to be 
calculated include (Musen, et al. 2012): 
Number of classes 
Number of individuals 
Number of properties 
Maximum depth 
Maximum number of siblings 
Classes with a single subclass 
Classes with more than 25 subclasses 
Classes with no definition 
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These metrics will be explained in Chapter 5, Results: Evaluation. 
 
Noy et al. (2010) advocate for the use of social networking software, eg, 
BioPortal, in ontology development and implementation. BioPortal allows 
interested parties to comment on and reference components of ontologies. 
This supports the evaluation and maintenance of ontologies. Figure 2.2 shows 
how ontologies may be developed collaboratively through social networking 
and how this supports the evaluation process. Collaborative development,  
 
Figure 2.2 Ontology Lifecycle (Noy et al. 2010) 
using Protégé, leads to a requirements gathering and deployment in 
applications, including BioPortal, a social networking website, which serves as 
a forum for publishing and soliciting feedback. 
 
2.4.4.1 Justification of Selection of Evaluation Methodology 
 
This ontology was a pilot, with unknown outcomes. Therefore a range of 
evaluation techniques were considered appropriate. Commonly used 
evaluation criteria, competency questions specific to the ontology, metrics and 
seeking opinions of others were used to evaluate the ontology.  
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Gruber’s (1993a) five common  
 criteria of consistency, completeness, expandability, conciseness, and 
sensitiveness were chosen to evaluate this ontology, due to their widespread 
use as evaluation mechanisms for ontologies. Competency questions are 
important to assess whether the ontology achieved its intended purpose. 
Metrics recommended by the National Center for Biomedical Ontology 
(Musen et al.2012) were included as metrics, such as number of classes and 
subclasses can show that an ontology was warranted. An attempt was made 
to make the ontology publicly available for comment, as collaboration is 
recommended by Noy (et al. 2010) and suggestions from interested parties 
could be used to improve the ontology. 
 
2.5 Clinical Practice Guidelines  
2.5.1 Introduction and History 
 
Clinical practice guidelines (CPGs), produced by professional societies to 
advise clinicians on the diagnoses and/or treatment of medical conditions, are 
becoming increasingly popular as a tool for improving the quality of health 
care.  The United Kingdom's National Health Service requires Acute and 
Primary Care Trusts to report on compliance with clinical practice guidelines 
sanctioned by the National Institute for Health and Clinical Excellence (NICE).  
NICE's emphasis on cost-effectiveness has caused some drug companies to 
lower the cost of their drugs in the UK.  Other countries, eager to seek the 
same influence over drug companies, are investigating NICE as a model for 
disseminating and monitoring the use of clinical practice guidelines.  
Insurance companies in the United States are experimenting with monitoring 
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the use of clinical practice guidelines to justify reimbursement of medical 
costs.  Automated monitoring of compliance, via electronic health records, can 
be facilitated by the use of ontologies to assist with communication between 
electronic health records (EHRs) and reporting systems. 
 
 
Various levels of expectations for health care quality have existed for 
hundreds of years, including medical education and licensing. The origin of 
the first clinical practice guideline is open to debate. Weisz (2007) points out 
that professional societies in the United States have had more influence over 
practice standards than those in many other countries due to multiple factors, 
including the lack of a centralised healthcare system. The profile of public 
health services increased in the nineteenth century, largely due to efforts to 
contain communicable diseases. The American Academy of Pediatrics’ 1938 
production of immunisation guidelines for children served as a model for 
further guideline development in the United States. CPGs began to proliferate 
in the 1970’s, with global spread over the past two decades.  
 
CPGs are not a panacea.  It is important to remember that published 
guidelines may not include the most recent research and therefore be out of 
date. Efforts to address quality control issues in guideline selection and 
development have led to international collaboration. The Appraisal of 
Guidelines Research and Evaluation (AGREE) Instrument (AGREE Research 
Trust 2001) is now available in twenty languages.  Although the AGREE 
Instrument has been endorsed by the World Health Organisation, other quality 
control mechanisms are available.  The Guidelines International Network, a 
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community mostly based in European Countries, North America, and New 
Zealand, was founded in 2002 (Ollenschlager et al. 2004). 
 
2.5.2 Computer-Interpretable Guidelines (CIGs) 
2.5.2.1 Architecture 
 
Guideline modelling can be approached in different ways. The knowledge-
centric approach to computer-interpretable guidelines involves modelling 
guidelines so that they are compatible with related software, for example:  
search, display, and/or execution (Sonnenberg and Hagerty 2006). The 
document-centric approach views the original guideline format as the 
information base. This information is reformatted, for example into elements, 
and then tagged to work with related software. Some researchers are moving 
towards a hybrid approach of knowledge-centric and document-centric.  
 
Arden Syntax is an example of the document-centric approach to CIGs. Arden 
Syntax is made up of medical logic modules (MLMs) (Hripcsak 1994). Evoking 
events, logic, action, and data mapping are the primary components of the 
MLMs. Clinical events evoke the logic, which is evaluated by the syntax using 
true/false criteria. Medical criteria and algorithms are used to specify the logic. 
The logic is actioned when components are assessed to be true. In order for 
the MLMs to work properly, the terms used in the institution-specific records 
(eg, information from local software records) must be mapped to the terms 
used in the MLM. Arden Syntax has been integrated into other CIG systems 
Wang et al. 2004). 
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Guideline modelling ontologies support automated compliance monitoring by 
formulating time-based task networks of clinical actions and decisions (Peleg 
2011).  These ontologies express concepts, abstractions and relationships, 
with tools for linking to electronic medical records.   
 
Although there is no single process for developing CIGs, Figure 2.3 shows 
some of the steps likely to be included in a hybrid model for CIGs. The first 
step involves clinician development of sample clinical scenarios, including 
recommended actions. These may be informed by clinical guideline literature, 
which also informs the logic to be extracted from the scenarios. This logic is 
the second step. The third step involves the refinement of the logic into clinical 
concepts or terms. Steps four and five are interchangeable. One links the 
clinical concepts to detailed data model, which is informed by an abstraction 
of a medical record (eg, virtual medical record) and the other maps the clinical 
concepts to a standard terminology or reference terminology.  The mapping in 
the latter of these two steps creates a vocabulary inventory. The final step is 
the computer-interpretable guideline itself, an amalgamation of the other 
steps.  
guideline  2)  guideline 3)  concepts in  
literature     logic      guideline          virtual  
               medical 
               record 
1)  clinical   4-5 detailed            
  scenarios             data 
             model 
reference 
         terminology 
 
        4-5 vocabulary 
6)  guideline    guideline        inventory  
    knowledge    model   
    base 
 
Figure 2.3. Steps and external relationships in a hybrid approach to 
modeling clinical practice guidelines for integration into workflow. The 
arrows represent information flow. Adapted from Tu et al. (2004).  
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2.5.2.2 Status 
 
Recent review articles on computer-interpretable guidelines (Sonnenberg and 
Hagerty 2006, Peleg et al. 2003, Isern and Moreno 2008, Leong et al. 2007) 
cover different studies, have different objectives, and use different search 
strategies. Sonnenberg and Hagerty focussed on how guideline expression 
activities have influenced guideline implementation and support. Peleg and 
colleagues compared 8 components of the structure of 6 guideline expression 
models: Asbru, EON, GLIF, GUIDE, PRODIGY, and PROforma. Isern and 
Moreno (2008) analysed eight guideline execution projects, some of which 
include models covered by Peleg. Peleg’s KDOM mapper has potentially 
resolved EMR compatibility issues via SQL/GLEE translation (Peleg et al. 
2008). Leong et al. (2007) have identified many free and open source tools for 
improving CIG systems.  Anani et al. (2012) used graphical software (Visual 
Understanding Environment) as a step towards creating CIGs via openEHR, 
an open source electronic health records initiative. 
 
Van Wyk and Van Wijk (2002) suggest that systems may need to interface 
with multiple guidelines in order to handle multiple co-morbidities. A review by 
Peleg et al. (2003) indicates that some ontologies can handle this issue, eg, 
GLIF, PROforma, and EON. However, Weng et al. (2010) note that ad hoc 
expression languages, such as EON, usually cannot handle formulas for 
quality indicators when the formula involves a relationship between two 
variables, raising questions about the methodologies used in the research 
cited by Peleg and Weng’s research. 
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Isern and Moreno’s (2008) review indicated that UMLS is the most popular 
controlled vocabulary tool used with guideline execution engines. It should be 
noted that UMLS is not a controlled vocabulary in and of itself, but a tool to 
map between selected controlled vocabularies that are integrated into UMLS. 
Sonnenberg and Hagerty (2006) believe that UMLS is not suited to temporal 
issues in guideline implementation. Shahar et al. (2006) have developed a 
‘Spock module’ to handle temporal issues. 
 
Many researchers appear to favour SNOMED for mapping CPGs to a clinical 
terminology. An advantage to SNOMED over most other controlled 
vocabularies is that it can be post-coordinated (Hrabak et al. 2007), therefore 
more flexible and able to handle complex concepts. Table 2.1 exemplifies the 
need for a flexible terminology by showing an attempt to map a NICE 
Hypertension CPG to the International Classification for Primary Care, with 
notes expressing the need for a more comprehensive clinical terminology. 
Cuggia et al. (2007) note that SNOMED is more suited to handling symptoms 
than ICD-10 and that DRGs may facilitate tracking care given by different 
departments. SNOMED can also map to CPT. (Elkin and Brown 2002). 
Bhensky et al. (2011) note the importance of identifying the version of clinical 
terminologies used.  
Indicator ICPC Proc 
ICPC 
Diag 
1 
ICPC 
Diag 
2 
ICPC 
RFE 1 
ICPC 
RFE 2 Notes 
BP above 140/90 >1x K31, if 
positive 
then K50 
K86 K87 
  
ICPC Diag 1 or 2 
Lifestyle advice K45 K85 
    
Urine test for protein K35 K22 
   
Need separate spec for 
protein 
Blood test for 
cardiovascular risk 
K34, if 
positive 
then K50 
K22 
   
Need separate spec for 
blood plasma glucose, 
electrolytes, creatinine, 
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Indicator ICPC Proc 
ICPC 
Diag 
1 
ICPC 
Diag 
2 
ICPC 
RFE 1 
ICPC 
RFE 2 Notes 
serum total cholesterol and 
HDL cholesterol 
12-lead 
electrocardiography 
K42, if 
positive 
K50 
K22 
   
Need to specify persistent 
(min 2 visits) 160/100 or 
more OR persistent BP 
above 140/90 w/ 10-yr risk 
of CVD at 20% 
Urine test for diabetes T35 T89 T90 
  
Need to specify drug type 
criteria if positive 
Test for kidney disease U34 &/or 
U35 
U14 U14 
  
ICPC 1 and/or 2 
Test for Accelerated 
Hypertension 
K39, if 
positive 
then K67 
K87 
   
Need to spec 180/110. 
Papilloedema and/or 
retinal hemmorage 
 
F01 F75? 
  
Need to spec papilloedema, 
check non-contusion for F75 
Assess for possible 
phaeochromocytoma 
If positive 
then K67 
K88 N01 K04 A09 Doublecheck coding 
allowance for 01 for diag 
Annual review to 
discuss BP, lifestyle, 
meds 
K31 & 
K45, 
possibly 
K50 
     
 Table 2.1. NICE Guideline for Hypertension mapped to International 
Classification for Primary Care. 
 
Kumar et al. (2003) have managed to reduce number of semantic types in 
UMLS from 100 to 9. This is intended to facilitate mapping to tasks within 
guidelines. Very little follow-up work has been done to indicate the success of 
Kumar’s project. 
 
CIG research is still evolving. It is worth noting that NICE (2013) still offers a 
spreadsheet mechanism for monitoring compliance with clinical practice 
guidelines. Figure 2.4 shows a screen shot from the compliance monitoring 
spreadsheet, using hypertension as an example. An ontology for clinical 
practice guides has the potential to incorporate or replace this spreadsheet, 
with guideline concepts and electronic health record components mapping to 
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a detailed data model, as previously shown in Figure 2.3. 
 
Figure 2.4 Screen shot from NICE (2013) Electronic Audit Tool, with 
hypertension as an example. 
 
 
2.6 Quality Indicators 
 
2.6.1 Definition and Assessment 
 
Quality Indicators have been defined in Chapter 1 as measurable 
mechanisms for describing the structure, process or outcomes of care 
(Campbell et al. 2002, National Library of Medicine 1998).  Donabedian 
(1966) explains that outcomes are frequently used as indicators of quality of 
health care. He warns that criteria for a successful outcome must be chosen 
carefully and considered in context. Other factors besides medical care may 
affect outcomes. Large amounts of time must pass before the outcome of 
some health care is known. The reason for success or failure is generally not 
identified in the recording of an outcome. 
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Process of health care, such as justification of diagnoses and selection of 
therapy, is another criteria often measured with quality indicators. These 
measurements are less stable, but often more directly associated with quality 
of health care than outcomes. Standards are often used to measure quality of 
process. A third means of measuring quality indicators is through health care 
structure.  Structure can be assessed by examining the setting and equipment 
used in health care. A challenge with this method is that the relationship 
between structure and process is not always easy to define. 
 
 
2.6.2 History and Development  
 
While the US Joint Commission initially evaluated quality of health care 
through subjective peer review, they became more selective about evaluation 
criteria during the 1970’s and joined the Continuous Quality Improvement 
movement during the 1980’s (Luce et al. 1994). Mark Friedman’s early 
twenty-first century work on Results Based Accountability has influenced 
quality monitoring in the UK as well as the US (Pugh [2009?]). There are 
numerous quality initiatives in the UK, including Payment By Results, Quality 
and Outcomes Framework, and the Quality, Innovation, Productivity and 
Prevention programme. These initiatives will be described in this section. 
 
At the start of the twenty-first century, the NHS began to focus on audit of 
process and outcomes in healthcare monitoring (O’Connor and Neumann 
2006), incorporating the concept of ‘quality of life’ into outcomes. Prices for 
‘Healthcare Resource Groups’ or instances of similar treatment were initially 
priced on a national scale and reduced to elective care as of 2006. This 
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initiative was known as ‘Payment By Results’ and was still in use as of 2012. 
An overly bureaucratic organisation of the system, involving NHS Connecting 
for Health, the Department of Health and the Health and Social Care 
Information Centre, has led to crippling administrative costs and the 
temptation to reduce quality of care to compensate, in light of fixed tariffs. A 
2011 report by the UK Audit Commission notes that Trusts’ classification of 
inpatient care versus outpatient care has placed an extra burden on 
management time that could be better spent on improving patient care (Audit 
Commission 2011). 
 
A shift to implementing clinical care pathways and clinical practice guidelines 
is attempting to address some of the issues of the UK Payment By Results 
system (O’Connor and Neumann 2006). Trusts are currently not required to 
comply with the NHS Quality and Outcomes Framework (QOF), managed by 
the National Institute for Health and Clinical Excellence (BMA and NHS 
Employers 2012). However, the indicators, developed by NICE, are taken into 
consideration in contract negotiations between NHS Employers and the 
General Practitioners Committee and will be part of a more formal approach 
for NHS Commissioning in 2013 (Department of Health/NHS Finance and 
Operations 2011). The NHS uses QMAS (Quality Management and Analysis 
System) to record levels of compliance with QOF.  The recording takes place 
either manually or through data extraction from electronic health records.  
 
The business rules for recording compliance with QOF are primarily a 
formula:  
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“Each dataset and business rule contains the information 
required to identify those patients who are eligible for inclusion 
on the disease register, indicator denominator and the indicator 
numerator.  The denominator is made up of the patient 
population eligible for the care, as outlined in the indicator 
wording, and the numerator is the number of patients who have 
actually received the care.” (NHS Employers 2012)   
 
These rules are explained in more detail in the NHS Primary Care document, 
“Reading and Understanding the Dataset and Business Rules of the Quality 
and Outcomes Framework: A Guide” (Foskett-Tharby 2008).   
 
Below is an example of a quality indicator developed by NICE, followed by 
two examples of AMA's 2012 Physician Quality Reporting System Quality 
Measures developed in the US.  
  
 
 
 
 
 
1. Example of a quality indicator developed by NICE. 
 
 
 
 
 
 
 
 
 
 
2. 1st example of AMA's 2012 Physician Quality Reporting System Quality 
Measures. 
 
 
 
 
3. 2nd example of AMA's 2012 Physician Quality Reporting System Quality 
Measures. 
 
Cardiovascular NICE indicator NM07 QOF ID: CHD14: (NICE 2010a)  
“The percentage of patients with a history of myocardial infarction from 1 April 
2011 currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin 
or an alternative anti-platelet therapy, beta-blocker and statin (unless a 
contraindication or side effects are recorded)” 
US 2012 Physician Quality Indicator: 0070: 
“Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or 
Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular 
Systolic Dysfunction (LVSD) - Percentage of patients aged 18 years and 
older with a diagnosis of heart failure (HF) with a current or prior left 
ventricular ejection fraction (LVEF) < 40% who were prescribed ACE 
inhibitor or ARB therapy either within a 12 month period when seen in the 
outpatient setting or at each hospital discharge” 
US 2012 Physician Quality Indicator 0081: 
“Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior 
Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction 
(LVEF < 40%) - Percentage of patients aged 18 years and older with a 
diagnosis of coronary artery disease seen within a 12 month period who 
also have prior MI OR a current or prior LVEF < 40% who were prescribed 
beta-blocker therapy.” 
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3. 2nd example of AMA's 2012 Physician Quality Reporting System Quality 
Measures. 
 
A counterpart to QOF is the Quality, Innovation, Productivity and Prevention 
programme (QIPP), sponsored by the Department of Health and overseen by 
NHS Improvement. QIPP emphasises workstreams and value for money and 
includes acute care as well as some primary care (NHS Information Centre 
2009a).   
 
The NHS Information Centre appears to be taking a more centralised role in 
providing access to NHS quality indicators (NHS Information Centre 2012a). 
In 2008, NHS information Centre and Department of Health surveyed NHS 
preferred quality indicators from a collated set (NHS Information Centre 
2008).  The resulting list includes over 200 indicators from diverse sources, 
such as the Quality and Outcomes Framework, Commissioning Data Sets, 
Hospital Episode Statistics, and various national audit efforts. The indicators 
are intended to support quality control efforts, NHS commissioning and patient 
choice (Department of Health 2012a).  The indicators have a separate 
metadata system (NHS Information Centre 2009b) and lack the formal logic of 
an ontology.  This set of indicators presents a useful opportunity to study NHS 
quality indicator features, with the intention of facilitating the gathering of data 
via computer for quality monitoring. While progress has recently been made 
(Department of Health 2012b) towards defining relationships between quality 
indicators, this has not been presented in an ontology context and there is 
further work to be done, including identification of inclusion and exclusion 
criteria, and establishing relationships between indicators from different sets. 
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2.6.3 Computer Interpretable Quality Indicators 
 
Computer-based monitoring of quality indicators has traditionally been based 
on clinical coding.  O’Toole et al. (2005) used electronic health records to 
monitor compliance with cardiovascular measurement sets. A data warehouse 
was created, using ICD-9 codes from EHRs. SQL queries were used to 
summarise clinical information, with analysis and report generation contracted 
to a commercial vendor. Weiner et al. (2005) found that EHR-based 
calculation of quality indicators had less false positives than manual chart 
review. A US initiative (Executive Office of the President 2010) to increase 
use of EHRs has led to improvements in compatibility of healthcare quality 
indicators with EHRs.  
 
2.6.3.1 Data Sourcing 
 
Data for quality indicators may be sourced from different service provision 
areas (Kelly 2012), including: 
• Inpatient encounters 
• Outpatient encounters 
• Accident and Emergency encounters 
• General Practice consultations 
• Prescription events 
 
While some of these data sources have been centralised in the UK, General 
Practice (GP) consultations have not been centralised. Data currently must be 
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submitted by individual practices, using MIQUEST or other services. 
However, some NHS quality indicators have been found to be too complex to 
be written as a MIQUEST query (Morris et al. 2004). A General Practice 
Extraction Service is under development to attempt to centralise GP data 
collection (Kelly 2012). 
 
2.6.3.2 Use of Arden Syntax 
 
Jenders (2008) tested Arden Syntax, which uses Medical Logic Modules 
(MLMs), to assess computer interpretability for a set of quality indicators 
ACOVE (Assessing Care of Vulnerable Elders).  However, most MLMs, 
originally intended as automated single reminders, have been designed for 
the purpose of screening and prevention (Ohno-Machado et al. 1998).  The 
results of Jenders’ study showed promise, though sometimes showed only 
results of tests ordered, rather than the record that tests were ordered prior to 
showing results.    
 
2.6.3.3 An Ontology for Public Health Indicators 
 
Surján et al. (2004, 2006) attempted to create an ontology for public health 
quality indicators that would work across different sets of public health 
indicators.  They found semantic limitations in the Resource Description 
Framework backend for Protégé’s ontology editor and a need for integration 
of other domain ontologies, such as economic, social and environmental.  
Their model works better for some types of indicators than for others and is 
subject-specific to Public Health. While Public Health is a broad subject area, 
 70 
quality indicators used to assess public health issues may be limited in scope.  
Wynden et al. (2010) have developed a Health Ontology Mapper that is 
intended to support integrated data repositories. The Mapper emphasises 
clinical terminologies and is not specific to quality indicators. 
 
2.6.3.4 United States Quality Data Model 
 
The US National Quality Forum recently released a Quality Data Model, 
intended to organise clinical concepts in such a way as to facilitate 
communications with electronic health records and clinical information 
systems (Sheber 2012). Their model takes a knowledge-centric approach to 
US quality measures, requiring quality indicator developers to conform to the 
framework, which is based on data supplied in EHRs. It involved a large-scale 
effort, with funding from the US government and input from representative 
electronic health records vendors and insurance companies (National Quality 
Forum 2009). The Forum’s Health IT Expert Panel has also made 
recommendations as to which indicators should be used (National Quality 
Forum 2008), taking into consideration US priorities.    
   
2.6.3.5 Challenges for Computer-Interpretable Quality Indicators 
 
The development and implementation of computer interpretable quality 
indicators is still evolving (Thompson et al. 2012, Velamuri 2010, Moriarty et 
al. 2010). Issues with accuracy of electronic health records present a 
considerable challenge. The US Department of Health and Human Services 
(2012) has questioned the accuracy of hospitals’ and clinics’ self-reported 
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quality-monitoring data for the Centers for Medicare and Medicaid Services. 
Roth et al. (2009) rated accessibility of data in electronic health records for 
over 400 healthcare quality indicators. They identified the following challenges 
affecting automated health care quality indicator data extraction:  
• Temporal issues, such as retaining outdated data,  
• Duplicate data in multiple formats (eg, clinical coding vs 
free text),  
• Vague documentation of patient education,  
• Inaccurate medication lists,  
• Incomplete and outdated diagnoses,  
• Incomplete documentation in general (eg, blank data 
fields),  
• Inconsistent use of ‘Chief Complaint’ (suggests that 
automated quality monitoring may be more suitable for 
chronic conditions, which are easier to identify), and  
• Variation in EHR flexibility. 
 
Application of computer-interpretable quality indicators can be hampered by 
lack of available data in electronic health records (Roth et al. 2009). Inclusion 
criteria had to be simplified in Jenders’ application of Arden Syntax to quality 
indicators, due to lack of corresponding EHR data. The use of queries 
containing exclusion criteria raised the number of false positives in a study 
conducted by Baker et al. (2007). To address this issue, Persell et al. (2010) 
have suggested the inclusion of exceptions to quality indicators in the 
recording of normal clinical workflow. Persell’s (et al. 2010) solution focuses 
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on enabling EHRs to better supply data that may be related to exclusion 
criteria. An ontology for quality indicators that specifies inclusion and 
exclusion criteria will facilitate computerised recording of quality indicator data 
by supplying indicator elements that may be useful to query writers and others 
involved in quality monitoring, as well as developers of electronic health 
records. These elements will need to be available in electronic health records. 
The ontology can highlight information that is either vital to include in health 
records or warning indicator developers that indicators need to be worded in 
such a way that facilitates data extraction. This document-centric approach, 
described (Sonnenberg and Hagerty 2006) as using the original clinical 
guideline format as the information base for computerisation, applied to 
quality indicators in this case, is useful in that it does not require EHR 
compatibility. It is instead intended as a stage toward EHR compatibility. 
 
2.7 Summary 
 
This chapter has reviewed literature on the concept of health care quality, 
clinical practice guidelines and quality indicators, with respect to computer 
interpretability and underscored the need for the research proposed for this 
thesis. While much progress had been made regarding the development of 
ontologies for clinical practice guidelines, efforts to develop ontologies for 
health care quality indicators are in early stages. Apart from the US National 
Quality Forum, (2008, 2009, Sheber 2012), very little work appears in the 
literature showing that the limitations of reliance on formulas to calculate 
quality indicators have been addressed. These limitations include:  
1) Inadequate translation (Morris et al. 2004),  
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2) Increased false positives for exclusion criteria (Baker et al. 2007),  
3) Discouraging the addition of new criteria to quality indicators due to the 
need to rewrite formulas (Mabotuwana and Warren 2010),  
4) Missing clinical detail (Persell et al. 2010) 
5)  Inadequacy of relying on clinical coding (Benin et al. 2011). 
Identification of levels of indicator relationships can serve as a step towards 
repackaging formulas into reusable components, making it easier to tailor and 
revise queries.  
 
Some research described in this chapter (Surján 2004, 2006, Jenders 2008) 
has been specific to a particular area of healthcare, inviting exploration of 
attributes of a diverse set of quality indicators. This same research towards 
the development of computer-interpretable quality indicators (Surján 2004, 
2006, Jenders 2008) has shown a need to improve specification of inclusion 
and exclusion criteria, along with categorisation beyond screening and 
prevention. Jenders’ work with Arden Syntax (2008), appears limited in that 
Arden Syntax is most suited for the purpose of screening and prevention, 
while a large set of quality indicators may cover many more areas. It will be 
useful to apply the same Institute of Medicine categories used to describe this 
limitation of Arden Syntax (Ohno-Machado et al. 1998) to help justify the need 
for a separate ontology.  
 
Chan et al. (2010) note a need for research into attributes of quality indicators 
to support electronic health record compatibility. The National Quality Forum 
(2012a) has acknowledged that their selection of quality indicators is heavily 
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dependent on the ability of EHRs to supply data. Jenders’ use of Arden 
Syntax was also dependent on the ability of EHRs to supply data, as lack of 
data interfered with the development of queries for inclusion and exclusion 
criteria. Parsons et al. (2012) state that more studies are needed to specify 
which measures are best calculated using claims or administrative data or a 
combination of data sources. A smaller scale research project than that of the 
US could be used to inform similar projects in countries with less resources 
and different levels of EHR implementation than the US.  An ontology that is 
more flexible than the US framework will allow developers of indicators and 
indicator sets to work at a pace that suits local, regional or national priorities, 
resources and staffing. The next chapter will describe the method chosen for 
this research. 
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Chapter 3 Methodology 
3.1 Introduction 
 
This chapter will explain the method chosen for this research and how the 
research was produced. The aim of the project was to investigate whether the 
conceptualisation stage of ontology development for a large set of health care 
quality indicators can facilitate flexible specification of inclusion criteria, along 
with specification beyond screening and prevention and identification of levels 
of indicator relationships. Ontology development has been described as an 
iterative process and is necessarily exploratory when the domain contains 
uncertainties. (Sachs 2006). A modified version of an evolving prototype 
methodology, Methontology, was chosen for this project, as one of several 
methods for creating an ontology.  
 
The nine components of Methontology are: specification, knowledge 
acquisition, conceptualisation, formalisation, integration, implementation, 
documentation, evaluation and maintenance. Specification involves 
explaining the intended use of the ontology, along with the intended audience, 
and scope of terms to be represented. Knowledge Acquisition takes place 
during the specification process and may continue during other processes. 
Knowledge Acquisition often involves literature reviews and interviews.  
Conceptualisation is the informal representation of domain terms in the form 
of concepts, instances, verbs, relations, and properties. Formalisation uses 
frames-oriented or description logic systems to model the ontology. 
Integration attempts to address a common standard for ontologies, by 
incorporating definitions from other ontologies. Implementation occurs when 
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the ontology is translated into a formal language. Evaluation involves 
assessing the ontology for completeness, consistency and redundancy. 
Documentation entails the selection and organisation of documents 
produced during the entire process. 
 
Maintenance and implementation are not part of this development process, as 
this is a pilot ontology. Application of the other categories will be described in 
the chapter. Consistency, completeness, expandability, conciseness and 
sensitiveness are among the criteria used to evaluate the ontology.  
 
 
3.2 Application of Methontology 
 
3.2.1 Specification and Knowledge Acquisition 
 
Table 4.1 in Chapter 4 summarises the Specification for the proposed 
ontology. The ontology is intended to diminish workload for staff involved in 
quality monitoring by reducing duplication of effort required to calculate data 
for NHS healthcare quality indicators. The Knowledge Acquisition element, 
interpreted as acquiring knowledge relevant to development of the proposed 
ontology, is covered in Chapter 2, Literature Review, particularly 2.6.3.5, 
Challenges for Computer-interpretable Quality Indicators, Ontology 
Development Platforms and the Quality Indicator sections 2.4.3.5 and 2.6 and 
in 2.4.4,  Evaluation of Ontologies. Interviews, although sometimes used 
during the Knowledge Acquistion process in Methontology, can be vulnerable 
to bias and interpretation difficulties on the part of the interviewee. Interviews 
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were therefore excluded from the Knowledge Acquisition process for the 
development of this ontology. Interviews would be worth considering for future 
development of this ontology.   
 
3.2.2 Integration and Documentation 
 
The first modification to Methontology was due to exploratory work with an 
already developed ontology, GLIF (Guideline Interchange Format) (Peleg et 
al. 2004a), to ascertain whether a new ontology was indeed warranted. This 
modification can also be considered as part of an attempt to integrate other 
ontologies. GLIF was developed, in part to resolve software compatibility 
issues with Arden Syntax (Jenders 2008, Peleg et al. 2001). 
 
The following paragraphs describe the attempt to encode an endocrine 
indicator using GLIF, with encoding issues noted: 
 
The indicator selected for encoding was Endocrine, etc. Indicator (NICE 
2010b) NM14 QOF ID: DM26, which states: 
 
 
 
 
The indicator was identified by NICE as follows: 
NM14 QOF ID: DM26 
BMA/NHS Employers 
   
An attempt to encode the indicator, using GLIF, was documented as: 
 
   Has parts 
 
Patient State = Diabetes 
[The percentage of] patients with diabetes = Decision Step 
“The percentage of patients with diabetes in whom the last IFCC-HbA1c is 
59 mmol/mol (equivalent to HbA1c of 7.5% in DCCT values) or less (or 
equivalent test/reference range depending on local laboratory) in the 
preceding 15 months” 
 78 
Branches to: in whom the last IFCC-HbA1c is 59 mmol/mol (equivalent 
to HbA1c of 7.5% in DCCT values) or less (Decision) 
Which is Synchronized with: (or equivalent test/reference range 
depending on local laboratory) (Decision) 
in the preceding 15 months = Decision step 
 
Limited metadata and a lack of depth show this indicator is not compatible 
with GLIF. Individual authors for quality indicators are not specifically 
identified on the NICE website, although a referring link is given to National 
QOF Guidance, and a code, rather than mneumonic name is given. This limits 
the detail anticipated by the GLIF encoding methodology. Additionally, the 
above may conceivably simply be entered as eligibility criteria for a complex 
guideline. GLIF is intended to accommodate complex guidelines, with the 
ability to model events, logical criteria, and actions (Peleg 2001). Clinical 
practice guidelines are more complex than quality indicators (Walter 2004). 
GLIF was therefore ruled out as inappropriate.   
 
The attempt to encode a quality indicator with GLIF contributed to the 
intention that the newly developed ontology would emphasise eligibility 
criteria.   The goal of emphasising eligibility criteria was informed by Benin et 
al (2011) and modified to emphasise defining the target population, using 
inclusion/exclusion criteria.  Benin et al. (2011) suggest separating the target 
population from the monitored outcome during the ontology development 
process. A modified version of Benin’s method follows: 
Indicator Target Population (denominator) 
1) Create ontology that establishes target population.  
2) Determine if target population can also be identified using SNOMED-based 
or other administrative data source. 
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3) If Yes, continue with plan. If No, explore alternative mechanisms before 
continuing with plan. 
4) Identify target population using SNOMED-based or other administrative 
(eg, READ) or alternative data source. 
5) Create Venn diagram of the target populations identified. 
 
Indicator Outcome (numerator) 
1) Revise ontology to establish indicator outcome among those patients in the 
target population 
Although Benin’s principles cannot be tested for this ontology, due to lack of 
access to electronic health records, the principles have been kept in mind 
during the ontology development. 
 
The Integration, or the incorporation of definitions from other ontologies, has 
also been addressed in the ontology itself, by incorporating clinical codes and 
their corresponding terms from the Unified Medical Language System. 
Documentation is a focus of this chapter and also Tables 4.1, Ontology 
Specification, 4.2, Glossary of Terms, and 5.1, Number of Indicators by 
Institute of Medicine Purpose for Clinical Guidelines, and Appendices 2-8. 
 
Maintenance and Implementation are not part of this development process, 
as this is a pilot ontology. There is potential for further development and 
maintenance.  
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3.2.3 Conceptualisation 
 
Conceptual knowledge can be defined as “a combination of atomic units of 
information and meaningful relationships between those units” (McCormick 
1997). The Conceptualisation stage in Methontology involves the informal 
representation of domain terms in the form of concepts, instances, relations, 
and properties. Categorical sorting, repertory grid analysis and formal concept 
analysis are conceptualisation techniques selected for the development of this 
ontology. These techniques were chosen from Payne’s et al. (2007) literature 
review on conceptual knowledge acquisition. 
 
 
3.2.3.1 Conceptualisation Techniques Considered 
 
Payne et al. (2007) reviewed literature on conceptual knowledge acquisition, 
describing a taxonomy of knowledge acquisiton techniques with three main 
categories: Knowledge Unit Elicitation, Knowledge Relationship Elicitation and 
Combined Elicitation. Knowledge Unit Elicitation is very similar to the 
Knowledge Acquisition stage in Methontology, involving interviewing and/or 
observations. Knowledge Relationship Elicitation is similar to the 
Conceptualisation stage in Methontology, involving categorical sorting, 
repertory grid analysis and/or formal concept analysis. Combined Elicitation 
involves protocol analysis, discourse analysis, sub-language analysis, 
laddering and/or group techniques.   
 
Categorical sorting is useful for identifying relationships between units of 
information.  Categories are an important component of this ontology and 
 81 
similar to the concept of class, mentioned in repertory grid analysis.  
Repertory grid analysis involves setting up a table or grid, with units of 
information organised by class.  Classes of information units are created 
using the ontology development software, Protégé 3.4.1, chosen for this 
project. Formal concept analysis emphasises relationships between units of 
information, though in a more complex way, with entities and entity-attribute 
pairings. Formal concept analysis has been particularly popular with ontology 
developers (Cimiano et al. 2004, Payne et al. 2007).  
 
Protocol and discourse analyses are suited to problem-solving or reasoning 
and analysis of text or recorded speech. While some analysis of the text of the 
metadata for quality indicators  is applied during the development of this 
ontology, the analysis is used to highlight issues for ontology development, 
rather than integration into the ontology itself.   Sub-language analysis is also 
text-based and often involves natural language processing, which is not part 
of this thesis, but may be worth considering in future quality indicator ontology 
research.  
 
Conceptual laddering is relational in nature, utilising tree structures and 
hierarchical relationships. Laddering could be useful to this ontology, though 
could be unwieldy to apply to a large set of quality indicators. Group 
techniques emphasise consensus and can be subject to bias if the power 
distribution between the parties involved is disparate. Group techniques would 
be appropriate to consider for formal implementation of this ontology. 
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3.2.3.2 Conceptualisation Applied to this Ontology 
 
Much of the conceptualisation for this ontology is described in Chapter 4, 
Results: Methontology Components and the Ontology. Specifically, 4.2, 
Conceptualisation, includes subsections 4.2.1, Glossary of Terms, 4.2.2.1, 
Indicators Categorised by Quality Indicator Dimensions and Next Stage 
Review Pathways, 4.2.3, Indicators listed by Institute of Medicine Purpose, 
with Related Indicators, 4.2.4, Inclusion and Exclusion Criteria, 4.4.3 Form 
Editing and Issues Log, 4.4.1.  
 
3.2.3.2.1 Appendix 2, the NHS HSCIC’s Metadata Headings list 
 
Section 4.2.1, Glossary of Terms, explains how the Glossary was created, 
with reference to the NHS HSCIC’s Metadata Headings list (Appendix 2) and 
its use as inspiration for the Glossary of Terms, the starting point for 
conceptualisation of the ontology. Definitions for the NHS HSCIC’s Metadata 
Headings list are available from the NHS Information Centre’s (2009b) 
Indicator Metadata Library Guide, along with clarifying information, such as 
purpose and examples. 
 
3.2.3.2.2 Appendix 3, Quality Indicator Dimensions and Next Stage Review 
Pathway 
 
Appendix 3 (Quality Indicator Dimensions and Next Stage Review Pathways), 
explained in 4.2.2.1, Indicators Categorised by Quality Indicator Dimensions 
and Next Stage Review Pathways, as part of the conceptualisation results, 
shows quality indicators grouped by dimension, clinical pathway, and source. 
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This information was taken from the metadata supplied by the NHS HSCIC for 
each indicator, with the source sometimes subjectively imputed by the 
researcher. This was due to variability in information supplied by the NHS 
HSCIC. Grouping indicators by dimension and clinical pathway shows a 
different conceptualisation for the indicators than the one provided by the 
NHS HSCIC because it shows a repertory grid analysis of the indicators, with 
dimension and clinical pathway applied as categories or classes. 
 
A Snapshot rule was created to address different status levels of the 
indicators when their metadata was entered into Appendix 3.  If an indicator 
had a status of Dropped at the time of recording metadata into Appendix 3, 
the instance was not entered into the ontology. If an indicator had a status of 
Dropped after it was recorded into Appendix 3, the indicator was entered as 
an instance into the ontology. If an indicator had a status of Replaced by, at 
the time of recording into Appendix 3, the indicator was not entered into the 
ontology. If an indicator had a status of Replaced by after recording the 
indicator into Appendix 3, it was entered into the ontology. 
 
3.2.3.2.3 Appendix 4, Indicators by US Institute of Medicine Purpose, with 
Related Indicators 
 
Appendix 4 categorises the indicators by US Institute of Medicine purpose 
(Field and Lohr 1992), along with related indicators and is explained in 4.2.3, 
Indicators listed by Institute of Medicine Purpose, with Related Indicators. This 
categorisation was subjectively determined by the researcher, using examples 
 84 
given by the IoM for guidance to assign purpose(s). It was not based on 
information supplied by the NHS HSCIC.   
 
A secondary purpose of Appendix 4 was to list broader, narrower and same 
level related indicators for each indicator indexed. This was accomplished by 
analysing words in the NHS HSCIC metadata for Definition and Title 
(renamed ‘Statement’ in this ontology) for each indicator. For example, it was 
determined that the indicator, CV34 (Statement = “ST-elevation myocardial 
infarction (STEMI) patients who received thrombolytic treatment within 60 
minutes of call”) is broader than indicator CV36 (Statement = “ST-elevation 
myocardial infarction (STEMI) patients who received thrombolytic treatment 
within 60 minutes of call, who [also] received primary angioplasty within 120 
minutes of call (call to balloon time)”) because CV36 includes the criteria 
specified for CV34, but includes additional criteria. Thus, CV 34 is broader 
than CV 36. 
 
3.2.3.2.4 Appendix 5, Inclusion and Exclusion Criteria 
 
Appendix 5, explained in 4.2.4, Inclusion and Exclusion Criteria, lists layers of 
inclusion and exclusion criteria for each indicator. Inclusion criteria were taken 
NHS HSCIC metadata for Definition and Title (renamed ‘Statement’ in this 
ontology). Exclusion criteria are taken from any field that mentions “excludes” 
or a similar word or phrase. Number of layers of criteria, including 
identification of phrases of relevant text, was subjectively determined by the 
researcher. The NHS HSCIC sometimes identified a numerator and 
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denominator in their metadata. This information, when made available, was 
taken into consideration by the researcher. 
 
3.2.3.2.5 Appendix 6, Issues Log 
 
Appendix 6 is an Issues Log, established by the researcher to track issues 
encountered during the ontology development process. Column headings 
include Date, Issue, Date Resolved, and How. Resolution of the issue is 
recorded in the ‘How’ column.  
 
3.2.4 Formalisation 
 
Formalisation has been addressed through the use of the Protégé platform 
for ontology development. Selection of the Protégé platform was influenced by 
the availability of instructional materials and its suitability for people new to 
ontology development. Selection of the platform for ontology development is 
explained in section 2.4.3.5.1, Justification of Selection of Protégé 3.4.1. 
Formalisation is also discussed in Chapter 4, section 4.4, Formalisation: The 
Ontology. Formalisation included the creation of classes and subclasses, 
along with slots and subslots (properties) of the classes and subclasses. 
 
When creating a new ontology in Protégé 3.4.1, the default screen has a 
Class Browser on the left side of the screen and a Class Editor on the right 
side. The researcher added new classes by clicking on the sun icon in the 
Class Browser and renaming the classes in the Class Editor, with definitions 
copied from the Glossary of Terms entered into the Documentation box in the 
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Class Editor. Constraints were kept to a minimum to keep the ontology 
flexible. Roles for each class were specified as concrete if they could be 
represented with instances. Roles were specified as abstract if they  could not 
be represented with direct instances. 
 
Slots were added for each class by clicking on the sun icon in the Template 
Slots section of the Class Editor or by clicking on the Slots tab towards the top 
of the screen, followed by the sun icon in the Slot Browser and using the Slot 
Editor to change the default name for each slot. Cardinality for each slot was 
specified as Multiple or Single, depending on whether more than one value 
could be entered for that slot. 
 
The Forms tab allowed the researcher to organise the slots in a logical order. 
By selecting a Display Slot of Unique Identifier for the Indicators class, the 
researcher enabled search results for queries of the finished ontology (using 
the Queries tab toward the top of the screen) to identify individual indicators. 
 
3.2.4.2.6 Appendix 7, Classes and Subclasses 
 
Appendix 7, explained in 4.4.1, Classes and Subclasses, shows the classes 
and subclasses of the ontology, along with their definitions. The classes and 
subclasses were identified from the initial Glossary of Terms, created at the 
beginning of the conceptualisation process for this ontology. Most of the 
definitions were taken from the NHS Information Centre for Health and Social 
Care’s Metadata Guide (2009b), from Darzi’s Next Stage Review (2008), by 
the US Medical Institute Purposes for Guidelines (Field and Lohr 1992). 
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Definitions for the Indicator class and Formula subclass, Inclusion/Exclusion 
Criteria, were created by the researcher.  
 
3.2.4.2.7 Appendix 8, Slots and Subslots 
 
Appendix 8, explained in 4.4.2, Slots and Subslots, shows the properties 
identified for the classes and subclasses. The slots and subslots for the 
Dimensions classes were taken from Darzi’s Next Stage Review (2008). The 
initial Glossary of Terms, created at the beginning of the conceptualisation 
process for this ontology and categories identified in the tables used to 
conceptualise the ontology were used to identify the other slots. Section 4.2.1, 
Glossary of Terms, shows which headings in the Glossary of Terms were 
sourced or modified from the NHS HSCIC and which headings were created 
by the researcher. Definitions for the slots were created by the researcher. 
 
3.2.5 Instances 
 
The process for populating Protégé with instances of the indicators involved 
copying and pasting metadata from the tables grouping related indicators 
together and listing inclusion and exclusion criteria (Appendices 3-5). The 
metadata was recorded into the slots for the class of Indicators. The Instance 
Editor was accessed by highlighting the word ‘Indicator’ in the Class Browser 
on the left side of the screen and clicking on the Instances tab towards the top 
of the screen. This resulted in a display of slots previously created by the 
researcher for the class of Indicators. 
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Instances were not recorded for the other classes in the ontology, due to time 
constraints and the priority of making related components of indicators 
searchable. Metadata was not recorded for slots with no values and 
consistently not recorded for the Version slot, as information regarding 
indicator version was rarely available and deemed low priority for a pilot 
ontology. 
 
3.3 Summary 
 
This chapter has described the methodology used for this research. 
Methontology was identified as the preferred method, along with Protégé 
3.4.1 as the preferred development platform. The project specification was 
introduced, including the intended use, intended audience, and scope of 
terms. Application of Methontology components during this project was 
explained. The creation of Appendices 3-8 was described, with Appendix 2 
noted as inspiration for the Glossary of Terms. The next two chapters review 
the results of this research. 
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Chapter 4 - Results: Methontology Components and 
the Ontology 
 
This chapter presents the results of the development of the ontology, using 
Methontology. The results of the specification, knowledge acquisition, 
conceptualisation, formalisation, integration and documentation components 
of Methontology, used to develop the ontology, are summarised, with the 
evaluation component described in Chapter 5. The aim of the project was to 
develop a pilot ontology that specifies inclusion and exclusion criteria, along 
with relationships between quality indicators and categorisation of indicators 
by Institute of Medicine (Field and Lohr 1992) purpose.  
 
Table 4.1 shows the Specification for the ontology. Developed as part of the 
Conceptualisation process, a Glossary of Terms defines the initial metadata 
for individual indicators (Table 4.2).  Table 4.3, created by the NHS 
Information Centre (2009a) and included to show the context for developing 
Appendix 3 (Quality Indicator Dimensions and Next Stage Review Pathways), 
shows numbers of indicators for pathways and associated dimensions. 
Appendix 3 shows quality indicator listed by dimension, clinical pathway, and 
source. Appendix 4 categorises the indicators by type and purpose, along with 
related indicators. Appendix 5 lists layers of inclusion and exclusion criteria for 
each indicator. Formalisation, the creation of the ontology itself, is described 
in Section 4.4. The resulting ontology, made available in Appendix 9, is a 
mechanism for finding common components of healthcare quality indicators 
from different sources. 
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4.1 Specification and Knowledge Acquisition 
The Specification, shown in Table 4.1, notes that the ontology is intended to 
diminish workload for staff involved in quality-monitoring by reducing 
duplication of effort required to calculate data for NHS healthcare quality 
indicators. The intended audience includes: Clinical auditing communities, 
quality indicator developers, organisers of quality indicator sets and providers 
of access to quality indicator sets. The scope of terms includes: Public Health 
Indicators, GP Practice indicators, Commissioning indicators, Acute care 
indicators, Inclusion and exclusion criteria, Numbers and percentages, and 
Physical and mental symptoms. 
 
Intended 
use 
Replacement of tailored queries for quality indicators with 
searchable, reusable components  
Intended 
audience 
Clinical auditing communities, Quality indicator developers, 
Organisers of quality indicator sets, Providers of access to 
quality indicator sets 
Scope of 
terms 
Public Health Indicators, including those from the Compendium 
of Population Health Indicators and the Local Basket of 
Inequalities Indicators 
GP Practice indicators 
Commissioning indicators, including the NHS Outcomes 
Framework 
Acute care indicators, including the Summary Hospital-level 
Mortality Indicator 
Inclusion and exclusion criteria 
Numbers and percentages, including age, dates, dosages and 
test results 
Physical and mental symptoms 
Table 4.1. Ontology Specification 
The Knowledge Acquisition element, interpreted as acquiring knowledge 
relevant to development of the proposed ontology, is covered in the Chapter 
2, Literature Review, particularly 2.4.3.5, Ontology Development Platforms, 
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and the Computer-interpretable Quality Indicator section 2.6.3 and Summary 
2.7 and in 2.4.4,  Evaluation of Ontologies in Chapter 2. The Knowledge 
Acquisition element showed that computer-interpretable quality indicators are 
in very early stages, with interoperability a key concern. 
 
4.2 Conceptualisation  
 
Conceptualisation involved the informal representation of domain terms in the 
form of concepts, instances, relations, and properties. Following the 
development of a glossary of terms, the conceptualisation techniques of 
categorical sorting and repertory grid analysis were used to analyse 
relationships between classes of information. The categorical sorting and grid 
analysis took the form of tables, created in Microsoft Word.  
 
The categories of Clinical Pathway and Quality Dimension, along with 
Dimension and related sets chosen were based on Lord Darzi’s Next Stage 
Review (Darzi 2008), a vision for the NHS, collated from ten Strategic Health 
Authorities. The categories for Purpose were chosen from the [US} Institute of 
Medicine’s (Field and Lohr 1992) purposes listed for clinical practice 
guidelines. These were applied to the quality indicators selected for this 
project due to Ohno-Machado’s (et al. 1998) comment that Arden Syntax is 
best suited for Prevention and Screening guidelines. Arden Syntax was 
originally intended to facilitate computer-interpretable guidelines and was 
applied to quality indicators in 2008 (Jenders 2008). This is further explained 
in 4.2.3, Indicators listed by Institute of Medicine Type and Purpose 
Categories with Related Indicators, and discussed in 6.2.2.2, 
Conceptualisation: Categorisation of Indicators by Purpose. 
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4.2.1 Glossary of Terms 
 
The Methontology approach recommends development of a Glossary of 
Terms (Table 4.2). Appendix 2 shows the NHS Health and Social Care 
Information Centre (NHS HSCIC) Metadata Headings list, used to inspire the 
Glossary of Terms and the starting point for conceptualisation. As the list of 
indicators was supplied by the NHS HSCIC, it was deemed appropriate to 
consider the metadata headings used to describe the indicators by the NHS 
HSCIC for the glossary of terms. Definitions for the NHS HSCIC’s Metadata 
Headings list are available from the NHS Information Centre. (2009b) 
Indicator Metadata Library Guide, along with clarifying information such as 
purpose and examples.  
 
The headings selected from the NHS HSCIC were: Library Reference 
Number/Identifier (renamed ‘Unique Identifier’ as this metadata should not be 
duplicated), Source (renamed ‘Reference’ as ‘Source’ is ambiguous), Title 
(renamed ‘Statement’ as Titles are generally not duplicated in other types of 
metadata and in library catalogues), Calculation/Methodology/ Formula 
(renamed ‘Formula’ and used in a narrower context), URL (this is a 
modification of the NHS HSCIC’s ‘Accessibility’ heading, which refers to 
potentially unlimited published information relating to the indicator), Publisher, 
Version (renamed ‘Version History’), Other Related PI’s (renamed Relations) 
and Notes (with a slightly different definition).  
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The following headings were added to supplement those chosen from the 
NHS HSCIC list: Creator, Access Point, Clinical Terminology Code, 
Dimension, Next Stage Review Pathway and Purpose. Although the NHS 
HSCIC had a ‘Creator/Producer’ heading, this referred to the party 
responsible for providing the outcome data for the indicator, rather than the 
creator of the indicator formula, methodology or intent. Access Point was 
added, due to the intended audience including clinical auditing communities 
and providers of access to indicator data sets. Clinical Terminology Code was 
added because clinical codes can assist with sourcing data for indicator 
outcomes. Dimension, Next Stage Review Pathway and Purpose were added 
to assist with categorical sorting and grid analysis and to support the 
objectives of this research. 
 
Term Explanation 
Unique Identifier Unambiguous reference number or string of letters and/or 
numbers  
Reference The source from which the indicator has been derived; normally 
the dataset applied [Referred to as ‘Source’ in IC Metadata 
Guide] 
Statement A sentence or paragraph clearly describing what is being 
measured [Referred to as ‘Title’ in NHS IC Metadata Guide] 
Formula Formula for determining indicator data result 
Creator Developer of the indicator content [NHS IC definition differs in 
that it refers to the party responsible for creating the data 
requested by the indicator] 
Publisher Party or parties responsible for making indicator available 
Version History Record of revisions to the indicator 
Access Point Location(s) of results 
Relations Other indicators which may need to be considered in 
conjunction with this indicator and vice versa 
Clinical Terminology 
Code 
The clinical term or terms used to source data to calculate the 
indicator, along with the corresponding codes  
URL URL with the most detail about methodology 
Dimension Three dimensions, identified from a collated vision from ten 
NHS Strategic Health Authorities (Darzi 2008): 
1) Effectiveness 
2) Safety 
3) Patient Experience 
Next Stage Review Eight priority clinical areas, also known as pathways, identified 
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Pathway in a collated vision from ten NHS Strategic Health Authorities 
(Darzi 2008) :  
1) staying healthy 
2) maternity and newborn care 
3) children and young people 
4) mental health 
5) long-term conditions 
6) planned care 
7) acute care 
8) end of life care 
Purpose The Institute of Medicine (Field and Lohr 1992) purposes 
[intended for clinical practice guidelines, but applied here to 
quality indicators]: 
Screening and prevention 
Diagnosis and prediagnosis management of patients 
Indications for use of surgical procedures 
Appropriate use of specific technologies and tests as part of 
clinical care 
Indicators for care of clinical conditions 
Notes Miscellaneous information to support the organisation and 
referencing of quality indicators. 
 
Table 4.2. Glossary of Terms. The majority of the terms have been sourced 
or modified from the NHS Information Centre’s Metadata Guide (NHS 
Information Centre 2009b).  The original Metadata Guide list of terms appears 
in Appendix 2. 
 
4.2.2 Quality Indicator Dimensions and Next Stage Review 
Pathways 
 
In 2008, Professor the Lord Darzi of Denham KBE published a collated vision 
for the NHS from ten Strategic Health Authorities (Darzi 2008).  The Strategic 
Health Authorities were asked to focus on eight clinical areas, also known as 
pathways. They include: Acute Care, Children’s Health, End of Life Care, 
Learning Disabilities, Long Term Conditions, Maternity and Newborn, Mental 
Health, Other, Planned Care and Staying Healthy. Darzi identified three broad 
dimensions, Effectiveness, Safety and Experience, to categorise the eight 
clinical areas. The NHS Information Centre has indicated the Next Stage 
Review Pathway for each indicator in their 2009 list, along with which of the 
three dimensions identified in Lord Darzi‘s highly cited paper (2008) applies to 
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the indicator. Table 4.3, created by the NHS Information Centre (2009a), 
shows number of indicators in the each Next Stage Review Pathway and their 
related Dimensions. Although the indicators themselves are not identified in 
this table, it is a useful summary of the totals for the dimensions within each 
pathway.   
Pathway
 
Quality Dimension
 
  Safety  Effectiveness  Experience  
Acute Care  18   
Children's Health  5   
End of Life Care  3   
Learning disabilities  1   
Long Term Conditions  45  1  
Maternity and Newborn  3   
Mental Health 3  11   
Other  4  28  
Planned Care 8  91  29  
Staying Healthy  3   
Table 4.3. Numbers of Indicators for Pathways and Associated 
Dimensions. (NHS Information Centre 2009a). 
 
 
4.2.2.1 Indicators Categorised by Quality Indicator Dimensions and 
Next Stage Review Pathways 
 
Appendix 3 shows the indicators grouped by their respective Dimensions and 
Next Stage Review Pathways. While the NHS HSCIC listed the Next Stage 
Review (Darzi 2008) Dimension and Clinical Pathway for each indicator and 
created a table showing the number of indicators for each Dimension and 
Clinical Pathway, they did not create a table showing which indicators were 
assigned to each area and grouping these indicators together. Such a table is 
useful to the conceptualisation process because it shows how different 
indicators, including indicators from different sources, are related. 
 96 
 
4.2.3  Indicators listed by Institute of Medicine Purpose, with 
Related Indicators  
 
Appendix 4, Indicators listed by Institute of Medicine Type and Purpose 
Categories, with Related Indicators, is inspired by Ohno-Machado’s (et al. 
1998) comment that Arden Syntax is best suited for Prevention and Screening 
guidelines. The intention of Appendix 4 was to assess how many of the 2009 
list of indicators fit into the category of Prevention and Screening and are 
therefore suited to expression in Arden Syntax. A secondary purpose was to 
list broader, narrower and same level related indicators for each indicator 
indexed. The Institute of Medicine  purposes are described as follows: 
Screening and prevention: Eg, Vaccination for pregnant women 
who are planning international travel. 
Diagnosis and prediagnosis management of patients: Eg, 
Evaluation of chest pain in the emergency room.  
Indications for use of surgical procedures: Eg, Indications for 
carotid endarterectomy. 
Appropriate use of specific technologies and tests as part of 
clinical care: Eg, Use of autologous or donor blood for 
transfusions.  
Guidelines [Indicators for the purposes of this research] for 
care of clinical conditions: Eg, Management of patients following 
coronary-artery bypass graft. (Field and Lohr 1992) 
 
4.2.4 Inclusion and Exclusion Criteria 
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Appendix 5 lists inclusion and exclusion criteria for each indicator, taken from 
the NHS Information Centre’s Statement metadata. Boolean criteria are kept 
within the same level, unless they require additional, separate steps.  Number 
of layers vs number of concepts can sometimes be an issue, particularly with 
respect to patient experience indicators.   
 
Inclusion criteria are generally taken from the indicator Statement, for the 
sake of continuity and to keep excessive efforts required to pull formulaic 
detail from the metadata and from the referring links to a minimum. Exclusion 
criteria are taken from any field that mentions “excludes” or a similar word or 
phrase.   
 
 
4.3 Integration and Documentation  
 
The Integration, or the incorporation of definitions from other ontologies, has 
also been addressed in the ontology itself, by incorporating clinical codes and 
their corresponding terms from the Unified Medical Language System. Clinical 
Terminology Code is one of twenty-nine slots developed as part of the 
ontology (See 4.4.2, Slots and Subslots, and Appendix 8, Slots and Subslots). 
Because the attempt to apply GLIF, an ontology intended for computer-
interpretable guidelines, to a quality indicator showed that GLIF was overly 
complex for that indicator, no definitions were incorporated from GLIF. 
Additionally, the definitions for the classes in GLIF did not appear compatible 
with the classes determined from the NHS Information Centre for Health and 
Social Care’s Metadata Guide (2009b). The definitions ruled out from GLIF 
were: 
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The Decision_Step class represents decision points in the 
guideline. A hierarchy of decision classes provides the ability to 
represent different decision models.  
The Action_Step class is used for modelling actions to be 
performed. Action steps contain tasks. Two distinct types of tasks 
can be modeled: medically oriented actions such as a 
recommendation for a particular course of treatment, and 
programming-oriented actions such as retrieving data from an 
electronic patient record. Nesting of steps, discussed in Section 8, 
allows recursive specification of actions and decision. In other 
words, through nested steps, one can specify details of high-level 
actions and decisions as subguidelines.  
The Branch_Step and Synchronization_Step allow modelling of 
multiple simultaneous paths through the guideline.  
Patient_State_Steps serve as entry points into the guideline as 
well as allow for labeling patient states (e.g., a state of taking one 
anti-hypertensive drug). (Peleg 2004b)  
 
Documentation of each of the Methontology steps applied is a focus of much 
of this thesis, including selection and organisation of chapters, figures, tables 
and appendices. The following components of Methontology were not used 
for this research: Implementation and Maintenance. Formalisation will be 
described in the next section of this chapter. Evaluation will be described in 
Chapter 5. 
4.4 Formalisation: The Ontology 
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The ontology was developed using Protégé 3.4.1 as a platform. Classes of 
Dimension, Next Stage Review Pathway, Indicator and Purpose were created, 
with Subclasses shown in Figure 4.1, as viewed via the publicly available 
National Center for Biomedical Ontologies website, (Musen et al. 2012). The 
ontology itself is on a CD attached to the end of this thesis. Appendix 9 
explains how to access the ontology. The explanation also appears at the end 
of this chapter. 
 
Figure 4.1. Ontology Classes and Subclasses. 
 
4.4.1 Classes and Subclasses 
 
The Classes and Subclasses, along with their definitions, are shown in 
Appendix 7.  Definitions were inspired by the NHS Information Centre for 
Health and Social Care’s Metadata Guide (2009b), from Darzi’s Next Stage 
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Review (2008), by the US Medical Institute Purposes for Guidelines (Field and 
Lohr 1992) and by the Anglo-American cataloguing rules (American Library 
Association et al. 2012). Cataloguing, a technique for creating or improving 
access to information and principle focus of Library Science, can be applied to 
metadata regarding digital and non-digital information resources to facilitate 
organisation and access. 
 
4.4.2 Slots and Subslots  
 
Following creation of classes and subclasses, thirty slots (properties) and nine 
subslots were created and assigned to the classes and/or subclasses. The 
Indicators class was assigned twenty-nine slots. The Dimension subclass of 
Effectiveness was assigned four slots. The Dimension subclass of Patient 
Experience was assigned three slots. The Dimension subclass of Safety was 
assigned three slots. The slots, organised by their assigned class or subclass, 
are defined in Appendix 8. 
 
4.4.3 Form Editing and Issues Log  
 
Form editing was limited to the Indicators class, as the time required to enter 
instances of the Indicators led to the slots for the other classes receiving low 
priority. Figures 4.2 and 4.3 show two screen shots for the Indicators Form.  
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Figure 4.2. First part of the form to enter Instances of the Indicators in 
Protege. 
 
 
Figure 4.3. Second part of the form to enter Instances of the Indicators 
in Protege. 
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An Issues Log (Appendix 6) was created to track problems with using Protege 
and with the ontology development. This log shows the date the issue was 
discovered, a description of the issue, the date the issue was resolved, and 
how the issue was resolved 
4.4.4 Instances 
 
 Following creation of the ontology framework of classes, subclasses, slots, 
subslots and forms, instances of the quality indicators were entered into the 
ontology.  This involved entering metadata supplied by the NHS IC for each 
indicator into the forms. Appendices 3-5 were used to categorise relevant 
metadata from the NHS IC. The categorisation supported entry of instances. 
   
4.4.5 The Ontology 
 
The ontology is object-oriented, where properties are subordinate to classes 
and are modelled in terms of class A has Property (slot) P. Queries are used 
to gather information from the ontology, making it useful to clinical auditing 
communities, quality indicator developers, organisers of quality indicator sets 
and providers of access to quality indicator sets to reduce effort involved in 
healthcare quality monitoring. Clinical auditing communities, organisers of 
quality indicator sets and providers of access to quality indicator sets can 
search for quality indicators with common criteria, even though they are from 
different sources. Quality indicator developers may learn from the ontology by 
noting areas that could be simplified through more easily accessible and/or 
clearer metadata. 
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The software used to develop the ontology, Protégé 3.4.1, is freely available 
(Stanford Center for Biomedical Informatics Research 2014b). Although 
Protégé 3.4.1 is easy to learn, the resulting ontology could not be saved as a 
simple file.  An attempt was made to make the ontology publicly available on 
the Internet via the National Center for Biomedical Ontologies website (Musen 
et al. 2012).  The result was limited to a view of classes and subclasses, 
which has since disappeared from the website.  
 
The ontology can be found in the CD attached to the back of this thesis. The 
user will need to install Protégé Frames 3.4.1 (Stanford Center for Biomedical 
Informatics Research 2014b). After installing Protégé 3.4.1, ask it to open a 
project.  The attached CD will need to have been inserted into the computer’s 
CD drive. Select Open Other, then the Pilot Ontology folder and the 
Protégé 3.4.1 folder. Then select the NHS Quality Indicators Ontology pprj 
file. 
 
Once you have opened the ontology, click cancel on the pop-up window that 
asks you to Choose an associated ChAO. Then click Close on the pop-up 
window that says No ChAO. The default screen shows the classes in the left 
frame. Click the triangle next to each class to view subclasses. There are 
tabs towards the top of the screen, above the frames, to view Slots, Forms, 
Instances and Queries. Subslots can be viewed if a triangle is to the left.  
 
Instances have been entered for the Indicators class. Click on Indicator in 
the left frame and an Instance Browser frame will appear in the middle of the 
screen, showing unique identifiers for all 222 indicators. Click on one of the 
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unique identifiers and its properties (slots) will appear in the right-hand 
frame, including relationships to other indicators. 
 
End users involved in monitoring healthcare, will find the Queries window 
most useful, to search for quality indicators from different sources that 
have common criteria. After clicking on the Queries tab, three frames will 
appear: the Query frame, The Results frame and the Query Library frame. 
The upper left frame is the Query frame, where the query is entered, with 
sections to specify a class, slot and string. To add a class, click on the box 
icon with a plus sign above the text box under the word ‘Class’. Select the 
Indicator class. To add a slot, click on the box icon with a plus sign above the 
white space under the word ‘Slot’. Classes and slots must be specified before 
entering the desired string, so that Protégé knows where to look. The desired 
string may be typed directly in the text box. Classes and slots may be 
removed from the query by clicking the box with the minus sign above the 
Class and Slot text boxes. Clicking the magnifying glass icon above the Class 
and Slot text boxes results in a pop-up window with descriptive information for 
the class or slot selected. The query operator, ‘contains’ may be changed by 
clicking the down-arrow next to the term. Other options include: ‘does not 
contain’, ‘ is’, ‘is not’, ‘begins with’, and ‘ends with’. Click on the Find 
button, in the bottom right corner of the Query frame to run the query.  For 
example, Figure 4.4 shows a query for the term ‘blood’ in the Formula slot of 
the Indicators class. The Results frame shows a list of indicators with the 
word ‘blood’ in their formulae. Double-clicking on an indicator in the results list 
will call up a pop-up window, with information about the indicator. 
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Figure 4.4. Query for Indicators with the Term ‘Blood’ in the Formula 
Slot. 
 
Multi-part queries (eg, two terms, two different classes or two different slots) 
may be entered by clicking the More button in the bottom left section of the 
Queries frame. Queries may be saved by entering a title under Query Name 
in the Query Library frame towards the bottom left of the screen and clicking 
the Add to the Query Library button towards the bottom right of the Query 
Library frame. 
 
 
4.5 Summary 
 
This chapter has presented the results of the application of Methontology to 
develop a pilot ontology for the 2009 set of healthcare quality indicators 
provided by the NHS Information Centre (2009a). An attempt was made to 
specify inclusion and exclusion criteria, along with relationships between 
quality indicators and categorisation of indicators by Institute of Medicine 
(Field and Lohr 1992) purpose. Conceptualisation was the primary component 
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of preparation for development of the ontology itself. A Glossary of Terms was 
created to support identification of the metadata for individual indicators.  
Quality indicator dimensions and pathways, categorisation of the indicators by 
type and purpose, along with related indicators; and layers of inclusion and 
exclusion criteria for each indicator were noted as tables in appendices in this 
thesis. The formalisation of the ontology involved creating classes, slots, 
instances and test queries, using Protégé 3.4.1. Use of the ontology, including 
searching for indicators with common criteria has been described. The next 
chapter continues the results of the ontology development in the form of 
evaluation. 
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Chapter 5 Results: Evaluation 
 
This chapter covers the evaluation of the ontology. Five common evaluation 
criteria (Gruber 1993a) are applied, including consistency, completeness, 
expandability, conciseness, and sensitiveness. Competency questions, to 
assess whether the ontology achieves its intended purpose, are answered. 
Metrics described by the US National Center for Biomedical Ontology (Musen 
et al. 2012) are calculated. The ontology was made publicly available for 
comment. Experts were contacted to review the ontology and stakeholders 
were consulted regarding the usefulness of this research. 
 
 
5.1. Consistency 
 
Consistency, with respect to ontology evaluation, refers to lack of conflict in 
definitions.  Appendix 7 shows the definitions for the classes and subclasses 
in the ontology. Appendix 8 shows the definitions for the slots and subslots. 
For example, the definition for the class of Dimension is “Aspect of quality; 
identified from Darzi’s (2008) UK Department of Health report, collating vision 
from 10 UK Strategic Health Authorities.” There is some inconsistency in the 
definitions, in that the definition for Formula is “Calculation methodology for 
determining indicator data result” and the definition for Inclusion/Exclusion 
Criteria, which is a subclass to Formula, is “The inclusion and exclusion 
criteria are generally taken from the indicator Statement, due to metadata 
inconsistencies.” Bearing in mind that the information for Formula is not 
always taken from the indicator Statement, there could be conflicting 
information, for example, more detail that could add to the criteria for 
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inclusion. Examples, rather than definitions, are given for the subclasses of 
the class, Purpose. This could potentially interfere with the consistency of the 
ontology. 
 
5.2 Completeness 
 
Completeness refers to the availability of information for definitions, whether 
this is explicit or inferred. This ontology is incomplete in that not all that is in 
the ontology is explicitly stated. Nor can the missing information necessarily 
be inferred from information that is included in the ontology. For example, the 
slot, Access Point, has a definition of “Location(s) of results of indicator 
assessment.”  This definition does not include all the possible locations of the 
results of indicator assessment. 
 
Completeness can also be assessed through development of competency 
questions as a frame of reference.  These questions should be designed to 
test whether the ontology fulfills its purpose.  Competency questions 
developed for this ontology are shown in 5.6. 
 
5.3 Expandability 
 
Expandability refers to whether new definitions may be added without 
compromising definitions that have already been created. New definitions may 
be added to this ontology.  However, classes, slots and instances may need 
to be reviewed to keep redundancy to a minimum and to identify any 
relationships. For example, definitions from GLIF were ruled out during the 
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Integration component of Methontology, due to appearing incompatible with 
definitions chosen from the NHS HSCIC’s Metadata Guide, US Institute of 
Medicine’s purposes for guidelines (Field and Lohr 1992) and Darzi’s Next 
Stage Review (2008). The ontology may require significant reorganisation to 
accommodate the following GLIF definition: “Patient_State_Steps serve as 
entry points into the guideline as well as allow for labeling patient states (e.g., 
a state of taking one anti-hypertensive drug) (Peleg 2004b).” If 
Patient_State_Steps becomes a slot, there would be redundancies with 
information entered for Inclusion/Exclusion criteria. A similar issue would arise 
with the incorporation of the GLIF definition: “The Action_Step class is used 
for modelling actions to be performed. Action steps contain tasks. Two distinct 
types of tasks can be modelled: medically oriented actions such as a 
recommendation for a particular course of treatment, and programming-
oriented actions such as retrieving data from an electronic patient record….” 
Again, there would be redundancies with Inclusion/Exclusion criteria. 
 
5.4 Conciseness 
 
Conciseness refers to whether the ontology provides useful and precise 
information.  Redundancies are allowed, provided they are necessary to the 
ontology. There are some redundancies in this ontology.  Next Stage Review 
Pathway, Dimension, and Purpose are all designated as classes as well as 
slots.  This was deemed necessary because although they are properties of 
Instances of the class Indicators, they are also primary concepts in the 
ontology, with subclasses in their own right.  While the Dimension subclasses 
 110 
have slots, they currently have no Instances and therefore their slots appear 
to have no use.  
 
5.5 Sensitiveness 
 
Sensitiveness refers to how small changes to a definition could alter 
properties that have already been specified. An ontology is said to be 
sensitive if its architecture might be altered with small changes to a definition. 
Changes to a definition after it has become linked to already-defined 
properties will require a review of relationships and inclusion/exclusion 
criteria. If the definition for Purpose is modified to encompass a different set of 
potential indicator purposes, for example the categories used by the US 
National Guideline Clearinghouse (see 6.2.2.2, Conceptualisation: 
Categorisation of Indicators by Purpose), the properties (slots) would need to 
be respecified. Therefore, this ontology has high sensitivity. 
 
5.6 Competency Questions 
 
The competency questions in this section are intended to show the types of 
questions this ontology seeks to answer and to confirm that it achieves its 
purpose. The purpose of this ontology is to support reduction/duplication of 
workload in gathering data for quality indicator monitoring. Additionally, the  
ontology is intended to answer the research questions asked in this thesis: 
1) What attributes of health care quality indicators influence the development 
of an ontology that emphasises specification of inclusion and exclusion 
criteria, along with specification beyond screening and prevention? 
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2) What relationships between health care quality indicators identify 
complexity of indicator relationships? 
Questions 5.6.1, 5.6.2 and 5.6.5 involve related indicators and are intended to 
address the second research question. Questions 5.6.3 and 5.6.4 and 5.6.6 
through 5.6.10 involve inclusion criteria, exclusion criteria, and indicator 
purposes, and are intended to address the first question. 
 
5.6.1 Which of this set of NHS healthcare quality indicators share 
some of the same criteria? 
 
The question may be answered by conducting a keyword query of the 
ontology, specifying a class of Indicators and a slot specific to the required 
criteria. For example, Figure 5.1 shows a query for indicators with the word 
blood in the slot Formula. Double-clicking on the name of an indicator in the 
Results frame causes a new window to pop up, with the full information on 
that indicator (Figure 5.2). 
 
Figure 5.1 Query for Indicators with the Term ‘Blood’ in the Formula 
Slot. 
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Figure 5.2. Pop-up Window for QOF CKD 3, one of 12 indicators listed in 
the results for the Query for Indicators with the Term ‘Blood’ in the 
Formula Slot. 
 
5.6.2 Which of this set of NHS healthcare quality indicators share 
broader or narrower criteria? 
 
The ontology is partially successful in answering this question. A query for 
each instance of the class Indicators for the Broader or Narrower Than slots 
may be created to find indicators that have broader or narrower criteria than 
the indicator specified in the query. There does not appear to be a Wildcard 
option in Protégé 3.4.1 to create a query to find all indicators with a particular 
slot that has information entered. To create a list of all indicators that have 
broader or narrower criteria than other indicators in the set, a query would 
need to be entered for each of the indicators. 
 
5.6.3 Which of this set of NHS healthcare quality indicators have 
inclusion criteria containing a particular term or set of terms?   
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This question can be answered by creating a query using key terms for the 
slot Inclusion Criteria Full for the Indicators class.  Figure 5.3 shows a sample 
query showing common inclusion criteria for cardiac infarction (STEMI) 
patients.  Figure 5.4 shows a sample query showing common inclusion criteria 
for thrombolytic treatment. 
 
 
Figure 5.3. Query showing common inclusion criteria for cardiac 
infarction (STEMI) patients. 
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Figure 5.4. Common inclusion criteria for indicators involving 
thrombolytic treatment. 
 
5.6.4 Which of this set of NHS healthcare quality indicators have 
exclusion criteria containing a particular term or set of terms? 
 
This question can be answered in a manner similar to 5.6.3, specifying 
Exclusion Criteria Full as the slot. 
 
5.6.5 How many of this set of NHS healthcare quality indicators are 
in a particular indicator set and in a particular care pathway? 
 
This question can be answered with two queries, linked using the More button 
below the query frame. Figure 5.5 shows a query for indicators with a 
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reference set from NICE that are in the Next Stage Review Pathway of 
Planned Care. 
 
Figure 5.5. Query for indicator sets from NICE that are in the Planned 
Care clinical pathway. 
 
5.6.6 How many indicators can be categorised by each Institute of 
Medicine purpose for clinical practice guidelines? 
 
This question is answered by creating separate queries for each Institute of 
Medicine category of purpose.  By querying the class of Indicator and Slot of 
Purpose, with a keyword of Screening, we find that there are 28 indicators in 
this set that have a common purpose of Screening and Prevention.  Figure 
5.6 shows the query and results. Figure 5.7 shows that there are twenty-one 
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indicators with a purpose of Diagnosis and Prediagnosis of Patients. Figure 
5.8 shows that there are four indicators with a purpose of Indications for the 
Use of Surgical Procedures. Figure 5.9 shows that there are twenty-five 
indicators with a purpose of Appropriate use of specific technologies and tests 
as part of clinical care. Figure 5.10 shows that there are 148  indicators with a 
purpose of Indicators for care of clinical conditions. 
 
Figure 5.6. Query for Indicators with a purpose of Screening and 
Prevention. 
 117 
 
Figure 5.7. Query for indicators for Diagnosis and Prediagnosis of 
Patients. 
 
 
Figure 5.8. Query for indicators with a purpose of Indications for the Use 
of Surgical Procedures. 
 118 
 
Figure 5.9. Query for indicators with a purpose of Appropriate use of 
specific technologies and tests as part of clinical care. 
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Figure 5.10. Query for indicators with a purpose of Indicators for care of 
clinical conditions. 
 
Table 5.1 summarises the Number of Indicators by Institute of Medicine (Field 
and Lohr 1992) Clinical Guideline Category.   
Category Number of 
indicators 
Prevention and Screening 28 
Diagnosis and prediagnosis management of patients 21 
Indications for use of surgical procedures 4 
Appropriate use of specific technologies and tests as part 
of clinical care 
25 
Indicators for care of clinical conditions 149 
Table 5.1. Number of Indicators by Institute of Medicine Clinical 
Guideline Category (Field and Lohr 1992) 
 
Six indicators shared joint IoM criteria, three of which paired Diagnosis and 
prediagnosis management of patients with Appropriate use of specific 
technologies and tests as part of clinical care. 
 
5.7 Metrics 
 
Calculations have been made for the following metrics for ontologies (Musen 
et al. 2012): number of classes, number of individuals, number of properties, 
maximum depth, maximum number of siblings, average number of siblings, 
classes with a single subclass, classes with more than 25 subclasses, classes 
with no definition. These statistical metrics (Noy and McGuiness [2002]) 
identify baseline information for the ontology, enabling others to compare 
ontology characteristics. These metrics may also be used to identify potential 
modelling deficiencies and/or completeness of the ontology.  
 
5.7.1 Number of classes  
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A class is “a concept in the domain of the ontology” (Musen et al. 2012). 
There are 4 classes, with 18 subclasses. These are listed in Appendix 7. 
 
5.7.2 Number of individuals  
Individuals are instances of each class. There are 222 individuals. 
 
5.7.3 Number of properties  
 
Properties are slots, including subslots. There are 39 properties. The slots 
and subslots are listed in Appendix 8, Slots and Subslots. 
 
5.7.4 Maximum depth  
 
Maximum depth refers to the maximum depth of the hierarchy tree of classes, 
subclasses, slots and subslots.  Parent-child type relationships are considered 
to measure depth of the hierarchy tree. There are 7 subslots for the slot, 
Inclusion/Exclusion Criteria. This is the maximum depth of this ontology. 
 
5.7.5 Maximum number of siblings 
 
Maximum number of siblings refers to the maximum number of siblings at one 
level in the hierarchy tree. This includes classes and subclasses, slots and 
subslots. There are a maximum of 17 subslot siblings for the class, Indicators. 
Most of these are assigned to different slots, which are all assigned to the 
Indicators class. 
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5.7.6 Classes with a single subclass 
 
A class, previously defined as “a concept in the domain of the ontology” 
(Musen et al. 2012), with only one direct subclass, is a sign there may be a 
modelling problem or that the ontology is not complete (Noy and McGuiness 
[2002]). There are no classes with a single subclass. 
 
5.7.7 Classes with more than 25 subclasses 
 
More than a dozen subclasses for a given class indicate that additional 
intermediate categories may be necessary (Noy and McGuiness [2002]). 
There are no classes with more than 25 subclasses. 
 
5.7.8 Classes with no definition 
 
Definitions for each of the classes are shown in Appendix 7, Classes and 
Subclasses. There are no classes with no definition. 
 
5.8 Public Availability, Stakeholder Consultation and Expert 
Review 
 
The ontology was made available for public comment at: 
http://bioportal.bioontology.org/ontologies/3243. No comments were received. 
A limitation of the public version of the ontology is that properties and 
instances are not displayed, leaving very little on which to comment.  It is 
noted that few, if any, comments were made on any of the ontologies 
available at the National Center for Biomedical Ontology (Musen 2012) 
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website and that access to the limited view of classes and subclasses for this 
ontology is no longer available. 
 
Stakeholders, including EHR vendors, NHS staff and representatives from 
NICE and the NHS HSCIC were consulted regarding the usefulness of the 
ontology. Two academic Health Informatics experts examined the ontology. 
Two EHR vendors expressed interested in the ontology. Both vendors have 
dashboard components in their software. At least one of the vendors currently 
emphasises clinical practice guidelines, rather than quality indicators, in their 
dashboard.  
 
A former NHS staff member, whose work had emphasised clinical 
governance, commented that the ontology could be very useful, as he had 
previously spent large amounts of time reading through full text 
documentation to ascertain necessary components for quality monitoring. A 
Director for the NHS South Commissioning Support Unit was more concerned 
with taking action over outcomes, rather finding and extracting data. Emails 
were sent to the NHS HSCIC and to NICE, requesting a discussion of the 
usefulness of this research. Although the email to the HSCIC was 
acknowledged, no discussion was scheduled. Academic experts in Health 
Informatics from Chile and the UK were willing to comment on the ontology. 
The Chilean expert gave similar feedback to the assessments made in 5.1 – 
5.5 in this chapter, including some concern regarding the overlap between 
slots and classes. The UK expert suggested that the number of slots could be 
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reduced and that perhaps the Indicators could be browsed in different ways 
and tailored to stakeholders.  
 
5.9 Evaluation Conclusions and Future Ontology 
Development 
 
Common evaluation criteria for ontologies appear heavily influenced by the 
platform chosen for ontology development and by the availability of metadata 
for conceptualisation. Protégé 3.4.1 allows designation of concepts to be slots 
as well as classes, thus allowing for redundancies and reducing conciseness. 
Instability of NHS information points interfered with completeness in that slot 
instances cannot be completely specified with any long-term certainty. 
 
The next step in development of this ontology would be to find more experts 
willing to comment on the ontology. Discussions with appropriate 
representatives from NHS healthcare stakeholders, particularly the NHS 
HSCIC, would benefit revision of the ontology. A more recent indicator set 
could be used for the next ontology and compared with the development of 
the ontology for the 2009 indicator set. 
 
5.10 Summary 
 
This chapter has presented an evaluation of the ontology including 
consistency, completeness, expandability, conciseness, and sensitiveness. 
Competency questions were answered. Metrics were calculated. The ontology 
was made publicly available for comment, stakeholders were consulted and 
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future opportunities for evaluation were discussed. The next chapter will offer 
a discussion of the ontology development process and of the ontology itself. 
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Chapter 6 Discussion 
 
This chapter provides a discussion of the ontology development process and 
the ontology itself. Included is a discussion of the purpose of the research, 
choice of indicator set, methodology and platform chosen to develop the 
ontology. Evaluation of the ontology and research limitations are also 
discussed in this chapter.  
 
6.1 Purpose of Research and Choice of Indicator Set 
 
Although the motivation was to create an ontology that can reduce duplication 
of effort in NHS healthcare quality monitoring, this research project was 
exploratory in nature, emphasising feasibility and underscored by the 
research questions stated in Chapter 1: 
1) What attributes of health care quality indicators influence the development 
of an ontology that emphasises specification of inclusion criteria, along with 
specification beyond screening and prevention? 
2) What relationships between health care quality indicators identify 
complexity of indicator relationships? 
 
The set of over 200 indicators was chosen to attempt to address some of the 
gaps in the research identified in Chapter 2’s literature review. The gaps 
included research on healthcare quality indicator purposes, an ontology for 
healthcare quality indicators that is not dependent on data available in EHRs, 
a healthcare quality indicator ontology that covers many clinical subject areas, 
and a healthcare quality indicator ontology that does not require indicator 
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developers to fit into a framework. The literature review found that, along with 
being data-dependent, Arden Syntax may be limited to the purpose of 
screening and prevention (Ohno-Machado et al. 1998). Arden Syntax 
(Jenders 2008) and Surján’s (et al. 2006) ontology for Public Health Indicators 
were applied to a subject-specific indicator set. The US Quality Data Model 
(2008) requires indicator developers to fit into a specified framework. 
 
6.2 Ontology Development Process 
 
6.2.1 Approach to Ontology Development 
 
Methontology was chosen as the method to develop the ontology. This 
evolving approach worked well. Iterative in nature, Methontology allowed 
scope for backtracking and exploratory work. The exception to the flexible 
application of this method was the Evaluation component. Much of the 
evaluation criteria, including metrics and competency questions, could not be 
properly applied until the ontology was considered complete, at a minimum of 
a pilot stage. This limited practical application of the Evaluation component of 
Methontology to primarily the end stage of the ontology development, rather 
than throughout the development lifecycle. 
 
6.2.2 Conceptualisation  
 
Conceptualisation played an important role in the identification of attributes 
and relationships of this set of quality indicators. The next four sections, 
6.2.2.1-6.2.2.4, describe the conceptualisation for indicator Dimension and 
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Next Stage Review Pathway, Purpose, Clinical Code, and Inclusion/Exclusion 
criteria. Indicator Purpose and Dimension and Next Stage Review Pathway 
were identified as both classes and slots in this ontology, due to their being 
properties of the indicators and their use to categorise the indicators. Clinical 
Code and Inclusion/Exclusion criteria were identified as properties of the 
indicators. While some of the slots assigned to the Indicators class, such as 
Unique Identifier, were easy to conceptualise, Clinical Code and 
Inclusion/Exclusion criteria were complex, with more options for organisation 
than other properties of the indicators.   
 
6.2.2.1 Conceptualisation: Dimensions and Next Stage Review 
Pathway 
 
The US Institute of Medicine’s highly cited “Crossing the Quality Chasm…” 
report (2001) specifies six domains of healthcare quality: safety, 
effectiveness, patient-centeredness, timeliness, efficiency, and equity.  The 
first three of these domains are the same as the dimensions specified in the 
Darzi report (2008) used by the NHS Information Centre to help categorise 
the 2009 set of indicators. The similarity between the IoM’s domains of 
healthcare quality and the UK domains supports the use of Darzi’s categories 
to classify the indicators. Darzi’s Dimensions are: Effectiveness, Safety and 
Experience. Darzi’s Pathways are: Acute Care, Children’s Health, End of Life 
Care, Learning Disabilities, Long Term Conditions, Maternity and Newborn, 
Mental Health, Other, Planned Care and Staying Healthy. 
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The number of indicators for the clinical pathways identified in Darzi’s Next 
Stage Review report (2008) were identified by the NHS IC in Table 4.3. A 
logical next step was to name the indicators in each of the pathways with a 
goal of making searching for indicators in a particular pathway possible in the 
ontology. Appendix 3 shows categorical sorting for the quality indicator 
Dimensions and Next Stage Review pathways for each indicator.  
 
6.2.2.2 Conceptualisation: Categorisation of Indicators by Purpose 
 
Appendix 4 classes the indicators by purpose, with a summary of the Institute 
of Medicine’s (IoM) purposes at the beginning of the appendix. Categorisation 
of the IoM (Field and Lohr 1992) purposes for guidelines to the set of 
indicators supported the hypothesis that Arden Syntax is inadequate to 
express different types of indicators. This categorisation showed that the most 
common purpose was indicators for the care of clinical conditions, rather than 
screening and prevention. Arden Syntax has been described as best suited 
for screening and prevention (Ohno-Machado et al. 1998). Indicators were 
indexed as specifically as possible in Appendix 4.  Where more specific 
categories would be possible had the information given been more specific 
(eg, treatment vs surgery), this has been noted (eg, WCC 2.25, Percentage of 
patients waiting no more than 31 days for cancer treatment) [Treatment not 
specific enough - could be surgery, radiotherapy or other]).  
 
Categorisation of the indicators also showed that their purposes are unevenly 
related. The broadest purpose is care of clinical conditions. Appropriate use of 
specific technologies and tests as part of clinical care is the second broadest 
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purpose. Screening and prevention, Diagnosis and prediagnosis management 
of patients and indications for use of surgical procedures are equally narrower 
than care of clinical conditions and appropriate use of specific technologies 
and tests as part of clinical care. Some indicators could be categorised with 
more than one purpose. Indicators with a purpose of diagnosis and 
prediagnosis management of patients that had more than one purpose were 
most often paired with appropriate use of technologies.  
 
Two other categorisation systems worth considering for future healthcare 
quality indicator ontologies include those developed by the US National 
Guideline Clearinghouse (Agency for Healthcare Research and Quality 
[2012]) and those developed by the US National Quality Forum (2012b).  The 
National Guideline Clearinghouse uses eleven categories, very similar to the 
IoM’s, though with more easily identifiable individual components, to descibe 
the major focus of guidelines. The nine categories relevant to quality 
indicators are: 
Assessment of Therapeutic Effectiveness 
Diagnosis 
Evaluation 
Management 
Prevention 
Rehabilitation 
Risk Assessment 
Technology Assessment 
Treatment 
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The National Guideline Clearinghouse categories were cited and expanded 
upon (Bernstam et al. 2000).  However, the additional proposed categories, 
Clinical Trial and Risk Assessment, seem unnecessary for quality indicators.  
Bernstam’s work was evaluated, concluding that 89 out of 100 National 
Guideline Clearinghouse guidelines could be classified within the same 
category (Bernstam et al. 2001). There is ongoing discussion of categorisation 
of quality indicators, along with the concern that if quality monitoring 
emphasises a particular area of quality monitoring, for example prevention 
and management of chronic disease, it may be to the detriment of other areas 
of quality monitoring, for example appropriate use of tests (Bishop 2013). 
Thus, both broad and narrow categories for healthcare quality indicators are 
advisable to provide an overview of the spread of areas of healthcare 
addressed by quality indicators. 
 
The National Quality Forum’s (2012b) Quality Data Model contains twenty-
seven categories. The categories tend to be more specific to information likely 
to be available in EHRs than the Institute of Medicine or National Guideline 
Clearinghouse categories. The categories include attributes such as 
‘Admission Date and Time’, ‘Dosage’ and ‘Severity’. There is some overlap in 
these categories, including ‘Radiation Dosage’, which is narrower than 
‘Dosage’. The National Quality Forum category of ‘Related To’ was identified 
as a property of indicators for this ontology. Some of the National Quality 
Forum categories could be used in combination with broader categories from 
the National Guideline Clearinghouse or the IoM. 
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6.2.2.3 Conceptualisation: Clinical Codes 
Clinical codes and their corresponding term(s), rather than NHS IC assigned 
Subject, were assigned to specify clinical components of the indicators.  The 
NHS IC assigned subjects appeared arbitrary and ranged from clinical 
conditions to quality indicator set (eg, World Class Commissioning).  Clinical 
areas were sometimes also covered under Topic, under the Planned Care 
element of the NSR Pathway within the NHS IC metadata scheme.  By using 
Clinical Code as a subject-related slot, the ontology may, in the future, be 
useful for some quality-monitoring via EHRs. Data quality and availability has 
been criticised as a challenge for quality-monitoring via EHRs (Roth et al. 
2009). 
6.2.2.4 Conceptualisation: Inclusion/Exclusion Criteria 
Relationships between indicators focussed primarily on relationships between 
inclusion criteria.  Boolean logic was inconsistently applied for layers of 
Inclusion/Exclusion criteria, when the term ‘or’ appeared between concepts. 
For example, CV38 has one inclusion layer of Cardiac Rehabilitation Audit 
and one layer of exclusion criteria:  
CV38 Inclusion Criteria 1) Submission of 20 cases or more 
per month OR more than 70% case 
ascertainment. 
CV38 Exclusion Criteria 1) Submission of less than 20 cases 
per month 
 
However, QOF STROKE 12 has four layers of inclusion criteria with a 
separate layer for one OR statement, but not another because both terms on 
either side of the word ‘or’ are tied to the same concept for one statement. Eg, 
A side effect may also be a contraindication. The other statement shows two 
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separate concepts on either side of the word ‘or’. Eg, ‘non-haemorrhagic is 
not the same as or similar to TIA.  
QOF STROKE 12 Inclusion Criteria 1) patients with a stroke 
 2) shown to be non-haemorrhagic, 
 3) or a history of TIA, 
 4) who have a record that an anti-
platelet agent (aspirin, clopidogrel, 
dipyridamole or a combination), or an 
anti-coagulant is being taken 
QOF STROKE 12  Exclusion criteria 1) unless a contraindication or side 
effects are recorded 
 
Semantics in the text of some of the indicators also influenced the number of 
layers of Inclusion/Exclusion criteria. There were sometimes more concepts 
than layers, due to the likelihood of concepts being likely to be grouped 
together. These dependencies were recorded at same level. For example, 
”the number of doctors washing their hands between seeing patients” shows a 
dependency between doctors and patients.  “Access to scanning within 3 
hours of admission” has two concepts that are recorded at same level 
because “within 3 hours of admission” must apply to scanning.  
 
Semantics of indicator text also resulted in temporal issues being recorded 
inconsistently in this pilot.  Levels of Inclusion/Exclusion criteria were recorded 
differently in the following two indicators, due to the use of parenthesis in the 
second indicator: 
QOF BP 4  
1) patients with hypertension  
2) in whom there is a record of the blood pressure  
3) in the previous 9 months 
QOF BP 5  
1) patients with hypertension  
2) in whom the last blood pressure (measured in the previous 9 months)  
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3) is 150/90 or less 
The record of blood pressure in QOF BP 4 appears less dependant on the 
date of measurement because the date range of measurement does not 
appear in parenthesis. QOF BP 5 notes that the last measurement must have 
occurred within the previous 9 months. This shows a greater dependency 
between the two concepts. 
 
6.2.3 Integration 
 
Integration of other ontologies included efforts to find relevant ontologies 
through literature searching and the National Center for Biomedical Ontology 
(Musen et al. 2012) website. UMLS was the most successful Integration 
component, though was not without challenges (see 6.2.4.1).  An attempt to 
apply GLIF, an ontology for clinical practice guidelines, to a quality indicator, 
was unsuccessful. A possible solution to increased slot redundancies with the 
incorporation of definitions from GLIF could be to incorporate Look-up tables 
linking Inclusion/Exclusion criteria to their respective Step in GLIF or to use a 
newer, more flexible version of Protégé (eg, Protégé 4). 
 
6.2.4 Formalisation 
 
Formalisation, the frames-based creation of the ontology, involved creating 
classes, slots, forms and instances, using Protégé 3.4.1. Categorical sorting 
and repertory grid analysis were used to identify the classes and subclasses 
listed in Appendix 7 and the relationship slots and subslots listed in Appendix 
8 (eg. Is Broader Than). The Glossary of Terms in Table 4.2, modified from 
the NHS Information Centre’s Metadata Guide (NHS Information Centre 
 134 
2009b), served as a starting point for the majority of slots and subslots. US 
Institute of Medicine Purpose for Guidelines (Field and Lohr 1992) and Lord 
Darzi’s (2008) Next Stage Review dimensions and clinical pathways were 
applied to both classes/subclasses and slots due to their being concepts 
within the healthcare domain as well as attributes of quality indicators. 
Formalisation of the ontology was largely dependent upon available metadata, 
as metadata about the indicators was needed to enter Instances into the 
ontology. Formalisation for the Clinical Codes, Inclusion/Exclusion Criteria, 
Formula, and Reference slots is discussed in 6.2.4.1 – 6.2.4.4. Formalisation 
for Instances of the indicators is discussed in 6.2.4.5. 
 
6.2.4.1 Formalisation: Clinical Codes 
 
Difficulties with clinical coding included lack of medical expertise, lack of 
UMLS expertise, duplicate concepts for codes from different sources in UMLS 
and the granularity of indicator text not always being at the same level as the 
text corresponding to the most relevant clinical code. For example, QOF DM 
23 included the phrase: “or equivalent test/reference range depending on 
local laboratory”. Some ranges specified in indicators did not show as an 
option in UMLS, requiring general codes that resulted in the same coding for 
different indicators For example,,  VSA09 had criteria of ‘aged 53-70. The 
code wound up being very broad, C0001779, ‘Age’, as there was no code 
specific to the age range, 53-70). 
 
In an attempt to comply with Bhensky’s et al. (2011) recommendation to 
identify the version of any clinical terminologies used, a subslot to Clinical 
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Code, Clinical Terminology Code Version, was created. This subslot had to be 
deleted, as its status as a subslot does not accomplish the task intended.  It 
inherited the superslot, but would not allow the user to attach a version. To 
identify terminology versions, the complete terminology for each coding 
system used would need to be integrated into the ontology, with a look-up 
feature.  Surján et al. (2006) also found semantic limitations using Protégé to 
develop an ontology for Public Health indicators. They were unable to 
distinguish between a person who has died and the person who certified the 
death in their ontology.  
 
6.2.4.2 Formalisation: Inclusion/Exclusion Criteria 
 
Inclusion/Exclusion Criteria needed to be layered from full to minimum instead 
of 1st layer, 2nd layer, etc. because slots and subslots include content of 
narrower slots. Additional slots for Number of Inclusion Criteria and Number of 
Exclusion Criteria were added to handle queries based on Inclusion/Exclusion 
criteria.  This was intended to compensate for backward nature of layers of 
criteria and to enable queries for related indicators to be structured from 
common and initial criteria inwards. Conceptually, the order for some levels of 
criteria sometimes mattered more than others. The reason for the concern 
was the ability to specify a particular layer of criteria, but not others. It was 
later decided that key-word searching the full set of layers would be sufficient. 
 
The NHS HSCIC metadata field that most frequently contained exclusion 
information was Definition. This is in contrast to the location of inclusion 
criteria, which appeared in more than one field. While some exclusion criteria 
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appear to have been inconsistently applied in the metadata supplied by the 
NHS IC, the information may be inferred in other indicators where the 
information is not explicitly stated. For example, CA01 has inclusion criteria of  
1) stroke patients  
2) given Aspirin or alternative e.g. clopidogrel,  
3) within 48 hours of stroke  
and  
exclusion criteria of:  
“patient is receiving palliative care, OR patient died OR patient has an 
intra-cerebral haemorrhage.”  
The first two exclusion criteria may be applicable to many of the other 
indicators, but are not necessarily stated in those indicators.  
 
Future versions of this ontology would benefit from development of rules or 
guidelines for specification of inclusion/exclusion criteria. This could at least 
partially address some of the semantic challenges in translating indicator text 
into ontology concepts. A smaller and/or more uniform indicator set would 
make it easier to identify inclusion criteria with greater accuracy, though would 
also defeat the purpose of this research. 
 
6.2.4.3 Formalisation: Formula 
 
While a referring URL was initially sometimes included in the ontology for the 
Formula slot, if a referring URL was supplied as the metadata for Formula by 
the NHS IC, this was later changed to the text from a slot with relevant text 
(eg, QOF PC2, “The practice has regular (at least 3 monthly) multidisciplinary 
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case review meetings where all patients on the palliative care register are 
discussed”). The variability in the source of information for what the NHS IC 
refers to as ‘Formula/Calculation/Methodology’ may be due to some indicators 
being calculated as fractional formulae and some indicators being calculated 
via a ratings system (eg, PE 49, “Score for patients who reported that the 
hospital room or ward was very or fairly clean”). Due to inconsistencies in the 
information supplied by the NHS IC, the formula was sometimes taken from 
the Detailed Descriptor, Statement or Definition section of the NHS IC 
metadata; whichever had the most relevant and succinct information. The 
source for the formula is given in brackets in the Formula slot for each 
indicator in the ontology. The metadata for Statement, Detailed Descriptor, 
Definition and/or Formula/Calculation/Methodology are sometimes the same. 
When this occurs, only one source is noted.  
 
6.2.4.4 Formalisation: Reference 
 
The column, Indicator Set or Creators, in Appendix 3, Quality Indicator 
Dimensions and Next Stage Review Pathways, lists the information used to fill 
in the Reference slot in the ontology. The information for this slot was taken 
from the NHS IC Source metadata. Inconsistencies in metadata for NHS IC 
Source names meant that some set names may be unreliable or that the 
indicator is not part of a named set. The NHS IC Source information for LT13-
22 is an example of variations in metadata.  Sometimes Source is listed as 
UK Renal Registry.  Sometime it is listed as National Renal Dataset. 
Therefore, the set name was sometimes replaced by the imputed author of 
the formula for the indicator. Sometimes there is more than one party 
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responsible for the development of the indicator. This is the reason for 
including alternate information in the third column in Appendix 3. Reliability of 
the Reference/Source information could be improved by developing authority 
records for the parties involved in quality indicator development and use. 
Authority records trace history and variations in name changes.  
 
6.2.4.5 Formalisation: Instances 
 
Prior to entering instances, a Snapshot rule was created to address different 
status levels of the indicators.  If an indicator had a status of Dropped at the 
time of recording data into Appendix 3, the instance was not entered into the 
ontology. If an indicator had a status of Dropped after it was recorded into 
Appendix 3, the indicator was entered as an instance into the ontology. If an 
indicator had a status of Replaced by, at the time of recording into Appendix 
3, the indicator was not entered into the ontology. If an indicator had a status 
of Replaced by after recording the indicator into Appendix 3, it was entered 
into the ontology.  Relationships and sometimes URL are not given in 
Appendix 3 if indicator is no longer in use. 
 
6.3 Platform 
 
Protégé 3.4.1 was a good choice for someone new to ontology development 
to organise this set of indicators. More abstract capabilities offered by newer 
versions of Protégé would reduce redundancies caused by duplication of 
Dimension, Next Stage Review Pathway and Purpose as both Classes and 
Slots. However, newer versions of Protégé lacked appropriate training 
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materials for people new to ontology development. A recent comparative view 
of versions of Protégé offers recommendations for different versions of 
Protégé, depending on purpose (Stanford Center for Biomedical Informatics 
Research 2013). Given that Frames support was not yet available for Protégé 
4, Protégé 3.4.1 should be viewed as appropriate for this research, noting that 
Protégé 3.5 was not yet available at the time of this project. 
 
6.4 Evaluation  
 
Evaluation of ontologies is difficult, in part, due to differing definitions of 
ontologies and different development platforms. There does not appear to be 
a single preferred method of evaluating ontologies (Gruber 1993a, Gomez-
Perez 2004, Rogers 2006). The methods selected to evaluate this ontology, 
included assessment of consistency, completeness, expandability, 
conciseness, and sensitiveness; competency questions, to assess whether 
the ontology achieves its intended purpose; and metrics. The ontology was 
made publicly available for comment and stakeholders and academic experts 
were contacted to comment on the ontology.  
 
6.4.1 Consistency and Completeness 
 
Consistency of definitions of classes and subclasses should be reconsidered 
if this pilot ontology is revised. Explanatory information and examples are 
sometimes given in place of a pure definition in the current ontology. It may be 
useful to compare the consistency of the definitions for this ontology with 
consistency of definitions for ontologies for clinical practice guidelines. 
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Completeness of definitions could also be improved, though this may not be 
possible for some definitions. Given the ever-changing nature of the NHS and 
related organisations, it is unlikely that a list of all possible options to fill 
certain slots, eg, Access Point, would remain current and complete.    
 
6.4.2 Expandability 
 
Expandability is limited by the classes and slots already defined within the 
ontology. New definitions may be added if they are assessed against current 
definitions for redundancy and/or contradictory information. The Dimension 
slots require further development in that they need to be populated with 
instances. The architecture of the ontology would likely be impacted by small 
changes to definitions, eg, Purpose, and therefore has high sensitivity. This is 
not necessarily a negative outcome and the evaluation criteria of sensitivity 
seems unnecessary for this ontology. 
 
6.5 Usefulness of the Ontology 
 
The Competency questions in 5.6 show some of the types of queries the 
intended audience might use to search the ontology. Queries can be used to 
gather information from the ontology, making it useful to clinical auditing 
communities, quality indicator developers, organisers of quality indicator sets 
and providers of access to quality indicator sets to reduce effort involved in 
healthcare quality monitoring. Clinical auditing communities, organisers of 
quality indicator sets and providers of access to quality indicator sets can 
search for quality indicators with common criteria, even if they are from 
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different sources. Auditing communities may therefore be able to gather or 
extract data for common criteria, rather than gathering the data separately for 
each indicator. Query writers for indicators, including those working for 
vendors of electronic health records, may store components of queries for 
common criteria and build queries for specific indicators out of common 
components, specifying additional components as necessary. Quality 
indicator developers may learn from the ontology by noting areas that could 
be simplified through more easily accessible and/or clearer metadata. The 
indicator developers could work towards modifying the indicators with a view 
towards a consistent metadata framework. 
 
Experts and stakeholders were contacted to comment on the ontology.  While 
one NHS stakeholder said his job was more about responding to outcomes 
than the quality monitoring process, another NHS stakeholder suggested that 
the ontology could reduce time needed to find relevant components of quality 
indicators and recommended that the ontology be patented.  The most 
common view among academic experts was that the ontology could be a 
useful tool for finding relevant quality indicators and indicator components.  
Two EHR vendors have expressed interest in the ontology. 
 
6.6 Limitations 
 
This study was limited by unpredictable changes in the indicators and 
indicator subsets, lack of previous experience in ontology development, lack 
of medical expertise, lack of previous experience in clinical coding and poor 
quality metadata about the indicators. The Conceptualisation and 
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Formalisation stages were labour-intensive, due to the large, diverse nature of 
this set of quality indicators and poor standard of metadata readily available 
for the indicator set. The NHS Information Centre for Health and Social Care 
(NHS IC) was the primary source for metadata for instances of the indicators, 
as it was the site of access to the set of indicators used for this project. 
 
Changes in the indicators and indicator sets could become more predictable 
through lessons learned from this study and through research into patterns in 
indicator development. Lack of expertise and experience can be addressed 
through collaborative studies. Preparatory studies, involving data availability in 
EHRs, could help to inform the conceptualisation process for the development 
of computer-interpretable healthcare quality indicators. However, there is 
room for debate as to whether data for all healthcare quality indicators should 
be made available through electronic health records. It has been suggested 
that Patient Experience scores are less likely to be maintained as part of an 
electronic health record (Roth et al. 2009). 
 
6.7 Summary 
 
This chapter has considered the results of the research, including the 
ontology development process and evaluation of the ontology itself. The 
methodology and platform chosen to develop the ontology were reviewed, 
with their respect to their usefulness to this project. Comments were made on 
the evaluation methods and results. Limitations of the study were discussed. 
The next chapter will review the contribution this research has made, the 
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research objectives and make suggestions for future healthcare quality 
indicator ontology development. 
Chapter 7 Conclusions 
 
This chapter describes the contributions to research made by this project. 
Section 7.1 offers a reminder of research gaps in the area of computer-
interpretable quality indicators and ontologies for healthcare quality indicators 
and shows how this research has responded to those gaps. The hypothesis 
and objectives of this research are reviewed in 7.2, followed by a recap of the 
benefit of this ontology to clinical auditing communities, quality indicator 
developers and EHR vendors. Conclusions are drawn for each of the review 
items.  
 
7.1 Research Contributions 
 
This project sought to reduce duplication of effort in finding data for NHS 
healthcare quality indicators, to resolve issues identified in previous efforts to 
develop quality-monitoring ontologies or computer-interpretable quality 
indicators, to explore attributes of and relationships between healthcare 
quality indicators, and to identify areas for future computer-interpretable 
quality indicator development for the United Kingdom’s Department of Health 
and National Health Service. This research is timely and potentially responds, 
in part, to a recent call for tools to support effective and efficient data 
collections (Informatics Services Commissioning Group 2013). 
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As previously identified in the literature review, 2.6.3.5, Challenges for 
Computer-Interpretable Quality Indicators, and discussion, 6.1, Purpose of 
Research and Choice of Indicator Set, the gaps in previous research in this 
area included classification of healthcare quality indicator purposes over a 
broad range of indicators, an ontology for healthcare quality indicators that is 
not dependent on data available in EHRs, a healthcare quality indicator 
ontology that covers many clinical subject areas, and a healthcare quality 
indicator ontology that does not require indicator developers to fit into 
framework. Being dependent on data available in EHRs led to difficulties using 
Arden Syntax to express inclusion and exclusion criteria (Jenders 2008). As 
well as being data-dependent, Arden Syntax, which was used to express a set 
of indicators for elderly care (Jenders 2008) may be limited to the purpose of 
screening and prevention (Ohno-Machado et al. 1998). Arden Syntax 
(Jenders 2008) and Surján’s (et al. 2006) ontology for Public Health Indicators 
were applied to a subject-specific indicator set. The US Quality Data Model 
(2008) requires indicator developers to fit into a specified framework. Chan et 
al. (2010) advocate for research into attributes of quality indicators to support 
electronic health record compatibility. This research resulted in an ontology 
that is not dependent upon data available in EHRs, is not subject-specific, and 
does not require indicator developers to fit into a specified framework.  
 
A review of research into computer-interpretable guidelines (Sonnenberg and 
Hagerty 2006) identified knowledge-centric, document-centric and hybrid 
approaches to guideline modelling. This description of approaches can also 
be applied to development of computer-interpretable quality indicators. The 
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knowledge-centric approach requires taking software compatibility into 
consideration and may be compared to the US Quality Data Model requiring 
developers to use a framework. The document-centric approach views the 
original indicator as the information base. The information is then reformatted, 
for example into elements, and tagged to work with related software. The 
research for this thesis took a document-centric approach, classifying 
metadata and representing the quality indicators with Protégé 3.4.1. The 
hybrid approach would seek a compromise between the knowledge-centric 
and document-centric approaches, perhaps asking indicator developers to 
uniformly develop certain components of the indicators. 
 
7.2 Review of Hypothesis and Research Objectives 
The research hypothesis and objectives were developed to address some of 
the research gaps discovered during the literature review. 
7.2.1 Hypothesis 
 
The hypothesis of this research was that the conceptualisation stage of 
ontology development for a large set of health care quality indicators can 
facilitate specification of inclusion and exclusion criteria, along with 
categorisation beyond screening and prevention and identification of levels of 
indicator relationships. The hypothesis was correct, with the limitation that 
availability, accessibility, complexity and accuracy of relevant metadata has a 
major influence on conceptualisation and formalisation. 
 
Stated as two research questions, the hypothesis translated to: 
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1) What attributes of health care quality indicators influence the development 
of an ontology that emphasises specification of inclusion and exclusion 
criteria, along with specification beyond screening and prevention? 
2) What relationships between health care quality indicators identify 
complexity of indicator relationships? 
The attributes for inclusion and exclusion criteria and specification beyond 
screening and prevention are explored in Appendix 5, Layers of 
Inclusion/Exclusion Criteria and in Appendix 4, Indicators by Purpose, with 
Related Indicators. Concluding statements about the attributes are in 7.2.2.1, 
Attributes Suited to Ontology Coverage. Complexity of indicator relationships 
is discussed in 7.2.2.2, Relationships, Inclusion and Exclusion Criteria. 
 
7.2.2 Research Objectives  
 
The conceptualisation process achieved the first of the research objectives 
and partially achieved the second and third objectives. The research 
objectives were: 
1) To identify relationships in a large, diverse set of quality indicators  
2) To identify layers of inclusion and exclusion criteria for a large, diverse set 
of quality indicators  
3) To determine the attributes of quality indicators most suited to ontology 
coverage 
4) To determine whether there any features of quality indicators that do not 
need an ontology to facilitate quality-monitoring 
5) To develop a preliminary ontology for a large, diverse set of quality 
indicators 
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7.2.2.1 Attributes Suited to Ontology Coverage 
 
Attributes most suited to ontology coverage were determined during the 
conceptualisation process by deciding the classes and subclasses and their 
assigned slots and subslots. Some of the attributes, such as Next Stage 
Review Pathway, are specific to NHS quality indicators. It would be worth 
exploring the National Quality Forum’s Data Model (2012b) to determine 
whether any of their data elements would fit into a future version of this 
ontology. Consultation with stakeholders may further assist with assessment 
of quality indicator attributes most suited to ontology coverage. 
 
By analysing a diverse set of quality indicators, we have seen that not all 
indicators are fractional in nature.  Patient Experience indicators tend to use a 
scale rating system, rather than numerator and denominator. Determining 
layers of inclusion criteria presented a challenge for some Patient Experience 
indicators, due to an awareness that the data for these types of indicators 
would likely involve numbers tallied from surveys, rather than queries written 
for electronic health records or other reporting systems. Some fractional 
indicators include defining criteria for components of the indicators. 
Incorporating definitions into layers of inclusion and exclusion criteria could be 
attempted by increasing numbers of layers of the criteria or by creating look-
up tables. 
 
The evaluation of the ontology showed that while the Safety class and 
Dimension subclasses have slots, they currently have no Instances and 
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therefore their Slots appear to have no use. The Dimension slots of 
Complication Rates, Mortality Rates, Patient-Reported Outcome Measures, 
Survival Rates, Compassion, Dignity, Respect, Cleanliness, Drug Errors, and 
Healthcare-related Infections, could be useful to clinical audit communities 
searching the ontology for related indicators. Future versions of this ontology 
should include instances of the indicators for each of these slots. 
 
7.2.2.2 Relationships, Inclusion and Exclusion Criteria 
 
Broader, narrower and same level indicators are specified in Appendix 4, 
Indicators by Purpose, with Related Indicators. Appendix 5 shows an initial set 
of layers of inclusion/exclusion criteria for each indicator. Variations in 
complexity of the indicator formulae and inconsistent and incomplete 
metadata regarding the formulae somewhat interfered with the fulfillment of 
the inclusion/exclusion criteria objective during the conceptualisation process. 
This research showed that healthcare quality indicators can be complex and 
are not necessarily  “Simplistic algorithms that provide clear scoring 
instructions for processes that can be measured practically” (Walter 2004).  
Some of the indicators were not algorithms (eg, Patient Experience). Many of 
the indicators were complex, involving definitions and methods applicable to a 
portion of the indicator. Indicator complexity supports the decision to break 
down indicator components into inclusion and exclusion criteria. 
 
There is potential for further specification of layers of inclusion/exclusion 
criteria, incorporating elements from metadata outside the indicator 
Statement. The NHS HSCIC metadata for Definition sometimes included 
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information that could be incorporated into inclusion/exclusion criteria. Some 
metadata from the NHS HSCIC’s Formula/Calculation/Methodology or 
Detailed Descriptor sections could also be incorporated. The information 
given in these sections could not always be incorporated directly, as it often 
included non-formulaic detail or formulaic detail that included unfamiliar 
computer programming language terms. The addition of look-up tables for 
definitions and relevant computer programming terms could facilitate 
interoperability between different monitoring systems. 
 
7.2.2.3 Specification Beyond Screening and Prevention 
 
One of the objectives of this research was to determine whether a diverse set 
of healthcare quality indicators shared a common purpose of screening and 
prevention. This research showed that the most common purpose was Care 
of Clinical Conditions, thus suggesting that Arden Syntax may be inadequate 
to express different types of indicators. While this contention was originally 
made regarding the use of Arden Syntax to express CPGs, it would be 
prudent to test Arden Syntax directly on indicators with different purposes, 
along with indicators with multiple levels of inclusion or exclusion criteria.  The 
Medical Logic Modules used in Arden Syntax historically have relied on 
singular criteria: one set of data for input, one application of criteria logic and 
one set of resulting actions. It is worth considering whether simple quality 
indicators, rather than just those with a purpose of screening and prevention, 
may be suitable for Arden Syntax. 
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IoM guideline purposes were selected to categorise the indicators because 
they were used to describe the suitability of Arden Syntax for representing 
clinical guidelines. There are just five IoM purposes (Field and Lohr 1992): 1) 
Screening and Prevention, 2) Diagnosis and prediagnosis management of 
patients, 3) Indications for use of surgical procedures, 4) Appropriate use of 
specific technologies and tests as part of clinical care, and 5) Guidelines for 
care of clinical conditions. The IoM categories represent both broad and 
narrow aspects of healthcare purposes. Broad and narrow categories for 
healthcare quality indicators are advisable to provide an overview of the 
spread of areas of healthcare addressed by quality indicators. Five categories 
may be too limited to adequately describe quality indicator purpose, however. 
Clinical guidelines have now progressed to organisation by a greater number 
of purposes. Some of these new categories are worth considering for 
healthcare quality indicators, bearing in mind that quality indicators are 
frequently derived from clinical guidelines (Mertz 2009, Kotter 2012). 
Categorisation by a larger range of purposes, such as the purposes 
developed by the US National Guideline Clearinghouse (Agency for 
Healthcare Research and Quality [2012]) and the US National Quality Forum 
(2012b) may facilitate a more useful and meaningful classification.  
 
7.2.2.4 Features of Quality Indicators that Do Not Need an Ontology 
to Facilitate Healthcare Quality Monitoring 
 
The fourth objective, to determine whether there are any features of quality 
indicators that do not need an ontology to facilitate healthcare quality 
monitoring, may be addressed, at least in part, by the difficulty encountered 
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with integrating indicator formulae into this ontology. Improved metadata for 
formulae and look-up tables for different layers of inclusion/exclusion criteria 
may be able to solve this problem in the future. Testing the ontology with end 
users may also help to determine features of quality indicators that do not 
need an ontology to facilitate healthcare quality monitoring. 
7.2.2.5 A Preliminary Ontology 
 
The conceptualisation stage facilitated the final objective, to develop a 
preliminary ontology for a large, diverse set of quality indicators. The use of 
Protégé 3.4.1 to create the ontology resulted in some slots/widgets being 
intentionally primitive, allowing the user to enter more than one data type. This 
flexibility is sometimes considered necessary to accurately identify the 
information and make it both searchable and linked. For example, Clinical 
Terminology entries include both code(s) and term(s). The complete 
terminologies used would need to be integrated into the ontology, with a look-
up feature if the slot did not allow for more than one data type. The 
terminologies were browsed via UMLS, which requires registration. There 
may be licensing requirements for some of the terminologies to be used 
separately from UMLS. Data validation rules were kept intentionally broad, 
due to inconsistent and incomplete metadata supplied by the NHS IC. 
 
7.3 Benefits of the Ontology 
 
While a goal of interoperability between quality indicators and electronic 
health records (EHRs) is desirable, this conceptualisation process focused on 
the indicators themselves. This type of research and the resulting ontology 
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could be useful to countries in early stages of EHR implementation or that 
have not yet begun using EHRs. Countries that have already implemented 
EHRs, but recognise challenges in quality of data extraction from EHRs, may 
also be interested in this approach. The benefit is the ability to search for 
components of quality indicators from different sources, with a view to 
reducing duplication of effort in gathering data for indicators with common 
criteria, whether that data is gathered manually or electronically. EHR vendors 
could also learn from this ontology and work towards making indicator 
elements available in EHRs. 
 
Queries can be used to gather information from the ontology, making it useful 
to clinical auditing communities, quality indicator developers, organisers of 
quality indicator sets and providers of access to quality indicator sets to 
reduce effort involved in healthcare quality monitoring. The target audience 
can search for quality indicators with common criteria, even if they are from 
different sources. Clinical auditing communities may therefore be able to 
gather or extract data for common criteria, rather than gathering the data 
separately for each indicator. Query writers for indicators, including those 
working for vendors of electronic health records, may store components of 
queries for common criteria and build queries for specific indicators out of 
common components, specifying additional components as necessary. 
Quality indicator developers may learn from the ontology by noting areas that 
could be simplified through more easily accessible and/or clearer metadata. 
The indicator developers could work towards modifying the indicators with a 
view towards a consistent metadata framework. 
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7.4 Summary 
 
This chapter has described the contributions to research made by this project. 
The hypothesis and objectives of this research were reviewed. The 
conceptual analysis of this set of indicators serves as a snapshot into 
indicator status, categories and relationships. Categories of dimension, 
clinical pathway and purpose were identified as attributes of the indicators, 
along with broader, narrower and same level relationships between indicators 
from different sources and sets. The benefit is the ability to search 
components of quality indicators from different sources, with a view to 
reducing duplication of effort in gathering data for indicators with common 
criteria.  
This study made the following research contributions: 
1) Identified broader, narrower and same level criteria from different sets 
of NHS quality indicators, 
2) Developed an initial set of inclusion and exclusion criteria for a large, 
diverse set of NHS quality indicators, 
3) Reviewed literature on the use of ontologies for health care quality 
monitoring via electronic health records, 
4) Noted challenges in the development and use of metadata for NHS 
healthcare quality indicators, 
5) Compared broad purposes of a large, diverse set of NHS quality 
indicators.  
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The next chapter will make recommendations for the development of 
metadata for future healthcare quality indicator sets and future healthcare 
quality indicator ontology development. 
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Chapter 8 Considerations for future healthcare quality 
indicator ontology development 
 
This chapter proposes recommendations for the development of metadata for 
future NHS healthcare quality indicator sets. Suggestions for future NHS 
healthcare quality indicator ontology development are proposed, including 
interoperability with electronic health records and clinical practice guidelines. 
 
8.1 Indicator Metadata Readiness 
 
Future work should consider authority records for associated creators, 
publishers and relevant parties responsible for indicator content and 
distribution. Authority records would enable users of metadata to find the most 
appropriate name and history of name changes associated with parties 
responsible for indicator content and access. The International Federation of 
Library Association’s (2009) Statement of International Cataloguing Principles 
could be used as a starting point to develop standards for metadata for quality 
indicators. A companion guide to these principles, Resource Description and 
Access has been made available by the Joint Steering Committee for 
Development of RDA (2009).  
 
8.2 Potential to Integrate with EHRs 
 
Standards for information technology for decision support and quality 
monitoring have been criticised (Kawamoto et al. 2010) as being overly 
complex, having tooling limitations, and poor documentation on how the 
standards should be implemented. Feasibility of quality monitoring via EHRs 
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has been questioned by Jensen (2009), who showed that a majority of EHR 
systems did not have the capability to capture data for complex EHR-based 
measures, for example data elements based on workflow actions. Application 
of computer-interpretable quality indicators can be hampered by lack of 
available data in electronic health records (Roth et al. 2009). While the NHS 
has published standards for electronic health records (Academy of Royal 
Medical Colleges/NHS 2008), there is room for improvement with respect to 
coordinating these standards with conceptual elements of NHS quality 
indicators. 
 
While this ontology bypasses the need for data provided via EHRs, it is 
recognised that EHR compatibility is a desirable feature of computer-
interpretable quality indicators. Some of Kelly’s (2012) advice for predictive 
modelling could support interoperability between EHRs and computer-
interpretable quality indicators. The following summary of Kelly’s Technical 
Guidance for Data Sources could be used to create look-up tables to 
incorporate into this pilot ontology, with potential links to EHRs: 
“1. Create and maintain a comprehensive data dictionary for all data 
sources. 
2. Create an ER data model for all data sources. 
3. Document data formats for all data sources. 
4. Document data transport methods for all data sources. 
When selecting a predictive model: 
1. Ask which types of data (IP, OP, GP etc.) were used within the 
training dataset. 
2. Ask which data sources were used (e.g. SUS) for the training 
dataset. 
3. Ask when the data was extracted for the training set. 
4. Ask the scope of the data in the training dataset, specifically the 
historical scope (for example 4 years of data) and boundary scope (for 
example all GP registered patients in CCG X).“ 
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Although this summary pertains to predictive models and mentions training 
datasets, there are commonalities between quality indicators and the types of 
information likely to be included in this training set. SUS, or Secondary Uses 
Service is a repository for healthcare reporting data in England. The training 
dataset referred to in Kelly’s summary could be used to see how well it works 
with the pilot ontology developed for this research and to determine additional 
slots.  
 
The National Quality Forum (2012c) has published a style guide, intended to 
assist quality indicator developers with feasibility requirements for data 
elements in proposed quality indicators. The style guide was inspired by a 
2008 Information Technology Panel Report (National Quality Forum) that 
analysed quality indicator element availability in EHRs and made 
recommendations regarding quality indicator elements. There are ongoing 
issues regarding the NQF indicator sets, including duplication of value sets or 
components of value sets (Winnenburg and Bodenreider 2012). Efforts to 
integrate healthcare quality monitoring with EHRs are largely dependant on 
the quality of the data in the EHRs.  According to the NHS Information Centre 
(2012b), there is much room for improvement in the quality of data available in 
EHRs in England, drawing into question current viability of quality monitoring 
via EHRs in England.   
 
 
8.3 Integration of Quality Indicators with Clinical Decision 
Support 
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The National Quality Forum (2010) is also working to integrate quality 
monitoring with clinical decision support. Reporting structures are more 
complex for quality indicators than for CPGs, which are largely intended for 
local use, though sometimes may be monitored by public bodies. Advani et al. 
(2003) created quality indicators from clinical practice guidelines, using QUIL 
(Quality Indicator Language). Future quality indicator sets could more closely 
tie clinical practice guidelines with their relevant quality indicators, applying 
technologies such as QUIL. 
 
 
8.4 Summary of Considerations for Future Healthcare Quality 
Indicator Ontology Development 
 
This chapter has offered considerations for future healthcare quality indicator 
development, including metadata readiness, potential integration with EHRs 
and integration with clinical decision support. While this research focused on a 
set of quality indicators, future research could emphasise interoperability. The 
addition of look-up tables for authority records, indicator definitions, EHR 
standards and relevant computer programming terms could facilitate 
interoperability between different monitoring systems. Future quality indicator 
sets could more closely tie clinical practice guidelines with their relevant 
quality indicators, applying technologies such as QUIL. Categorisation by a 
larger range of purposes may also facilitate closer ties to CPGs. 
 
Searchability was an important benefit of this ontology. Look-up tables could 
facilitate clearer data elements for inclusion and exclusion criteria. The 
number and usefulness of slots should be reviewed. Testing a range of simple 
quality indicators, rather than just those with a purpose of screening and 
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prevention, with Arden Syntax could further validate the need for an ontology 
designed for healthcare quality indiators.  Further testing of the ontology with 
end users, with the support of a relevant NHS body, could help improve the 
ontology as well as publicise its usefulness. 
 161 
 162 
References 
 
Academy of Royal Medical Colleges/NHS. (2008) A Clinician’s Guide to 
Record Standards – Part 2: Standards for the structure and content 
of medical records and communications when patients are admitted to 
hospital. London: Digital and Health Information Policy Directorate. Available 
from: http://www.rcplondon.ac.uk/sites/default/files/documents/clinicians-
guide-part-2-standards.pdf [Accessed 19/2013]. 
 
Advani A, Goldstein M, Shahar Y and Musen M. (2003) Developing Quality 
Indicators and Auditing Protocols from Formal Guideline Models: Knowledge 
Representation and Transformations. AMIA Annual Symposium Proceedings 
2003. 11–15. Available from: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1480136/ [Accessed 23 August 
2013] 
 
Agency for Healthcare Research and Quality. [2012] National Guideline 
Clearinghouse. Available from: http://www.guideline.gov/about/classification-
scheme.aspx [Accessed 12/3/12]. 
 
The AGREE Research Trust. (2001) AGREE Instrument. Available from: 
http://www.agreetrust.org/instrument.htm [Accessed 5 November 2009]. 
 
Allen R., ed. 2007. Penguin English Dictionary. 3rd edition, revised. London: 
Penguin Books, Ltd.  
 
American Library Association, the Canadian Library Association, and the 
Chartered Institute of Library and Information Professionals. (2012) AACR2. 
Chicago: American Library Association. 
 
American Medical Informatics Association and American Health Information 
Management Association Terminology and Classification Policy Task Force. 
[2006] Healthcare Terminologies and Classifications: An Action Agenda for 
the United States. Available from: 
http://library.ahima.org/xpedio/groups/public/documents/ahima/bok1_032395.
pdf [Accessed 15/11/09] 
 
Anani N, Chen R, Prazeres M and Koch S. (2012) OpenEHR-Based 
Representation of Guideline Compliance Data through the Example of Stroke 
Clinical Practice Guidelines. Studies in Health Technology and Informatics  
(180):487-91. 
 
Arpırez J, Corcho O, Fernandez-Lopez M and Gomez-Perez A. (2001) 
WebODE: a scalable ontological engineering workbench. In: First 
International Conference on Knowledge Capture (KCAP01). Victoria: 2001. 
New York:ACM Press 6–13. 
 
 163 
Audit Commission. (2011) By definition: Improving data definitions and their 
use by the NHS: A briefing from the Payment by Results data assurance 
programme. Available from: http://www.audit-
commission.gov.uk/SiteCollectionDocuments/Downloads/20120419ByDefiniti
on.pdf [Accessed 23 April 2012]. 
 
Baker D, Persell S, Thompson J, Soman N, Burgner K, Liss D and  Kmetik K. 
(2007) Automated review of electronic health records to assess quality of care 
for outpatients with heart failure. Annals of Internal Medicine 146(4):270-277. 
 
Benin A, Fenick A, Herrin J, Vitkauskas G, Chen J and Brandt C. (2011) How 
good are the data? Feasible approach to validation of metrics of quality 
derived from an outpatient electronic health record. American Journal of 
Medical Quality 26(6):441-51.   
 
Bernstam E, Ash N, Peleg M, Tu S, Boxwala AA, Mork P, Shortliffe EH and  
Greenes R. (2000) Guideline classification to assist modeling, authoring, 
implementation and retrieval. AMIA Annual Symposium Proceedings 2000:66-
70.  
 
Bernstam E, Ash N, Peleg M, Tu S, Shortliffe EH and  Greenes R. (2001) 
Preliminary Evaluation of a Guideline Classification System. AMIA Annual 
Symposium Proceedings 2001: 863. 
 
Bernstein K and Andersen U. (2008) Managing care pathways combining 
SNOMED CT, archetypes and an electronic guideline system. Studies in 
Health Technology and Informatics 136:353-8. 
 
Bhensky M, Jolley D, Sundararajan V, Evans S, Ibrahim J and Brand C. 
(2011) Development and validation of reporting guidelines for studies 
involving data linkage. Australian and New Zealand Journal of Public Health 
35(5):486-9. 
 
Bishop T. (2013) Pushing the outpatient quality envelope. JAMA: Journal of 
the American Medical Association 309(13):1353-4.  
 
BMA and NHS Employers. (2011) Quality and Outcomes Framework 
Guidance for GMS Contract 2011/12. Available from: 
http://www.nhsemployers.org/SiteCollectionDocuments/QOFguidanceGMSco
ntract_2011_12_FL%2013042011.pdf  [Accessed 22 August 2013]. 
 
Bodenreider O. (2008) Biomedical Ontologies in Action: Role in Knowledge 
Management, Data Integration and Decision Support. In: IMIA Yearbook of 
Medical Informatics 2008. Methods Information in Medicine 2008 47 
Supplement 1:67-79.  
 
Bullinger A. (2008) Innovation and Ontologies: Structuring the Early Stages of 
Innovation Management. Wiesbaden: Gabler. 
 
Campbell S, Braspenning J, Hutchinson A and Marshall M. (2002) Research 
methods used in developing and applying quality indicators in primary care. 
 164 
Quality & Safety in Health Care 11:358-364. Available from: 
http://www.who.int/management/district/ResearchMethodsQualityIndicatorsP
HC.pdf [Accessed 26 January 2013]. 
 
Chan K, Fowles J and Weiner J. (2010) Review: electronic health records and 
the reliability and validity of quality measures: a review of the literature. 
Medical Care Research and Review: MCRR 67(5):503-27.  
 
Cimiano P, Hotho A, Stumme G and Tane J. (2004) Conceptual Knowledge 
Processing with Formal Concept Analysis and Ontologies. Lecture Notes in 
Computer Science. 
 
Correndo G and Terrenziani P. (2004). Towards a Flexible Integration of 
Clinical Guideline Systems With Medical Ontologies and Medical Information 
Systems. [Slide from PowerPoint Presentation] Symposium: Computerized 
Guidelines and Protocols, Prague, 13-14 April 2004. 
 
Corcho O, Fernandez-Lopez M and Gomez-Perez A. (2003) Methodologies, 
tools, and languages for building ontologies: Where is their meeting point? 
Data and Knowledge Engineering 46(1):41-64. Available from: 
http://www.dia.fi.upm.es/~ocorcho/documents/DKE2003_CorchoEtAl.pdf 
[Accessed 23 January 2013]. 
 
Cuggia M, Rossille D, Arnault A, Bouget J and Le Beux P. (2007)Towards a 
decision support system for optimising clinical pathways of elderly patients in 
an emergency department. Studies in Health Technology and Informatics 
129(2):840-4. 
 
Daniel-Le Bozec C, Buemi A, Mazuel L, Ouagne D and Charlet J. (2009) 
Functional requirements of terminology services for coupling interface 
terminologies to reference terminologies. Studies in Health Technology and 
Informatics 150:205-9. 
 
Daniel-Le Bozec C, Steichen O., Dart T, Dart T and Jaulent MC. (2007) The 
role of local terminologies in electronic health records. The HEGP experience. 
Studies in Health Technology and Informatics 129(1):780–784. 
 
Darr K. (2007) Quality improvement: the pioneers. Hospital Topics 85(4):35-8. 
 
Darzi A. (2008) High quality care for all: NHS next stage review: Final report. 
London: Department of Health. Available from:  
http://www.official-documents.gov.uk/document/cm74/7432/7432.pdf 
[Accessed 20 August 2013]. 
 
Denny M. (2004a) Ontology Editor Survey. Available from: 
http://www.xml.com/2004/07/14/examples/Ontology_Editor_Survey_2004_Ta
ble_-_Michael_Denny.pdf [Accessed 20 April 2014]. 
 
Denny M. (2004b) Ontology Tools Revisited. Available from: 
http://www.xml.com/pub/a/2004/07/14/onto.html [Accessed 20 April 2014]. 
 165 
Department of Health. (2012a) The NHS Outcomes Framework 2013-14.  
Available at: https://www.wp.dh.gov.uk/publications/files/2012/11/121109-
NHS-Outcomes-Framework-2013-14.pdf [Accessed 12 November 2012]. 
 
Department of Health. (2012b) The NHS Outcomes Framework 2013-14 – 
Technical Appendix.  Available from: 
https://www.wp.dh.gov.uk/publications/files/2012/11/121109-Technical-
Appendix.pdf [Accessed 25 January 2013]. 
 
Department of Health/NHS Finance and Operations. (2011) The Operating 
Framework for the NHS in England 2012/13. Available at: 
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPo
licyAndGuidance/DH_122738 [Accessed 25 January 2013]. 
 
Department of Health and Human Services [US]. (2012) Early assessment  
finds that CMS faces obstacles in overseeing the MEDICARE EHR Incentive 
Program. Available at: https://oig.hhs.gov/oei/reports/oei-05-11-00250.pdf 
[Accessed 25 January 2013]. 
 
Dietz J. (2006) Enterprise Ontology: Theory and Methodology. New York: 
Springer. 
 
Donabedian A. (1966) Evaluating the quality of medical care. Milbank 
Memorial Fund Quarterly 44:166-206.  
 
Elkin P and Brown S. (2002) Automated enhancement of description logic-
defined terminologies to facilitate mapping to ICD9-CM. Journal of Biomedical 
Informatics 35(5-6):281-8. 
 
Executive Office of the President, President’s Council of Advisors on Science 
and Technology. (2010) Report to the President[:] Realizing the full potential 
of health information technology to improve healthcare for Americans: the 
path forward. 
http://www.whitehouse.gov/sites/default/files/microsites/ostp/pcast-health-it-
report.pdf [Accessed 13 August 2013]. 
  
Fernandez-Lopez M, Gomez Perez A, Sierra J and Sierra A. (1999) Building a 
chemical ontology using methontology and the ontology design environment. 
IEEE Intelligent Systems. 14(1):37-46. 
 
Field M and Lohr K (Eds). (1992) Guidelines for clinical practice: from 
development to use. Institute of Medicine, Washington, D.C: National 
Academy Press. 
 
Foskett-Tharby (2008). Reading and Understanding the Dataset and Business 
Rules of the Quality and Outcomes Framework: A Guide. Available at: 
http://www.pcc.nhs.uk/uploads/reading_and_understanding_qof_business_rul
es.pdf (screened registration required).  [Accessed 23 April 2012]. 
 
 166 
Fox, M. (1992), "The TOVE Project: A Common-sense Model of the 
Enterprise", Industrial and Engineering Applications of Artificial Intelligence 
and Expert Systems. In: Belli, F. and Radermacher, F.J. (Eds.), Lecture Notes 
in Artificial Intelligence # 604. Berlin: Springer-Verlag 25-34. 
Gomez-Perez A. (2004) Evaluating Ontologies. In: Staab S and Studer R; 
(Eds.), Handbook on Ontologies. International Handbook on Information 
Systems. Berlin, Springer: 251-273. 
 
Gómez-Pérez A. (1996). Towards a framework to verify knowledge sharing 
technology. Expert Systems with Applications 4: 519–529 .  
 
Grabar N, Hamon T, and Bodenreider O. (2012)  Ontologies and 
Terminologies: Continuum or dichotomy. Applied Ontology 7 (4):375-386..  
 
Grover V and Kettinger WJ (2000). Process Think: Winning Perspectives for 
Business Change in the Information Age.176-178 
 
Gruber T. (2009) Ontology. In the Encyclopedia of Database Systems, Ling 
Liu and M. Tamer Özsu (Eds.), Berlin: Springer-Verlag. Available from: 
http://tomgruber.org/writing/ontology-definition-2007.htm [Accessed 23 
February 2013]. 
 
Gruber T. (1993a).Toward principles for the design of ontologies used for 
knowledge sharing. Knowledge Systems Laboratory Technical Report 93-04. 
Stanford: Stanford University. 
 
Gruber T. (1993b).  A Translation Approach to Portable Ontology 
Specifications. Knowledge Acquisition, 5(2):199-220. 
 
Guarino N and Giaretta P. (1995)  Ontologies and knowledge bases: Towards 
a terminological clarification. In: Mars N, (Ed.), Towards very large knowledge 
bases: Knowledge building and knowledge sharing. Amsterdam: IOS Press. 
25-26. 
 
Horrocks I. (2008). Ontologies and Databases. Presentation given at: 
Semantic Days. Stavanger, Norway, April 2008. Available at: 
http://www.cs.ox.ac.uk/ian.horrocks/Seminars/download/onto-db.ppt 
[Accessed 7 January 2013]. 
 
Hrabak K, Campbell J, Tu S, McClure R and Weida R. (2007) Creating 
interoperable guidelines: requirements of vocabulary standards in 
immunization decision support. Studies in Health Technology and 
Informatics.129 (2):930-4. 
 
Hripcsak G. (1994). Writing Arden Syntax Medical Logic Modules. Computers 
in Biology and Medicine 24(5):331-63. 
 
Informatics Services Commissioning Group. [July 2013] A collective approach 
to the reduction of burden and bureaucracy. Paper Reference: ISCG/005/002. 
Available from: http://www.england.nhs.uk/iscg/wp-
 167 
content/uploads/sites/4/2013/07/ISCG-005-002.pdf [Accessed 15 August 
2013]. 
 
Institute of Medicine. (2001) Crossing the Quality Chasm: A New Health 
System for the Twenty-First Century. Washington, DC: National Academies 
Press.   
 
Institute of Medicine. (2006). Rewarding provider performance: Aligning 
incentives in Medicare. Washington, DC: National Academies Press. 
 
International Federation of Library Associations. (2009) Statement of 
International Cataloguing Principles. Available from: 
http://www.ifla.org/files/assets/cataloguing/icp/icp_2009-en.pdf [Accessed 17 
August 2013]. 
 
Isern, D and Moreno A. (2008). Computer-based execution of clinical 
guidelines: A review. International Journal of Medical Informatics. 77:787–
808. 
 
Jenders RA. (2008) Suitability of the Arden Syntax for representation of 
quality indicators. AMIA Annual Symposium Proceedings 2008 6:991.   
 
Jensen R, Chan K, Weiner J, Fowles J and Neale S. (2009) Implementing 
electronic health record-based quality measures for developmental screening. 
Pediatrics124(4):e648-54. Epub 2009.  Available from: 
http://pediatrics.aappublications.org/content/124/4/e648.long [Accessed 6 
January 2010]. 
 
Joint Steering Committee for Development of RDA. (2009) RDA - Resource 
Description and Access: Objectives and Principles. Available from: 
http://www.rda-jsc.org/docs/5rda-objectivesrev3.pdf [Accessed 17 August 
2013]. 
 
Jones D, Bench-Capon T and Visser P. (1998) Methodologies for ontology 
development. Proceedings of the IT&KNOWS Conference of the 15th IFIP 
World Computer Congress 20-35.  
 
Kanter AS, Wang AY, Masarie FE, Naeymi-Rad F and Safran C. (2008). 
Interface terminologies: Brdiging the gap between theory and reality for Africa. 
Studies in Health Technology and Informatics 136: 27-32. 
 
Kawamoto K, Del Fiol G, Lobach DF and Jenders RA. (2010) Standards for 
scalable clinical decision support: need, current and emerging standards, 
gaps, and proposal for progress. The Open Medical Informatics Journal 
4:235-44. Available from: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097480/?tool=pubmed 
[Accessed 23 June 2011]. 
 
KBSI. [2000] Corporate Profile. Available from: http://www.kbsi.com/kbsi/ 
[Accessed 16 April 2014]. 
 168 
 
Kelly M. for NHS Networks. (2012). QIPP Digital Technology and Vision. 
Technical Guidance on Selecting and Implementing Predictive Modelling 
Solutions. Available from: http://www.networks.nhs.uk/nhs-networks/qipp-
digital-technology-and-
vision/documents/Technical%20Guidance%20on%20Selecting%20and%20Im
plementing%20Predictive%20Modelling%20Solutions%20v1.0.pdf/view 
[Accessed 8 July 2012]. 
 
Keramaris V and Danas K. (2014) Development of Medical Ontology 
"HoPRO" (Hospital PRocess Ontology). Studies in Health Technology and 
Informatics 202:75-8. 
 
Klein M, Fensel D, van Harmelen F and Horrocks I. (2001). The relation 
between ontologies and xml schemas. Electronic Transactions on Artificial 
Intelligence. Available from: 
http://www.cs.man.ac.uk/~horrocks/Publications/download/2001/etai01.pdf 
[Accessed 15 July 2013]. 
 
Kotter T, Blozik E and Scherer M. (2012) Methods for the guideline-based 
development of quality indicators - a systematic review. Implementation 
Science 7 (1):21. 
 
Kumar A, Ciccarese P, Quaglini S, Stefanelli M, Caffi E, and Boiocchi L. 
(2003) Relating UMLS semantic types and task-based ontology to computer-
interpretable clinical practice guidelines. Studies in Health Technology and 
Informatics 95:469-74. 
 
Leong T, Kaiser K and Miksch S. (2007) Free and open source enabling 
technologies for patient-centric, guideline-based clinical decision support: a 
survey. Yearbook of Medical Informatics 74-86. Erratum in: 2008 Yearbook of 
Medical Informatics 19. 
 
Luce J, Bindman A and Lee P. (1994) A brief history of health care quality 
assessment and improvement in the United States. The Western Journal of 
Medicine 160(3):263-8. 
 
Mabotuwana T and Warren J. (2010) ChronoMedIt--a computational quality 
audit framework for better management of patients with chronic conditions. 
Journal of Biomedical Informatics.43(1):144-58. 
 
McCormick R. (1997) Conceptual and Procedural Knowledge. International 
Journal of Technology and Design Education 7:141–159. 
 
Mertz J. (2009) What is HQMF – Health Quality Measures Format?  Blog 
Post. Available from: 
http://www.hl7standards.com/blog/2009/09/17/what-is-hqmf-health-quality-
measures-format/  [Accessed 21 March 2012]. 
 
 169 
Moriarty JP, Finnie DM, Johnson MG, Huddleston JM and Naessens JM. 
(2010) Do pre-existing complications affect the failure to rescue quality 
measures? Quality & Safety in Health Care 19(1):65-8. 
 
Morris CJ, Rogers S, Hammersley VS, Avery AJ and Cantrill JA.  (2004) 
Indicators for preventable drug related morbidity: application in primary care. 
Quality & Safety in Health Care 13:181–185. 
 
Musen M, Noy N, Shah N, Whetzel P, Chute C, Story M, Smith B; NCBO 
team. (2012) The National Center for Biomedical Ontology. Journal of the 
American Medical Informatics Association: JAMIA 19(2):190-5. 
 
National Library of Medicine. (1998) Quality Indicators, Health Care. Available 
from: http://www.ncbi.nlm.nih.gov/mesh/?term=quality+indicator [Accessed 21 
August 2013]. 
 
National Quality Forum (NQF). (2010) Driving Quality and Performance 
Measurement—A Foundation for Clinical Decision Support: A Consensus 
Report.  Washington, DC: NQF. Available from: 
http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=52
608 [Accessed 8 July 2013]. 
 
National Quality Forum (NQF). (2009) Health Information Technology 
Automation of Quality Measurement: Quality Data Set and Data Flow. 
Washington, DC: NQF. Available from: 
http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=57
067 [Accessed 7 July 2013]. 
 
National Quality Forum (NQF). (2008) Health Information Technology Expert 
Panel Report: Recommended Common Data Types and Prioritized 
Performance Measures for Electronic Healthcare Information Systems. 
Available from: 
http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=22
019 [Accessed 9 July 2013]. 
 
National Quality Forum (NQF). (2012a ). NQF Health Information Technology 
Advisory Committee (HITAC) Meeting Summary. July 13, 2012.  
 
National Quality Forum (NQF). (2012b) Quality Data Model June 2012 
Update.  Available from: 
http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=71
275 [Accessed 13 July 2013]. 
 
National Quality Forum (NQF). (2012c) Quality Data Model (QDM) Style 
Guide. Available from: 
http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=71
276 [Accessed 7 July 2013]. 
 
NHS Employers. (2012) Developing the QOF business rules. Available from: 
http://www.nhsemployers.org/PayAndContracts/GeneralMedicalServicesContr
 170 
act/QOF/DevelopingQOFbusinessrules/Pages/DevelopingtheQOFbusinessrul
es.aspx. [Accessed 23 April 2012].   
 
NHS Information Centre. (2008) How did we develop the Indicators for Quality 
Improvement? http://www.ic.nhs.uk/services/measuring-for-quality-
improvement/how-did-we-develop-the-indicators-for-quality-improvement. 
[Accessed 17/10/12]. 
 
NHS Information Centre. (2009a) Indicators for quality improvement: Full 
indicator list. Available from: https://mqi.ic.nhs.uk/IndicatorsList.aspx. 
[Accessed 4 July 2012]. 
 
NHS Information Centre. (2009b) Indicator Metadata Library Guide. Available 
from: 
http://www.hscic.gov.uk/media/10044/Indicator-Library-metadata-
guide/pdf/Indicator_Library_Metadata_User_Guide_v1_0.pdf  [Accessed 28 
May 2013]. 
 
NHS Information Centre. (2012a) Health and Social Care Information Centre 
Strategic Plan 2012 – 2015 and Business Plan 2012 – 2013. Available from 
http://www.ic.nhs.uk/webfiles/Board/Corporate%20documents/FINAL_HSCIC
_BusinessPlan_July2012.pdf [Accessed 6 July 2013]. 
 
NHS Information Centre. (2012b) The quality of nationally submitted health 
and social care data in England - First Annual Report 2012, Experimental 
Statistics. Available from: http://www.ic.nhs.uk/statistics-and-data-
collections/audits-and-performance/data-quality/the-quality-of-nationally-
submitted-health-and-social-care-data-in-england--first-annual-report-2012-
experimental-statistics  [Accessed 4 December 2012]. 
 
NICE. (2013) Glossary. Available from: 
http://www.nice.org.uk/website/glossary/glossary.jsp?alpha=C [Accessed 1 
August 2013]. 
 
NICE. (2010) NICE Menu of Indicators. [NM07 QOF ID: CHD14] Available 
from: 
http://www.nice.org.uk/aboutnice/qof/indicators_detail.jsp?summary=13071  
[Accessed 17 October 2012]. 
 
NICE. (2010b) NICE Menu of Indicators. [NM14 QOF ID: DM26] Available 
from: 
http://www.nice.org.uk/aboutnice/qof/indicators_detail.jsp?summary=13081  
[Accessed 18 October 2012]. 
 
NICE. [2013] Electronic Audit Tool: Hypertension Drug Treatment: 
Implementing NICE Guidance. Available from: 
http://www.nice.org.uk/nicemedia/live/13561/56062/56062.xls [Accessed 8 
August 2013]. 
 
 171 
North M. (2002) Translation of The Hippocratic Oath. National Library of 
Medicine. Available from: http://www.nlm.nih.gov/hmd/greek/greek_oath.html.  
[Accessed 18 April 2012]. 
 
Noy N and McGuiness D. [2002] Ontology Development 101: A Guide to 
Creating Your First Ontology. [Web page]. Available from: 
http://protege.stanford.edu/publications/ontology_development/ontology101-
noy-mcguinness.html [Accessed 14 April 2014]. 
 
Noy N and Tu S. (2003) Developing medical informatics ontologies with 
Protégé. AMIA 2003. [Tutorial slides]. Available from: 
http://protege.stanford.edu/amia2003/AMIA2003Tutorial.ppt  [Accessed 8 May 
2013]. 
 
Noy N, Tudorache T, Nyulas C and Musen M. (2010) The ontology life cycle: 
Integrated tools for editing, publishing, peer review, and evolution of 
ontologies. AMIA Annual Symposium Proceedings 2010 552-6. 
 
O'Connor R and Neumann V. (2006) Payment by results or payment by 
outcome? The history of measuring medicine. Journal of the Royal Society of 
Medicine 99(5):226-31. 
 
Ohno-Machado L, Gennari JH, Murphy S, Jain N, Tu S, Oliver D, Pattison-
Gordon E, Greenes R, Shortliffe E and Barnett G. (1998) The guideline 
interchange format: a model for representing guidelines. Journal of the 
American Medical Informatics Association: JAMIA 5(4):357-72. 
 
Ollenschlager G, Marshall C, Qureshi S, Rosenbrand K, Burgers J, Makela M, 
Slutsky J; Board of Trustees 2002, Guidelines International Netwrok (G-I-N). 
(2004) Improving the quality of health care: using international collaboration to 
inform guideline programmes by founding the Guidelines International 
Network (G-I-N) Quality & Safety in Health Care13:455-460. 
 
O'Toole M, Kmetik K, Bossley H, Cahill J, Kotsos T, Schwamberger P and 
Bufalino V. (2005) Electronic health record systems: the vehicle for 
implementing performance measures. The American Heart Hospital Journal 
3(2):88-93.  
 
Parsons A, McCullough C, Wang J and Shih S. (2012) Validity of electronic 
health record-derived quality measurement for performance monitoring. 
Journal of the American Medical Informatics Association: JAMIA 19(4):604-9. 
Available from: http://jamia.bmj.com/content/19/4/604.full [Accessed 4 April 
2012]. 
 
Payne P, Mendonça E, Johnson S and Starren J. (2007) Conceptual 
knowledge acquisition in biomedicine: A methodological review. Journal of 
Biomedical Informatics 40(5):582-602. Available from 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082059/  [Accessed 10 April 
2012]. 
 
 172 
Peleg M. (2011) The role of modeling in clinical information system 
development life cycle.  Methods of Information in Medicine 50(1):7-10. 
 
Peleg M, Boxwala A, Tu S Zeng Q, Ogunyemi O, Wang D, Patel V, Greenes 
R and Shortliffe E. (2004a) The InterMed approach to sharable computer-
interpretable guidelines: a review. Journal of the American Medical 
Informatics Association: JAMIA 11(1):1-10. 
 
Peleg, M; Boxwala, A; Bernstam, E; Tu S, Greenes R and Shortliffe E. (2001) 
Sharable representation of clinical guidelines in GLIF: Relationship to the 
Arden Syntax. Journal of Biomedical Informatics 34(3):170-181. 
 
Peleg M, Boxwala A, Tu S, Wang D, Ogunyemi O and Zeng Q. (2004b)  
Guideline Interchange Format 3.5 Technical Specification.  
 
Peleg M, Keren and Denekamp Y, (2008) Mapping computerized clinical 
guidelines to electronic medical records: knowledge-data ontological mapper 
(KDOM), Journal of Biomedical Informatics 41(1):180–201. 
 
Peleg M, Tu S, Bury J, Ciccarese P, Fox J, Greenes R, Hall R, Johnson P, 
Jones N, Kumar A, Miksch S, Quaglini S, Seyfang A, Shortliffe E and 
Stefanelli M. (2003) Comparing computer-interpretable guideline models: a 
case-study approach. Journal of the American Medical Informatics 
Association: JAMIA 10(1):52-68. 
 
Persell S, Dolan N, Friesema E, Thompson J, Kaiser D and Baker D. (2010) 
Frequency of Inappropriate Medical Exceptions to Quality measures. Annals 
of Internal Medicine 152 (4): 225-249.     
 
Popescu M and Xu D. (2009) Data Mining Applications Using Ontologies in 
Biomedicine. London: Artech House. 
 
Pugh, G. [2009?] Outcomes Based Accountability: a brief summary. IDEA.  
Available from: http://www.idea.gov.uk/idk/aio/8940584 [Accessed 23 April 
2012]. 
 
RAND Europe, Ernst & Young LLP. (2012) National Evaluation of the 
Department of Health’s Integrated Care Pilots.  Available from: 
http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/do
cuments/digitalasset/dh_133127.pdf. [Accessed 3 July 2012]. 
 
Rogers J. (2006) Quality assurance of medical ontologies. Methods of 
Information in Medicine.45(3):267-74. 
 
Román I, Roa L, Madinabeitia G and Milan A. (2007) Introducing guideline 
management in the healthcare information system architecture. Studies in  
Health Technology and Informatics 127:117-24. 
 
Roth C, Lim Y, Pevnick J, Asch S and McGlyn E. (2009) The challenge of 
measuring quality of care from the electronic health record. American Journal 
 173 
of Medical Quality: The official journal of the American College of Medical 
Quality. 2009; 24(5):385-94.  
 
Rubin D, Shah N and Noy N.  (2008) Biomedical Ontologies: a functional 
perspective. Briefings in Bioinformatics 9(1):75-90.  
 
Sachs E. (2006) Getting started with Protégé Frames. Available from: 
http://protege.stanford.edu/doc/tutorial/get_started/get-started.html [Accessed 
7 May 2013]. 
 
Semantic Web. (2012) METHONTOLOGY. Available from: 
http://semanticweb.org/wiki/METHONTOLOGY [Accessed 16 April 2014] 
 
Shahar Y. (2006) Hybrid specification, storage, retrieval and runtime 
application of clinical guidelines. Journal of the Neurological Sciences 27 
Suppl 3:S250-3. 
 
Shahar Y, Young O, Shalom E, Galperin M, Mayaffit A, Moskovitch R, 
Hessing A. (2004 ) A framework for a distributed, hybrid, multiple-ontology 
clinical-guideline library, and automated guideline-support tools. Journal of 
Biomedical Informatics 37(5):325-44. 
 
Sheber S. (2012)  NQF Releases Updated Quality Data Model. Journal of 
AHIMA  Available from: http://journal.ahima.org/2012/07/01/nqf-releases-
updated-quality-data-model/.  [Accessed 13 May 2013]. 
 
Sistrunk T. (1993) The function of praise in the contract of a medieval public 
physician. Journal of the History of Medicine and Allied Sciences 48(3):320-
34. 
 
Sonnenberg F and Hagerty C. (2006) Computer-interpretable clinical practice 
guidelines. Where are we and where are we going? Yearbook of Medical 
Informatics 145-58. 
Stanford Center for Biomedical Informatics Research. (2014a) Protégé: a free, 
open-source ontology editor and framework for building intelligent systems. 
Available from: http://protege.stanford.edu/ [Accessed 20 April 2014]. 
Stanford Center for Biomedical Informatics Research. (2014b) Protégé 
Desktop Older Versions. Available from: 
http://protegewiki.stanford.edu/wiki/Protege_Desktop_Old_Versions 
[Accessed 15/10/14]. 
Stanford Center for Biomedical Informatics Research (2014c) Ontology 101: A 
guide to creating your first ontology. Available from: 
http://protegewiki.stanford.edu/wiki/Ontology101 [Accessed 22 April 2014]. 
Stanford Center for Biomedical Informatics Research (2013) Choosing 
Between Versions of Desktop Protégé. Available from: 
http://protegewiki.stanford.edu/wiki/Protege4Migration 
 174 
Surján G, Szilágyi E and Kováts T. (2006) A pilot ontological model of public 
health indicators. Computers in Biology and Medicine 36(7-8):802-16. 
Available from: 
http://dare.uva.nl/document/201596 [Accessed 6 September 2012]. 
 
Surján G, Szilágyi E, Kovács T and Kincses G. (2004) Conceptual framework 
of health indicators: the IDA model. Studies in Health Technology and 
Informatics 107(2):1230-4.  
 
Thompson W, Rasmussen L, Pacheco J, Peissig P, Denny J, Kho A, Miller A 
and Pathak J. (2012) An evaluation of the NQF Quality Data Model for 
representing Electronic Health Record driven phenotyping algorithms. AMIA 
Annual Symposium Proceedings 2012 911-20. 
 
Tröhler U. (2011) The introduction of numerical methods to assess the effects 
of medical interventions during the 18th century: a brief history. Journal of the 
Royal Society of Medicine 104(11):465-74. Available from: 
http://www.jameslindlibrary.org/illustrating/articles/the-introduction-of-
numerical-methods-to-assess-the-effects-of-m [Accessed 6 April 2012]. 
 
Tu S, Musen M, Shankar R, Campbell J, Hrabak K, McClay J, Huff S, 
McClure R, Parker C, Rocha R, Abarbanel R, Beard N, Glasgow J, Mansfield 
G, Ram P, Ye Q, Mays E, Weida T, Chute CG, McDonald K, Molu D, Nyman 
M, Scheitel S, Solbrig H and Zill D, Goldstein M. (2004) Modeling guidelines 
for integration into clinical workflow. Studies in Health Technology and 
Informatics 107(1):174-8. 
 
Van Wyk J and Van Wijk M. (2002) Assessment of the possibility to classify 
patients according to cholesterol guideline screening criteria using routinely 
recorded electronic patient record data. Studies in Health Technology and 
Informatics 93:39-46. 
 
Velamuri S. (2010) QRDA--technology overview and lessons learned. Journal 
of Healthcare Information Management: JHIM 24(3):41-8. 
 
Walter L, Davidowitz N, Heineken P and Covinsky K. (2004) Pitfalls of 
converting practice guidelines into quality measures: lessons learned from a 
VA performance measure. JAMA: the Journal of the American Medical 
Association 291(20):2466-2470. 
 
Wang D, Peleg M, Bu D, Cantor M, Landesberg G, Lunenfeld E, Tu S, Kaiser 
G, Hripcsak G, Patel V, and Shortliffe E. (2003) GESDOR – a generic 
execution model for sharing of computer-interpretable clinical practice 
guidelines. AMIA Annual Symposium Proceedings 2003 694–698. 
 
Wang D, Peleg M, Tu S, Boxwala A, Greenes R, Patel V and Shortliffe E. 
(2002) Representation primitives, process models and patient data in 
computer-interpretable clinical practice guidelines: a literature review of 
guideline representation models. International Journal of Medical Informatics 
68 (1–3):59–70. 
 175 
 
Wang, D; Peleg, M; Tu, S, Boxwala A, Greenes R, Patel V and Shortliffe E. 
(2004) Design and implementation of the GLIF3 guideline execution engine. 
Journal of Biomedical Informatics 37 (5):305-318. 
 
WC3 (2014) Ontology Editors. Available from: 
http://www.w3.org/wiki/Ontology_editors [Accessed 15/10/14] 
 
Weiner M, Stump T, Callahan C, Lewis J and McDonald C. (2005) Pursuing 
integration of performance measures into electronic medical records: beta-
adrenergic receptor antagonist medications. Quality & Safety in Health 
Care.14(2):99-106. 
 
Weisz G, Cambrosio A, Keating P, Knaapen L, Schlich T, and Tournay VJ. 
(2007) The emergence of clinical practice guidelines. Milbank 
Quarterly.85(4):691-727. 
 
Weng C, Tu SW, Sim I and Richesson R. (2010) Formal representations of 
eligibility criteria: A literature review. Journal of Biomedical Informatics 43(3) 
451-467.. 
 
White, P and Roudsari, A. (2011) Use of Ontologies for Monitoring Electronic 
Health Records for Compliance with Clinical Practice Guidelines.  Studies in 
Health Technology and Informatics 164:103-9.   
 
Winnenburg R and Bodenreider O. (2012) Issues in creating and maintaining 
value sets for clinical quality measures. AMIA Annual Symposium  
Proceedings 2012 988-96. 
 
Woolf S, Grol R, Hutchinson A, Eccles M and Grimshaw J. (1999) Clinical 
guidelines: potential benefits, limitations, and harms of clinical guidelines. 
BMJ. 318(7182):527-30. 
 
Wynden R, Weiner MG, Sim I, Gabriel D, Casale M, Carini S, Hastings S, 
Ervin D, Tu S, Gennari JH, Anderson N, Mobed K, Lakshminarayanan P, 
Massary M and Cucina R. (2010) Ontology mapping and data discovery for 
the translational investigator. AMIA Summits on Translational Science 
Proceedings 1;2010:66-70.  Avail from: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041530/?tool=pubmed 
[Accessed 12 March 2012]. 
 
 
 176 
Appendix 1: MeSH Tree Structure for ‘Quality of Health 
Care’ 
(National Library of Medicine 1998) 
 
This appendix shows the US National Library of Medicine Medical Subject 
Headings Tree Structure for ‘Quality of Health Care’. The hierarchical Tree 
Structure has branches stemming from sixteen categories. This helps to 
conceptualise different aspects of healthcare quality, with narrower and same 
level components. ‘Clinical Practice Guidelines’ and ‘Quality Indicators, Health 
Care’ are two related aspects of healthcare quality. 
All MeSH Categories  
Health Care Category  
Health Services Administration 
Quality of Health Care  
Advance Directive Adherence 
Clinical Competence 
Guideline Adherence 
Outcome and Process Assessment 
(Health Care)  
Outcome Assessment (Health 
Care) + 
Process Assessment (Health 
Care) 
Peer Review, Health Care 
Professional Review Organizations 
Program Evaluation  
Benchmarking 
Quality Assurance, Health Care  
Benchmarking 
Clinical Audit + 
Guidelines as Topic + 
Laboratory Proficiency Testing 
Total Quality Management 
Quality Improvement 
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Quality Indicators, Health Care  
Risk Adjustment 
Standard of Care 
Utilization Review  
Concurrent Review 
Drug Utilization Review 
All MeSH Categories  
Health Care Category  
Health Care Quality, Access, and Evaluation  
Quality of Health Care  
Epidemiologic Factors  
Age Factors + 
Bias (Epidemiology) + 
Causality + 
Comorbidity 
Confounding Factors 
(Epidemiology) 
Effect Modifier, Epidemiologic + 
Reproductive History 
Sex Factors 
Health Care Evaluation Mechanisms  
Advance Directive Adherence 
Data Collection + 
Epidemiologic Research Design 
+ 
Epidemiologic Study 
Characteristics as Topic + 
Evaluation Studies as Topic + 
Guideline Adherence 
Organizational Case Studies 
Outcome and Process 
Assessment (Health Care) + 
Patient Satisfaction 
Program Evaluation + 
Root Cause Analysis 
Statistics as Topic + 
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Technology Assessment, 
Biomedical 
Peer Review, Health Care 
Standard of Care 
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Appendix 2: NHS Information Centre Metadata 
Headings List  
(NHS Information Centre 2009b) 
 
This appendix shows the NHS Health and Social Care Information Centre 
(NHS HSCIC) Metadata Headings list, used to inspire the Glossary of Terms 
and the starting point for conceptualisation. As the list of indicators was 
supplied by the NHS HSCIC, it was appropriate to consider the metadata 
headings used to describe the indicators by the NHS HSCIC for the glossary 
of terms. Definitions for the NHS HSCIC’s Metadata Headings list are 
available from the NHS Information Centre. (2009b) Indicator Metadata 
Library Guide, along with clarifying information such as purpose and 
examples. 
 
The headings selected from the NHS HSCIC were: Library Reference 
Number/Identifier (renamed ‘Unique Identifier’ as this metadata should not be 
duplicated), Source (renamed ‘Reference’ as ‘Source’ is ambiguous), Title 
(renamed ‘Statement’ as Titles are generally not duplicated in other types of 
metadata and in library catalogues), Calculation/Methodology/ Formula 
(renamed ‘Formula’ and used in a narrower context), URL (this is a 
modification of the NHS HSCIC’s ‘Accessibility’ heading, which refers to 
potentially unlimited published information relating to the indicator), Publisher, 
Version (renamed ‘Version History’), Other Related PI’s (renamed relations) 
and Notes (with a slightly different definition). 
 
Library Reference Number / Identifier  
Subject  
Category  
Title  
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Detailed Descriptor  
Rationale  
Definition  
Units  
Coverage  
Source  
Calculations/Formula/Methodology  
Creator  
Status  
Quality  
Date  
Version History  
Update Frequency  
Accessibility  
Publisher  
Other related PI's (Relation)  
Additional Information  
User Feedback  
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Appendix 3: Quality Indicator Dimensions and Next 
Stage Review Pathways  
 
The Dimensions are: Effectiveness, Safety and Experience. 
The Pathways are: Acute Care, Children’s Health, End of Life Care, Learning 
Disabilities, Long Term Conditions, Maternity and Newborn, Mental Health, 
Other, Planned Care and Staying Healthy. 
 
The column, Indicator Set or Creators, lists the information used to fill in the 
Reference slot in the ontology. The information for this slot was taken from the 
NHS IC Source metadata. Sometimes there is more than one party 
responsible for the development of the indicator. This is the reason for 
including alternate information in the third column. 
 
Prior to entering instances, a Snapshot rule was created to address different 
status levels of the indicators.  If an indicator had a status of Dropped at the 
time of recording data into the table, the instance was not entered into the 
ontology. If an indicator had a status of Dropped after it was recorded into the 
table, the indicator was entered as an instance into the ontology. If an 
indicator had a status of Replaced by, at the time of recording into the table, 
the indicator was not entered into the ontology. If an indicator had a status of 
Replaced by after recording the indicator into this table, it was entered into 
the ontology.  Relationships and sometimes URL are not given if the indicator 
is no longer in use. 
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Dimension Next 
Stage 
Review 
Pathway 
(NSR) 
Indicator 
Set(s) 
and/or 
creators 
URL closest to 
methodology 
Number of Indicators  
 
Effectivenes
s 
Acute 
Care 
Myocardial 
Ischaemia 
National 
Audit Project 
(RCP) 
http://www.hqip.org.
uk/myocardial-
ischaemia-national-
audit-project-minap/ 
[Link to RCP project 
site is broken] 
3 (CV34, CV35, CV36) 
 Acute 
Care 
Compendium 
of Public 
Health 
Indicators/Na
tional Centre 
for Health 
Outcomes 
Development 
(funded by 
NHS IC) for 
Numerator.  
Hospital 
Episode 
Statistics for 
Denominator 
https://indicators.ic.
nhs.uk/webview/ 
[frames-based – 
must click on links 
within website] 
5 (RA01, RA18, RA20, 
RA24)  
 Acute 
Care 
Commissioni
ng Data Sets, 
12 Months 
http://www.nhs.uk/S
corecard/Pages/ 
IndicatorFacts.aspx
?MetricId= 
6&OrgType=5 
3 (RA17, RA25 (no longer 
in use), RA26) 
 Acute 
Care 
Department 
of Health 
Vital Signs – 
Tier 1 
http://www.dh.gov.u
k/en/ 
Publicationsandstati
stics/Publications/ 
PublicationsPolicyA
ndGuidance/ 
DH_082542 
1 (CV10) 
 Acute 
Care 
National 
Sentinel 
Stroke Audit 
[CV01, CV02 
and CV06 
are also CQC 
indicators] 
(RCP) 
https://mqi.ic.nhs.uk
/documents/ 
Stroke Clinical 
Proforma 
2008 REVISED.doc 
[Links to RCP are 
broken] 
6 (CV01, CV02, CV06, 
CV13, CV14, CV20) 
 Acute 
Care 
Surgical Site 
Infection 
Surveillance 
Service 
(Health 
Protection 
Agency) 
NICE may be 
original 
source 
http://www.hpa.org.
uk/Topics 
/InfectiousDiseases/
InfectionsAZ/ 
SurgicalSiteInfectio
n/Guidelines/ 
1 (HC24) 
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Dimension NSR 
Pathway 
Indicator 
Set(s) and 
/or creators 
URL closest to 
methodology 
Number of Indicators 
 Childrens
’ Health 
Immunisation 
Team, NHS 
Information 
Centre? [May 
be Health 
Protection 
Agency] 
[Refers to a chapter 
with incomplete 
citation and no 
URL] 
Source for this 
table: 
https://mqi.ic.nhs.uk 
/IndicatorDefaultVie
w.aspx?ref= 
1.02.02 
3 (WCC 2.09, WCC 2.10, 
WCC 2.11) 
 Childrens
’ Health 
Child and 
Adolescent 
Mental 
Health 
Service 
[No longer collected 
by Dept of Health 
as no longer in Vital 
Signs performance 
measure] 
2 (CF01, CF02) [No longer 
in use] 
 End of 
Life Care 
Quality and 
Outcomes 
Framework 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/ 
QualityOutcomesFr
amework.aspx 
2 (QOF PC 2, QOF PC 3) 
 End of 
Life Care 
National 
Centre for 
Health 
Outcomes 
Development
Compendium 
indicators, 
World Class 
Commissioni
ng 
http://www.nchod.n
hs.uk/NCHOD/Com
pendium.nsf/17b89
58892856d4480257
3a30020fcd9/37353
698180d191d65257
51a00363101!Open
Document 
 
1(WCC 3.24) 
 Learning 
Disabilitie
s 
Quality and 
Outcomes 
Framework 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/ 
QualityOutcomesFr
amework.aspx 
1 (QOF LD 1) 
 Long 
Term 
Condition
s 
Quality and 
Outcomes 
Framework 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/ 
QualityOutcomesFr
amework.aspx, Also 
associated with 
Dept of Health. 
Data available via 
NHS Information 
Centre. 
15 (QOF AF 4, QOF AF 1, 
QOF AF 3, QOF CANCER 
3, QOF CANCER 
1, QOF CHD 1, QOF CHD 
2, QOF CHD 5, QOF CKD 
2, QOF CKD 1, QOF CKD 
3, QOF CKD 5, QOF HF1, 
QOF BP 1, QOF STROKE 
1) 
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Dimension 
 
NSR 
Pathway 
 
Indicator 
Set(s) 
 
URL 
 
Number of Indicators 
 Long 
Term 
Condition
s 
Cancer 
Policy Team, 
Department 
of Health 
http://transparency.
dh.gov.uk/cancer-
waiting-times/ 
 
6 (CWT 1, VSA08, 
VSA11a, VSA12, VSA13, 
VSA11b) 
 Long 
Term 
Condition
s 
NHS Cancer 
Screening 
Programmes 
/ NHS 
Information 
Centre [WCC 
2.23 is also 
an indicator 
for NHS 
Choices and 
the Care 
Quality 
Comission, 
WCC 2.25 
is/was 
associated 
with the Care 
Quality 
Comission         
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref=1.05.07 
[URL given on this 
page does not 
work] 
http://www.connecti
ngforhealth.nhs.uk/ 
systemsandservice
s/ssd/downloads/ 
cytology/contents/k
c53 [for WCC 2.23] 
5 (VSA09, VSA10, VSA15, 
WCC 2.23, WCC 2.25- no 
longer in use) 
 Long 
Term 
Care 
Myocardial 
Ischaemia 
National 
Audit Project 
http://www.hqip.org.
uk/myocardial-
ischaemia-national-
audit-project-minap/ 
[Link to RCP project 
site is broken] 
1 (CV47) 
 Long 
Term 
Care 
National 
Clinical Audit 
Support 
Programme 
(NCASP)/RC
P. CV37 is 
also an 
indicator for 
CQC 
England 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref= 
1.05.27 
[No other link given 
on IC site for CV37 
& 38, RCP link for 
CV09 is broken] 
3 (CV37, CV38, CV09) 
 Long 
Term 
Care 
National 
Sentinel 
Stroke Audit 
https://mqi.ic.nhs.uk
/documents/ 
Stroke Clinical 
Proforma 
2008 REVISED.doc 
[Links to RCP are 
broken] 
2 (CV16 -no longer in use, 
CV21 - not in public 
domain) 
 Long 
Term 
Care 
National 
Bowel 
Cancer Audit. 
CA40 has 
been 
incorporated 
into a NICE 
guideline 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref= 
1.05.32 
[No other URL 
given] 
2 (CA36 – no longer 
produced, CA40) 
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Dimension 
 
 
NSR 
Pathway 
 
 
Indicator 
Set(s) 
 
 
URL 
 
 
Number of Indicators 
 Long 
Term 
Care 
National 
Lung Cancer 
Audit 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref= 
1.05.34  [No other 
URL given] 
1 (CA41) 
 Long 
Term 
Care 
UK Renal 
Registry 
http://www.renalreg.
com 
10 (LT13, LT14a, LT14b, 
LT15, LT17, LT18, LT20a, 
LT20b, LT21, LT22) 
 Maternity 
and 
Newborn 
DoH Vital 
Signs 
National 
Priority Tier 2 
and NICE. 
Health 
Improvement 
Analytical 
Team, DH 
specified as 
Creator/Prod
ucer for 
VSB11. Info 
Ctr specified 
as 
Creator/Prod
ucer for 
VSB06 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref= 
1.06.01 
[URL given does 
not work] 
2 (VSB06 – related to Na’tl 
Indicator Set: NI 126, 
VSB11) 
 Maternity 
and 
Newborn 
Care Quality 
Commission 
[URL given defaults 
to CQC homepage: 
http://www.cqc.org.
uk/public 
1 (WCC2.06) 
 Mental 
Health 
Quality and 
Outcomes 
Framework 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/ 
QualityOutcomesFr
amework.aspx 
10 (QOF DEM 2, QOF 
DEM 1, QOF DEP 2, QOF 
DEP 1, QOF MH 9, QOF 
MH 4, QOF MH 6, QOF 
MH 7, QOF MH 8, QOF 
MH 5) 
 Mental 
Health 
DoH, 
Improving 
Access to 
Psychologica
l Therapies.  
Associated 
with NICE. 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref= 
1.07.12 
 
[IAPT URL given is 
broken, though can 
still access general 
IAPT site]  
1 ([QOF] MH 12 - Related 
to Vital Signs Indicator Tier 
3 Improve Access to 
Psychological Therapies , 
PSA 18 Indicator 5 : 
Improve Access to 
Psychological Therapies) 
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Dimension NSR 
Pathway 
Indicator 
Set(s) 
URL Number of Indicators 
 Other 
[Organ 
Donation] 
Potential 
Donor Audit, 
NHS Blood 
and 
Transplant 
(NHSBT) 
 
http://www.bmj.com
/content/ 
332/7550/1124.full?
maxtoshow= 
&HITS=10&hits=10
& 
RESULTFORMAT 
=&author1=Barber+
K&fulltext= 
donation& 
andorexactfulltext=a
nd&searchid= 
1&FIRSTINDEX=0&
sortspec= 
relevance&resource
type=HWCIT 
4 (LT25, LT26, LT27, 
LT24) 
 Planned 
Care 
Cancer 
Quality 
Information 
Network 
System. 
CA45 is/was 
also 
associated 
with NICE 
https://mqi.ic.nhs.uk
/ 
Search.aspx?query
=CA27& 
ref=1.09.01.01 
[Other URLs given 
do not work] 
6 (CA27, CA28, CA45 – 
these measures have 
been dropped, CA29, 
CA51, CA01 – still in use) 
 Planned 
Care 
National 
Bowel 
Cancer Audit 
https://mqi.ic.nhs.uk 
/IndicatorDefaultVie
w.aspx? 
ref=1.05.34  
[No other URL 
given] 
1 (CA42a – no longer in 
use) 
 Planned 
Care 
National 
Head and 
Neck Cancer 
Audit.  
Associated 
with National 
Clinical Audit 
Support 
Programme 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref= 
1.09.01.08 
[No other URL 
given] 
1 (CA42b) 
[This has been replaced 
by another indicator, with 
different descriptive 
information] 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Cancer  
National 
Lung Cancer 
Audit 
 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref= 
1.09.01.09 
[No other URL 
given] 
1 (CA42c) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Cardiova
scular] 
Quality 
Outcomes 
Framework 
QOF PP 1 
associated 
with NICE 
CG 67. 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/Quality
Outcomes 
Framework.aspx 
14 (QOF CHD 6, QOF 
CHD 7, QOF CHD 8, QOF 
CHD 9, QOF CHD 10, 
QOF CHD 11, QOF CHD 
12, QOF HF 2, QOF HF 3, 
QOF HF 4, QOF BP 4, 
QOF BP 5, QOF PP1, 
QOF PP 2 – described as 
‘Future Indicator’ with 
anticipated date) 
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Dimension 
 
NSR 
Pathway 
 
Indicator 
Set(s) 
 
URL 
 
Number of Indicators 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Cardiova
scular] 
Central 
Cardiac Audit 
Database 
from National 
Clinical Audit 
Support 
Programme. 
Associated 
with Care 
Quality 
Commission 
and now 
under the 
National 
Institute for 
Cardiovascul
ar Outcome 
Research. 
http://www.ucl.ac.uk
/nicor/audits 
 
http://heartsurgery.c
qc.org.uk/about-
aortic-valve.aspx 
(CV49) 
3 (CV48, CV49, CV52 – 
described as ‘Future 
Indicator’) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Cardiova
scular] 
Myocardial 
Ischaemia 
National 
Audit Project 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx? 
ref=1.09.02.17 
[Royal College of 
Physicians links are 
broken] 
5 (CV29, CV30, CV31, 
CV32, CV33) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
COPD] 
Quality 
Outcomes 
Framework 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/Quality
Outcomes 
Framework.aspx 
[QOF COPD 13 
associated with 
NICE CG12 and 
CCQ]  
6 (QOF COPD 12, QOF, 
COPD 10, QOF COPD 1, 
QOF COPD 8, QOF 
COPD 13 – described as 
‘Future Indicator’ with 
anticipated date, QOF 
COPD 11 – no longer in 
use) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Diabetes] 
Quality 
Outcomes 
Framework 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/Quality
Outcomes 
Framework.aspx 
18 (QOF DM 21, QOF DM 
7 – replaced by QOF DM 
12, QOF DM 9, QOF DM 
10, QOF DM 11, QOF DM 
12, QOF DM 13, QOF DM 
15, QOF DM 16, QOF DM 
17, QOF DM 18, QOF DM 
22, QOF DM 19, QOF DM 
2, QOF DM 5, QOF DM 
23, QOF DM 24, QOF DM 
25 - designated as ‘Future 
Indicator’ with anticipated 
date) 
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Dimension 
 
NSR 
Pathway 
 
Indicator 
Set(s) 
 
URL 
 
Number of Indicators 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Other] 
Quality 
Outcomes 
Framework 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/Quality
Outcomes 
Framework.aspx 
10 (QOF ASTHMA 8, QOF 
ASTHMA 3, QOF 
ASTHMA 6, QOF 
ASTHMA 1, QOF 
EPILEPSY 6, QOF 
EPILEPSY 5, QOF 
EPILEPSY 7, QOF 
EPILEPSY 8, QOF 
THYROID 2, QOF 
THYROID 1,) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Other] 
Hospital 
Episode 
Statistics via 
British 
Association 
of Day 
Surgery 
 
http://daysurgeryuk.
net/bads/ 
joomla/index.php/eff
iciency-
assessment-tool 
1 (TC05 – status 
unknown) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Other] 
Commissioni
ng Data 
Sets_36 
Months 
 
http://www.nhs.uk/S
corecard/ 
Pages/IndicatorFact
s.aspx? 
MetricId=94&OrgTy
pe=5 
2 (MR30, MR31) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Other] 
Department 
of Health 
http://transparency.
dh.gov.uk/ 
2012/07/05/diagnos
tics-information/ 
1 (TC03) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Other]  
Quality 
Outcomes 
Framework 
QOF CKD 6 
also 
associated 
with NICE 
CG 73 and 
SIGN 103 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/Quality
Outcomes 
Framework.aspx 
 
 
6 (QOF DEP 3, QOF CKD 
6, QOF SH 1, QOF SH 2, 
QOF SH 3 – described as 
‘Future Indicator’ with 
anticipated date) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Other]  
Hospital 
Episode 
Statistics 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref= 
1.09.05.21  
[No other URL 
given] 
1 (HES 1 – described as 
‘Future Indicator’ with no 
date) 
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Dimension 
 
 
NSR 
Pathway 
 
 
Indicator 
Set(s) 
 
 
URL 
 
 
Number of Indicators 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Other]  
Surgical Site 
Infection 
Surveillance 
Service 
(Health 
Protection 
Agency) 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref= 
1.09.05.22 
[Other URLs do not 
lead to 
methodology] 
3 (HC22, HC23, HC25) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Stroke] 
Quality 
Outcomes 
Framework 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/Quality
Outcomes 
Framework.aspx 
7 (QOF STROKE 13, QOF 
STROKE 5, QOF 
STROKE 7, QOF 
STROKE 8, QOF 
STROKE 6, QOF 
STROKE 12, QOF 
STROKE 10) 
 Planned 
Care 
[Extra 
column 
labelled 
‘Topic’ = 
Stroke] 
National 
Sentinel 
Stroke Audit  
(RCP) 
CV11 is also 
associated 
with DoH and 
VSA14, 
which is not 
part of this 
set 
https://mqi.ic.nhs.uk
/documents/ 
Stroke%20Clinical
%20Proforma% 
202008%20REVIS
ED.doc 
and  
https://mqi.ic.nhs.uk
/documents/ 
2008%20Clinical%2
0audit%20help-
booklet%20FINAL.d
oc 
6 (CV03, CV08, CV05, 
CV11, CV19, CV04) 
 Staying 
Healthy 
Quality 
Outcomes 
Framework 
http://www.nhsempl
oyers.org/ 
PayAndContracts/ 
GeneralMedicalSer
vicesContract/ 
QOF/Pages/Quality
Outcomes 
Framework.aspx 
3 (QOF OB 1, QOF 
SMOKING 3, QOF 
SMOKING 4) 
Patient 
Experience 
Long 
Term 
Condition
s 
DoH https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx? 
ref=2.01.01 
1 (VSC11) 
 Long 
Term 
Condition
s 
Estates 
Returns 
Information 
Collection 
Data 
http://www.hefs.ic.n
hs.uk/ 
1 (ERIC1) 
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Dimension NSR 
Pathway 
Indicator 
Set(s) 
URL Number of Indicators 
 Long 
Term 
Condition
s 
Care Quality 
Commission 
Inpatient 
Services 
Survey.  
Related to 
Outpatients 
departments 
survey, 
Emergency 
Department 
Survey, 
Children and 
Young 
Peoples' 
Survey 
http://www.cqc.org.
uk/public [URL 
given by NHS IC 
defaults to general 
website] 
May be able to 
search for MQ39, 
Q32 (PE41), Q35 
(PE42), Q36 (PE43, 
PE36 (Q47)) etc (ID 
numbers not always 
given), National 
Inpatient Survey 
2011 
15 (PE49, PE50, PE53, 
PE54, PE41, PE42, PE43, 
PE36, PE37, PE38, PE39, 
PE56, PE48, PE51, PE52 
– status unknown for most 
or all of  these indicators) 
 Other Patient 
Environment 
Action Team 
Assessment. 
National 
Patient 
Safety 
Agency, 
DoH, 
contracted 
with NHS IC. 
Data 
received by 
CQC and 
DoH 
http://www.nrls.nps
a.nhs.uk/patient-
safety-data/peat/ 
3 (PEAT 1, PEAT 2, PEAT 
3) 
 Other Patient 
Experience 
Headline 
Measures. 
DoH and 
CQC. 
http://webarchive.na
tionalarchives.gov.u
k/ 
+/www.dh.gov.uk/e
n/Publicationsandst
atistics/ 
PublishedSurvey/N
ationalsurveyofNHS
patients/ 
DH_087516 
8 (PEXIS1 – produced in 
part with data from PE04 & 
PE05, PEXIS2 – produced 
in part with data from 
PE23, PEXIS3 – produced 
in part with data from 
PE16, PE19 and PE20, 
PEXIS4 – produced in part 
with data from PE38, 
PE39 and PE42, PEXIS 5 
– produced in part with 
data from PE09, PE36, 
PE37, PE48, PE49 and 
PE51, PEXIS6 no longer 
in use, PEXIS7 no longer 
in use, PEXIS8 – no 
longer in use) 
 Other Patient 
Survey 
Programme. 
CQC  
http://www.cqc.org.
uk/public [URL 
given on NHS IC 
site defaults to this 
general URL – may 
be able to search 
CQC site using Q38 
on National 
Inpatient Survey] 
1 (PE58) 
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Dimension NSR 
Pathway 
Indicator 
Set(s) 
URL Number of Indicators 
 Planned 
Care 
Cancer 
Quality 
Improvement 
Network 
System 
http://www.cquins.n
hs.uk/ [more 
specific URL given 
is broken] 
1 (CA25) 
 Planned 
Care 
CQC http://www.cqc.org.
uk/public [URL 
given on NHS IC 
site defaults to this 
general URL – may 
be able to search 
CQC site for PE07 
using Q43, Q42 for 
PE15, Q41 for 
PE16, Q63 for 
PE18, Q64 for 
PE19, Q66 for 
PE21, Q67 for 
PE22, Q71 for 
PE26, Q77 for 
PE29, Q14 and 17 
for PE33, Q19 for 
PE34, Q46 for 
PE35, Q30 for 
PE06, Q59 for 
PE17, Q49 for 
PE09, Q76 for 
PE28, Q65 for 
PE20, Q68 for 
PE23, Q69 for 
PE24, Q70 for 
PE25 on National 
Inpatient Survey 
2011 
25 (PE07, PE08, PE15, 
PE16, PE18, PE19, PE21, 
PE22, PE26, PE29, PE33, 
PE34, PE35, PE06, PE04, 
PE05, PE17, PE09, PE28, 
PE27, PE20, PE23, PE24, 
PE25, PE11 – no longer in 
use) 
 Planned 
Care 
Monthly 
diagnostic 
waiting times. 
DoH 
http://transparency.
dh.gov.uk/2012/07/
03/monthly-
diagnostics-data-
2012-13/ 
1 (CV43) 
 Planned 
Care 
National 
Bowel 
Cancer Audit 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref=2.03.28 
[no other URL 
given] 
1 (CA35a – based on 
NICE guideline (not 
specified) 
 Planned 
Care 
National 
Lung Cancer 
Audit 
https://mqi.ic.nhs.uk
/ 
IndicatorDefaultVie
w.aspx?ref=2.03.29 
[no other URL] 
1 (CA35b – NCLA 
[NLCA?] standard) 
Safety Planned 
Care 
Health 
Protection 
Agency 
Infectious 
Diseases. 
DoH Vital 
Signs – Tier 
1. 
http://www.hpa.org.
uk/web/ 
HPAweb&HPAweb
Standard/HPAweb_
C/1233906819629 
2 (PS37, PS39, VSA03) 
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Dimension NSR 
Pathway 
Indicator 
Set(s) 
URL Number of Indicators 
 Planned 
Care 
Surgical Site 
Infection 
Surveillance 
Service 
(Health 
Protection 
Agency) 
http://www.hpa.org.
uk/ 
webc/HPAwebFile/
HPAweb_C/ 
1227774003731 
[mostly data, with 
someuseful 
background detail] 
1 (HC21) 
 Planned 
Care 
National 
Reporting 
and Learning 
System 
https://mqi.ic.nhs.uk
/documents/ 
RLS%20CQI%20in
dicator%20defs.doc 
3 (NRLS 1, NRLS 2, NRLS 
3) 
 Planned 
Care 
National Staff 
Survey. CQC 
http://www.cqc.org.
uk/media 
[URL given defaults 
to CQC Media 
page] 
1 (PS24) 
 Mental 
Health 
Mental 
Health 
Minimum 
DataSet, 
DoH, World 
Class 
Commissioni
ng 
https://mqi.ic.nhs.uk
/IndicatorDefaultVie
w.aspx?ref=3.03.01 
(MH06) 
https://mqi.ic.nhs.uk
/IndicatorDefaultVie
w.aspx?ref=3.03.03 
(MH17) 
3 (MH06, MH16, MH17) 
 194 
Appendix 4. Indicators by Purpose, with Related 
Indicators 
[referred to in referenced document as ‘Guidelines’, from Institute of Medicine 
1992 classic CPG report (Field and Lohr 1992)]   
 
The five purposes are: 
”1) Screening and prevention: Eg, Vaccination for pregnant women who are 
planning international travel.  
2) Diagnosis and prediagnosis management of patients: Eg, Evaluation of 
chest pain in the emergency room.  
3) Indications for use of surgical procedures: Eg, Indications for carotid 
endarterectomy.  
4) Appropriate use of specific technologies and tests as part of clinical care: 
Eg, Use of autologous or donor blood for transfusions.  
5) Guidelines for care of clinical conditions: Eg, Management of patients 
following coronary-artery bypass graft” 
 
Screening 
and 
Prevention 
 
Diagnosis and 
prediagnosis 
management of 
patients 
 
Indications 
for use of 
surgical 
procedures 
Appropriate 
use of 
specific 
technologies 
and tests as 
part of 
clinical care 
Indicators 
for care of 
clinical 
conditions  
WCC 2.09 
(Proportion 
of children 
completing 
MMR 
immunisation 
by 2nd 
birthday) 
Narrower 
aspect to 
WCC 2.10 
CV02 (patients 
given a brain scan 
within 24 hours of 
stroke) 
CV35 
(patients who 
received 
primary 
angioplasty 
within 120 
minutes of 
call) 
CV20 (With 
the increasing 
use of 
thrombolysis in 
appropriate 
stroke patients 
this will enable 
national 
benchmarking 
of rollout) 
CV34 
(patients 
who received 
thrombolytic 
treatment 
within 60 
minutes of 
call) 
Broader 
than CV36 
WCC 2.10 
(Proportion of 
children who 
complete 
MMR 
immunisation 
(1st and 2nd 
dose) by their 
5th birthday) 
Broader 
aspect to 
WCC 2.09  
CV06 (stroke 
patients given a 
swallow 
screening within 24 
hours of admission) 
CV36 
(patients 
who received 
primary 
angioplasty 
within 120 
minutes of 
call – joint 
criteria with 
Indicators 
for Clinical 
Conditions) 
QOF CHD 5 
(The percentage 
of patients with 
coronary heart 
disease whose 
notes have a 
record of blood 
pressure in the 
previous 15 
months) 
Narrower 
aspect to QOF 
CHD 1 
CV36 
(patients 
who received 
thrombolytic 
treatment 
within 60 
minutes of 
call – joint 
criteria with 
Indications 
for Surgical 
Procedures) 
Narrower 
than CV34 
and CV35 
 195 
Screening 
and 
Prevention 
 
Diagnosis and 
prediagnosis 
management of 
patients 
 
Indications 
for use of 
surgical 
procedures 
Appropriate 
use of 
specific 
technologies 
and tests as 
part of 
clinical care 
Indicators 
for care of 
clinical 
conditions  
WCC 2.11 
(Proportion 
of children 
who 
complete 
DTP 
immunisation 
by their 5th 
Birthday) 
CV13 (Acute units 
with 5/6 key 
characteristics 
(… access to  
scanning within 3 
hours of 
admission/24 hour 
brain imaging; policy 
for direct admission 
from A&E; …; acute 
stroke  
protocols/guidelines) 
– joint criteria with 
Indicators for 
Clinical 
Conditions) 
VSA11a 
(Cancer 31-
Day  
Subsequent 
Treatments 
Target 
(Surgery 
Treatments)) 
QOF CKD 2 
(The percentage 
of patients on 
the CKD register 
whose notes 
have a record of 
blood pressure 
in 
the previous 15 
months) 
Narrower 
aspect to QOF 
CKD 1. Broader 
than CKD 3. 
Related to CKD 
5. 
RA01, 
RA17, 
RA18, 
RA20, 
RA24, 
RA25, 
RA26 
(Preventing 
readmissions 
by learning 
from other 
Trusts’ data) 
 
VSA09 
(NHS 
Breast 
Screening 
Programme 
to women 
aged 53-70) 
CV14 (access 
to scanning for 
patients with a 
stroke within 3 
hours of 
admission) 
Related to 
CV13 (same 
level) 
CA40 
(Median 
number of 
lymph nodes 
examined in 
surgical 
specimen) 
Related to 
CA41 
CA41 
(Histological 
Confirmation 
Rate) Related 
to CA40 (not 
essential to) 
CV13 (Acute units 
with 5/6 key 
characteristics 
(continuous 
physiological 
monitoring; access 
to scanning within 3 
hours of 
admission/24 hour 
brain imaging; policy 
for direct admission 
from A&E; specialist 
ward round at least 
5 times a week; 
acute stroke 
protocols/guidelines) 
– joint criteria with 
Diagnoses Mgmt) 
Related to CV14 
(same level) 
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Screening 
and 
Prevention 
 
Diagnosis 
and 
prediagnosis 
management 
of patients 
 
Indications 
for use of 
surgical 
procedures 
Appropriate 
use of 
specific 
technologies 
and tests as 
part of 
clinical care 
Indicators for 
care of clinical 
conditions  
VSA10 
(Extension 
of NHS 
Bowel 
Cancer 
Screening 
Programme 
to men and 
women 
aged up to 
75) 
QOF AF 4 
(The 
percentage of 
patients with 
atrial fibrillation 
diagnosed 
after 1 April 
2009 with ECG 
or specialist 
confirmed 
diagnosis) 
TC05 
(Percentage 
of BADS 
(British 
Association of 
Day Surgery) 
Directory of 
Procedures 
(including 
electronic 
assessment) 
carried out as 
a day case 
or within 
appropriate 
length of stay) 
QOF DEP 2 
(In those 
patients with a 
new diagnosis 
of depression, 
recorded 
between the 
preceding 1 
April to 31 
March, the 
percentage of 
patients who 
have had an 
assessment of 
severity at the 
outset 
of treatment 
using an 
assessment tool 
validated 
for use in 
primary care) 
Joint Criteria 
with Diagnosis 
CV01 (stroke 
patients given 
Aspirin or alternative 
e.g. clopidogrel 
within 48 hours of 
stroke) 
VSA15 (All 
women to 
receive 
results of 
cervical 
screening 
tests within 
two weeks) 
CWT 1 
(patients first 
seen by a 
specialist 
within two 
weeks when 
urgently 
referred with 
suspected 
cancer) 
 QOF DEP 1 
(The percentage 
of patients on 
the diabetes 
register and/or 
the CHD 
register for 
whom case 
finding for 
depression has 
been 
undertaken on 
one occasion 
during the 
previous 15 
months using 
two standard 
screening 
questions) Joint 
Criteria with 
Screening 
CV10 (High risk 
stroke unit patients 
are scanned and 
treated within 24 
hours) 
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Screening 
and 
Prevention 
 
Diagnosis 
and 
prediagnosis 
management 
of patients 
 
Indications 
for use of 
surgical 
procedures 
Appropriate 
use of 
specific 
technologies 
and tests as 
part of 
clinical care 
Indicators for 
care of 
clinical 
conditions  
WCC 2.23 
(Proportion 
of women 
aged 25-49 
and 50-64 
screened for 
cervical 
cancer) 
QOF CHD 2 
(The percentage 
of patients with 
newly diagnosed 
angina 
(diagnosed after 
1 April 2003) who 
are referred for 
exercise testing 
and/or specialist 
assessment) 
 QOF MH 4 
(The percentage 
of patients on 
lithium therapy 
with a record of 
serum creatinine 
and TSH in the 
preceding 15 
months) 
HC24 (Rate of 
surgical site 
infection 
following open 
reduction of 
long bone 
fracture) 
Narrower than 
HC21 
VSA08 
(Breast 
Symptom 
Two Week 
Wait) 
CV47 
(Percentage of 
acute coronary 
syndrome 
patients 
who are seen by 
a cardiologist 
during 
admission.) 
 QOF MH 5 
(The percentage 
of patients on 
lithium therapy 
with a record of 
lithium levels in 
the therapeutic 
range within the 
previous 6 
months) 
CF01, CF02 
(Number of 
hospital 
occupied bed 
days on adult 
psychiatric 
wards of 
patients aged 
under 16, on 
admission, 
under the care 
of a psychiatric 
specialist) – no 
longer in use 
QOF CKD 3 
(The 
percentage of 
patients on the 
CKD register 
in 
whom the last 
blood 
pressure 
reading, 
measured 
in the previous 
15 months, is 
140/85 or 
less) 
Narrower 
aspect to 
QOF CKD 1 & 
QOF CKD 2. 
Related to 
CKD 5. 
LT13 
(Percentage of 
patients 
presenting to a 
nephrologist less 
than 90 days 
before RRT 
initiation.) 
 CA27 
(Pathology 
services: 
percentage 
compliance with 
3D measures) 
QOF PC2 (The 
practice has 
regular (at least 
3 monthly) 
multidisciplinary 
case review 
meetings where 
all 
patients on the 
palliative care 
register are 
discussed) 
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surgical 
procedures 
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clinical care 
Indicators for 
care of 
clinical 
conditions  
CA36 
(Percentage of 
bowel cancer 
cases where 
there is a 
histological 
report on the 
presence or 
absence of 
tumour in the 
resection 
margin) 
QOF DEP 2 (In 
those patients 
with a new 
diagnosis of 
depression, 
recorded between 
the preceding 1 
April to 31 March, 
percentage of 
patients who 
have had an 
assessment of 
severity at the 
outset 
of treatment…) 
Joint Criteria 
with Appropriate 
Use 
 CA28 (Imaging 
services: 
percentage 
compliance with 
3B 
Measures) 
QOF PC3 (The 
practice has a 
complete 
register 
available of all 
patients in need 
of palliative 
care/support 
irrespective of 
age) 
 
Screening 
and 
Prevention 
 
Diagnosis and 
prediagnosis 
management of 
patients 
 
Indications 
for use of 
surgical 
procedures 
Appropriate  
use of specific 
technologies and 
tests as part of 
clinical care 
Indicators for  
care of 
clinical 
conditions  
VSB06 
(Percentage 
of women in 
the relevant 
PCT 
population 
who have 
seen a 
midwife or a 
maternity 
healthcare 
professional, 
for health and 
social care 
assessment of 
needs, risks 
and choices 
by 12 weeks 
and 6 days of 
pregnancy) 
Narrower 
aspect to 
WCC 2.06 
QOF HF 2 (The 
percentage of patients 
with a diagnosis of 
heart failure (diagnosed 
after 1 April 2006) which 
has been confirmed by an 
echocardiogram or by 
specialist assessment) 
Related to QOF HF 3 
(same level).  Broader 
than CV29, CV30, CV31, 
CV32, CV33. Joint 
Criteria with Appropriate 
Use  
 
CA29 (Radiotherapy: 
percentage compliance 
with 3E Measures) 
WCC3.24 
(Percentage 
of all deaths 
that occur at 
home) 
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Screening 
and 
Prevention 
 
 
 
Diagnosis and 
prediagnosis 
management of 
patients 
 
 
 
Indications 
for use of 
surgical 
procedures 
 
 
Appropriate  
use of specific 
technologies and 
tests as part of 
clinical care 
 
 
Indicators for  
care of 
clinical 
conditions  
WCC 2.06 
(Smoking 
during 
pregnancy) 
Broader 
aspect to 
VSB06 
QOF BP 4 (The 
percentage of patients 
with hypertension in 
whom there is a record of 
the blood pressure in the 
previous 9 months) 
Broader aspect to QOF 
BP 5, QOF PP1 and QOF 
PP2. 
 
 QOF HF 2 (The 
percentage of patients 
with a diagnosis of 
heart failure (diagnosed 
after 1 April 2006) which 
has been confirmed by an 
echocardiogram or by 
specialist assessment) 
Related to QOF HF 3 
(same level). Joint 
Criteria with Diagnoses 
and Prediagnosis 
/Management 
QOF LD 1 (The practice 
can produce a register of 
patients with learning 
disabilities) 
QOF DEP 1 
(The 
percentage of 
patients on 
the diabetes 
register and/or 
the CHD 
register for 
whom case 
finding for 
depression 
has been 
undertaken on 
one occasion 
during the 
previous 15 
months using 
two standard 
screening 
questions) 
Joint Criteria 
with 
Appropriate 
Use 
CA42a  (Percentage of 
[Bowel Cancer] cases 
reported to the audit with 
modified Dukes staging 
recorded)  
 QOF COPD 12 (The 
percentage of all patients 
with COPD diagnosed 
after 1st April 2009 in 
whom the diagnosis has 
been confirmed by post 
bronchodilator spirometry) 
Joint criteria with 
Diagnoses/Prediagnoses 
Management.  
Narrower aspect to 
QOF COPD 1 and 13. 
Related to QOF 
COPD 8,10, 11 
(same level). 
QOF AF 1 (The 
practice can produce a 
register of patients with 
atrial fibrillation) 
Broader aspect to 
QOF AF 3 
 
CA42b 
(Percentage of [Head and 
Neck Cancer] cases 
reported to the audit with 
pre-treatment T Stage and 
N Stage recorded) 
   
 
CA42c 
(Percentage of patients 
reported to the audit that 
have stage recorded for 
their lung cancer) 
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Indications 
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procedures 
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use of specific 
technologies and 
tests as part of 
clinical care 
Indicators for  
care of 
clinical 
conditions  
QOF CHD 
6 (The 
percentage of 
patients with 
coronary heart 
disease in 
whom the last 
blood 
pressure 
reading 
(measured in 
the previous 
15 months) is 
150/90 
Narrower 
aspect to 
QOF CHD 
7. Related 
to QOF 
CHD 8, 
QOF CHD 
9, QOF 
CHD 10 
and 12 
(same 
level) 
QOF PP1 (In those 
patients with a new 
diagnosis of  hypertension 
(excluding those with pre-
existing CHD, diabetes, 
stroke and/or TIA) 
recorded between the 
preceding 1 April and 31 
March: the percentage of 
patients who have had a 
face to face 
cardiovascular risk 
assessment at the outset 
of diagnosis (within three 
months of the initial 
diagnosis) using an 
agreed risk assessment 
treatment tool)  Related to 
QOF PP2 and QOF BP5 
(same level). Narrower 
aspect to QOF BP 4  
 QOF COPD 11 (No 
longer in use)(The 
percentage of patients 
with COPD receiving 
inhaled treatment in whom 
there is a record that 
inhaler technique has 
been checked in the 
previous 15 months) 
Related to QOF 
COPD  8, 10, 12 
Narrower aspect to 
QOF COPD 1, 13. 
QOF AF 3 (The 
percentage of patients 
with atrial fibrillation 
who are currently 
treated with anti-
coagulation 
drug therapy or an anti-
platelet therapy) 
Narrower aspect to 
QOF AF 1 
QOF CHD 7 
(The 
percentage of 
patients with 
coronary heart 
disease 
whose notes 
have a record 
of total 
cholesterol in 
the previous 
15 months or 
less) Broader 
aspect to 
QOF CHD 6, 
QOF CHD 8, 
QOF CHD 9. 
Related to 
QOF CHD 10 
and 12 (same 
level) 
QOF COPD 12 (The 
percentage of all patients 
with COPD diagnosed 
after 1st April 2009 in 
whom the 
diagnosis has been 
confirmed by post 
bronchodilator spirometry) 
Joint criteria with 
Diagnoses/Prediagnoses 
Management.  
Related to QOF 
COPD 8,10, 11 
(same level). 
Narrower aspect to 
QOF COPD 1 and 
13) 
 QOF DM 9 (The 
percentage of patients 
with diabetes with a record 
of the presence or 
absence of peripheral 
pulses in the previous 15 
months) Related to QOF 
DM 2, 5, 7, 10, 11, 12, 13, 
15, 16, 17, 18, 22, 19, 21, 
22, 23, 24, 25 (same 
level) 
QOF CANCER 3 
(patients with cancer, 
diagnosed within the 
last 18 months who 
have a patient review 
recorded as occurring 
within 6 
months of the practice 
receiving confirmation 
of 
the diagnosis) 
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and 
Prevention 
 
Diagnosis and 
prediagnosis 
management of 
patients 
 
Indications 
for use of 
surgical 
procedures 
Appropriate  
use of specific 
technologies and 
tests as part of 
clinical care 
Indicators for  
care of 
clinical 
conditions  
QOF CHD 
8 (The 
percentage of 
patients with 
coronary heart 
disease 
whose last 
measured 
total 
cholesterol 
(measured in 
the previous 
15 months) is 
5mmol/l or 
less) 
Narrower 
aspect to 
QOF CHD 6, 
QOF CHD 7. 
Related to 
QOF CHD 9, 
QOF CHD 10 
and QOF 
CHD 12 
(same level) 
QOF DM 19 (The 
practice can produce a 
register of all patients 
aged 17 years and over 
with diabetes mellitus, 
which specifies whether 
the patient has Type 1 or 
Type 2 diabetes) Related 
to QOF DM 2, 5, 7, 9, 10, 
11, 12, 13, 15, 16, 17, 18, 
21, 22, 23, 24 (same 
level) 
 QOF DM 10 (The 
percentage of patients 
with diabetes with a record 
of neuropathy testing in 
the previous 15 months) 
Related to QOF DM 2, 5, 
7, 9, 11, 12, 15, 13, 16, 
17, 18, 22, 19, 21, 23, 24, 
25 (same level) 
QOF CANCER 1 (a 
register of patients with 
a diagnosis of cancer 
excluding non-
melanotic skin 
cancers) 
QOF CHD 
12 (The 
percentage of 
patients with 
coronary heart 
disease who 
have a record 
of influenza 
immunisation 
in the 
preceding 1 
September to 
31 March) 
Related to 
QOF CHD 6, 
QOF CHD 7, 
QOF CHD 8, 
QOF CHD 9, 
and  QOF 
CHD 10 
(same level)   
QOF DEP 3 (In those 
patients with a new 
diagnosis of depression 
and assessment of 
severity recorded between 
the preceding 1 April to 31 
March, the percentage of 
patients who have had a 
further assessment of 
severity 5-12 weeks 
(inclusive) after the initial 
recording of the 
assessment of severity. 
Both assessments should 
be completed using an 
assessment tool validated 
for use in primary care) 
 QOF DM 11 (The 
percentage of patients 
with diabetes who 
have a record of the blood 
pressure in the 
previous 15 months) 
Related to QOF DM 2, 5, 
7. 9, 10, 12, 13, 15, 16, 
18, 17, 22, 19, 21, 23, 24, 
25 
VSA12 (Cancer 31-
Day Subsequent 
Treatments Target 
(Radiotherapy)) 
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tests as part of 
clinical care 
Indicators for  
care of 
clinical 
conditions  
QOF BP 5 
(The 
percentage of 
patients with 
hypertension 
in whom the 
last blood 
pressure 
(measured in 
the previous 9 
months) is 
150/90 or 
less)  
Narrower 
aspect to 
QOF BP 4. 
Related to 
QOF PP1 and 
QOF PP2. 
QOF STROKE 13 
(The percentage of new 
patients with a stroke or 
TIA who have been 
referred for further 
Investigation)  
Narrower aspect to QOF 
STROKE 1 
 QOF DM 13 (The 
percentage of patients 
with diabetes who have a 
record of micro-
albuminuria testing in the 
previous 15 months 
(exception reporting for 
patients with proteinuria)) 
Related to QOF DM 2, 5, 
7, 9, 10, 11, 12, 15, 16, 
17, 18, 22, 19, 21, 23, 24, 
25 (same level) 
VSA13 (Extended 62-
Day Cancer Treatment 
Targets) 
QOF COPD 
8 (The 
percentage of 
patients with 
COPD who 
have had 
influenza 
immunisation 
in the  
preceding 1 
September to 
31 March) 
Narrower 
aspect to 
QOF COPD 
1. Related 
to QOF 
COPD 10, 
13, and 11 
CV05 (Proportion of 
stroke patients who see 
Physiotherapist within 72 
hours of admission) 
Narrower aspect to QOF 
STROKE 1 
 QOF DM 22 (The 
percentage of patients 
with diabetes who have a 
record of estimated 
glomerular filtration rate 
(eGFR) or serum 
creatinine testing in the 
previous 15 months) 
Related to QOF DM 2, 5, 
7, 9, 10, 11, 12, 13, 15, 
16, 17, 18 19, 21, 23, 24, 
25 (same level) 
WCC 2.25 (Percentage 
of patients waiting no 
more than 31 days for 
cancer treatment) 
[Treatment not specific 
enough - could be 
surgery, radiotherapy or 
other] 
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tests as part of 
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care of 
clinical 
conditions  
QOF DM 
21 (The 
percentage of 
patients with 
diabetes who 
have a record 
of retinal 
screening in 
the previous 
15 months) 
Related to 
QOF DM 2, 5, 
7, 9, 10, 11, 
12, 13, 15, 16, 
17, 18, 19, 22, 
23, 24, 25 
(same level) 
CV04 (Proportion of 
stroke patients who see 
occupational therapist 
within 4 working days) 
Narrower aspect to QOF 
STROKE 1 
 QOF DM 16 (The 
percentage of patients 
with diabetes who have a 
record of total cholesterol 
in the previous 15 months) 
Related to QOF DM 2, 5, 
7, 9, 10, 11, 12, 13, 15, 
17, 18, 19, 21, 22, 23, 24, 
25 (same level) 
QOF CHD 1 (The 
practice can produce a 
register of patients 
with coronary heart 
disease) Broader aspect 
to QOF CHD 5 
QOF DM 12 
(The 
percentage of 
patients with 
diabetes in 
whom the last 
blood 
pressure 
reading is 
145/85 or 
less) Related 
to QOF DM 2, 
5, 7, 9, 10, 11, 
13, 16, 17, 18, 
19, 21, 22, 23, 
24, 25 (same 
level) 
  QOF ASTHMA 8 (The 
percentage of patients 
aged eight and over 
diagnosed as having 
asthma from 1 April 2006 
with measures of 
variability or reversibility) 
Related to QOF ASTHMA 
3, 6, 1 (same level, due 
to exclusion criteria in 1) 
QOF CKD 5 (The 
percentage of patients on 
the CKD register with 
hypertension and 
proteinuria who are 
treated with [appropriate 
medication]) Narrower 
aspect to QOF CKD 1.  
Related to QOF CKD 2 & 
3 (same level) 
QOF DM 17 
(Percentage 
of patients 
with diabetes 
whose last 
measured 
total 
cholesterol 
within the 
previous 15 
months is 
5mmol/l or 
less) Related 
to QOF DM 2, 
5, 7, 9, 10, 11, 
12, 13, 15, 16, 
18, 19, 21, 22, 
23, 24, 25 
(same level) 
  QOF THYROID 2 (The 
percentage of patients 
with hypothyroidism with 
thyroid function tests 
recorded in the previous 
15 months) Narrower 
aspect of QOF THYROID 
1 
QOF HF 1 (The 
practice can produce a 
register of patients 
with heart failure) 
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procedures 
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technologies and 
tests as part of 
clinical care 
Indicators for  
care of 
clinical 
conditions  
QOF DM 
18 (The 
percentage of 
patients with 
diabetes who 
have had 
influenza 
immunisation 
in the 
preceding 
1 September 
to 31 March) 
Related to 
QOF DM 2, 5, 
7,  9, 10, 11, 
12, 13, 15, 16, 
17, 19, 21, 22, 
23, 24, 25 
(same level) 
  QOF CKD 6 (The 
percentage of patients on 
the CKD register whose 
notes have a record of an 
albumin:creatinine ratio (or 
protein:creatinine ratio) 
test in the previous 15 
months) 
QOF BP 1 (The 
practice can produce a 
register of patients 
with established 
hypertension) 
QOF 
STROKE 5 
(The 
percentage of 
patients with 
TIA or stroke 
who have a 
record of 
blood 
pressure in 
the notes in 
the preceding 
15 months) 
Narrower 
aspect to 
QOF 
STROKE 1. 
Related to 
QOF 
STROKE 5 
and 6. 
  CV03 (Proportion of 
stroke patients given a 
Mood Assessment) 
Narrower aspect to QOF 
STROKE 1 
QOF STROKE 1 (The 
practice can produce a 
register of patients with 
stroke or TIA) Broader 
aspect to QOF STROKE 
5, 6, 7, 8, 12, 13, CV03, 
CV05.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 205 
Screening 
and 
Prevention 
 
Diagnosis and 
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Indications 
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technologies and 
tests as part of 
clinical care 
Indicators for  
care of 
clinical 
conditions  
QOF 
STROKE 7 
(The 
percentage of 
patients with 
TIA or stroke 
who have a 
record of total 
cholesterol in 
the last 15 
months) 
Narrower 
aspect to 
QOF 
STROKE 1 
  CV11 (Number of higher 
risk TIA cases who are 
scanned and treated 
within 24 hours)  
CV37 (Participation 
Rates in the Heart Failure 
Audit) 
QOF 
STROKE 
10 (The 
percentage of 
patients with 
TIA or stroke 
who have had 
influenza 
immunisation 
in the  
preceding 1 
September to 
31 March) 
Narrower 
aspect to 
QOF 
STROKE 1 
  QOF COPD 10 (The 
percentage of patients 
with COPD with a record 
of FeV1 in the previous 15 
months) Narrower aspect 
to QOF COPD 1. Related 
to QOF COPD 8, 13, and 
11 (same level) 
CV38 (Participation rates 
in the Cardiac 
Rehabilitation Audit) 
QOF OB 1 
(The practice 
can produce a 
register of 
patients 
aged 16 and 
over with a 
Body Mass 
Index (BMI) 
greater than 
or equal to 30 
in the  
previous 15 
months) 
  QOF DM 2 (The 
percentage of patients 
with diabetes whose 
notes record BMI in the 
previous 15 months)  
Related to QOF DM 5, 7, 
9, 10, 11, 12, 13, 15, 16, 
17, 18, 19, 22, 23, 24, 25 
CV16 (Development of 
continuing education  
programmes on stroke 
units) 
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procedures 
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tests as part of 
clinical care 
Indicators for the 
care of clinical 
conditions  
QOF 
SMOKING 
3 (The 
percentage of 
patients with 
any (or any 
combination 
of) the 
following 
conditions: 
coronary 
heart disease, 
stroke or TIA, 
hypertension, 
diabetes, 
COPD, CKD, 
asthma, 
schizophrenia, 
bipolar 
affective 
disorder or 
other 
psychoses, 
whose notes 
record 
smoking 
status in the 
previous 15 
months) 
Broader 
aspect to 
QOF 
SMOKING 4   
  QOF DM 5 (The 
percentage of patients 
with diabetes who 
have a record of HbA1c or 
equivalent in the previous 
15 months) Related to 
QOF DM 2, 7, 9, 10, 11, 
12, 13, 15, 16, 17, 18, 19, 
21, 22, 23, 24, 25 (same 
level) 
CV09 (Proportion of 
sites with a community 
stroke team for longer 
term management 
attached to the stroke 
multidisciplinary team) 
    CV21 (Proportion of sites 
with formal links to 
patient/carer groups) 
    VSA11b (Cancer 31-
Day Subsequent 
Treatments Target 
(Drug Treatments)) 
Related to VSA 11a 
    LT14a (Percentage of 
prevalent haemodialysis 
(HD) 
patients with haemoglobin 
between 10.5 - 12.5 g/dl)  
Related to LT14b & LT15 
& LT17 & LT18 & LT20a 
& LT20b & LT21 & LT22 
(same level) 
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procedures 
Appropriate  
use of specific 
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clinical care 
Indicators for  
care of 
clinical 
conditions  
    LT14b (Percentage of 
prevalent peritoneal 
dialysis (PD) patients with 
haemoglobin between 
10.5 - 12.5 
g/dl) Related to LT14a & 
LT15 & LT17 & LT18 & 
LT20a & LT20b & LT21 & 
LT22 (same level) 
    LT15 (Percentage of 
prevalent haemodialysis 
(HD) 
patients with URR >65%) 
Related to LT14a & 
LT14b & LT17 & LT18 & 
LT20a & LT20b & LT21 & 
LT22 (level) 
    LT17 (Percentage of 
prevalent haemodialysis 
patients with phosphate 
between 1.1 - 1.8 mmol/L) 
Related to LT14a & 
LT14b & LT15 & LT18 & 
LT20a & LT20b & LT21 & 
LT22 (same level) 
    LT18 (Percentage of 
prevalent peritoneal 
dialysis patients with 
phosphate between 1.1 - 
1.8 mmol/L) Related to 
LT14a & LT14b & LT15 & 
LT17 & LT20a & LT20b & 
LT21 & LT22 (same 
level) 
    LT20a (Percentage of 
peritoneal dialysis patients 
with blood pressure of 
less than 130/80 mmHg ) 
Related to LT14a & 
LT14b & LT15 & LT17 & 
LT18 & LT21 & LT22
 
    LT20b (Percentage of 
patients with BP <130/80 
mmHg: 
Tx) Related to LT14a & 
LT14b & LT15 & LT17 & 
LT18 & LT20a & LT21 & 
LT22 (same level) 
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procedures 
Appropriate  
use of specific 
technologies and 
tests as part of 
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care of 
clinical 
conditions  
    LT21 (Percentage of 
prevalent haemodialysis 
patients with bicarbonate 
between 20 - 26 mmol/L) 
Related to LT14a & 
LT14b & LT15 & LT17 & 
LT18 & LT20a & LT20b & 
LT22 (same level) 
    LT22 (Percentage of 
prevalent peritoneal 
dialysis patients with 
bicarbonate between 22 – 
30 mmol/L) Related to 
LT14a & LT14b & LT15 & 
LT17 & LT18 & LT20a & 
LT20b & LT21 (same 
level) 
    VSB11 (Prevalence of 
Breastfeeding at 6-8 
weeks) 
    QOF DEM 2 (The 
percentage of patients 
diagnosed with 
dementia whose care has 
been reviewed in the 
previous 15 months) 
Narrower aspect to QOF 
DEM 1 
    QOF DEM 1 (The 
practice can produce a 
register of patients 
diagnosed with dementia) 
Broader aspect to QOF 
DEM 2 
    QOF MH 9 (The 
percentage of patients 
with schizophrenia, 
bipolar affective disorder 
and other psychoses with 
a review recorded in the 
preceding 15 months.) 
Narrower aspect to QOF 
MH 8. 
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prediagnosis 
management of 
patients 
 
Indications 
for use of 
surgical 
procedures 
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care of 
clinical 
conditions  
    QOF MH 6 (The 
percentage of [mental 
health] patients on the 
register who have a 
comprehensive care plan 
documented in the 
records agreed between 
individuals, their family 
and/or carers as 
appropriate) 
    QOF MH 7 (The 
percentage of patients 
with schizophrenia, 
bipolar affective disorder 
and other psychoses who 
do not attend the practice 
for their annual review 
who are identified and 
followed up by the 
practice team within 14 
days of non-attendance) 
Narrower aspect to QOF 
MH 8 
    QOF MH 8 (The 
practice can produce a 
register of people 
with schizophrenia, 
bipolar disorder and other 
psychoses) Broader 
aspect to QOF MH 7 and 
QOF MH 9. 
    MH12 (The number of 
people who are moving to 
recovery as a proportion 
of those who have 
completed a course of 
psychological treatment) 
    LT25 (Approach rate - 
The percentage of 
potential donors for whom 
solid organ donation was 
considered, whose family 
were approached for 
consent to donation) 
Broader aspect to LT26. 
Narrower aspect to LT24  
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    LT26 (Consent rate - 
The percentage of 
potential donors whose 
families were approached 
or made 
the approach for consent 
to donation who gave 
consent) Narrower 
aspect to LT24 & LT25. 
Broader aspect to LT27. 
    LT27 (Conversion rate - 
The percentage of 
potential 
donors who became 
actual donors) Narrower 
aspect to LT25 & LT26 & 
LT24 
    LT24 (Referral rate - The 
percentage of potential 
donors 
referred to a co-ordinator) 
Broader aspect to LT25, 
LT26, & LT27 
    CA51 (Compliance with 
3C-100 to 3C-500 
measures  (chemotherapy 
services)) 
    CA45 (Proportion of 
incident cases reviewed 
by Multi- 
Disciplinary Team (MDT) 
for all cancers) 
    CA01 (Percentage 
compliance with Peer 
Review by team (breast, 
lung, colorectal, local and 
specialist  gynaecology, 
local and specialist 
urology 
(including supranetwork 
testicular and penile, 
haematology and head & 
neck) 
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    QOF CHD 9 (The 
percentage of patients 
with coronary heart 
disease with a record in 
the previous 15 months 
that aspirin, an alternative 
anti-platelet therapy, or an 
anti-coagulant is being 
taken (unless a 
contraindication or side-
effects are recorded) 
Narrower aspect to QOF 
CHD 7. Related to QOF 
CHD 6, 8, 10 and12 
(same level) 
    QOF CHD 10 (The 
percentage of patients 
with coronary heart 
disease who are currently 
treated with a beta blocker 
(unless a contraindication 
or side-effects are 
recorded)) Related to 
QOF CHD 6, 8, 9 and 12 
(same level) Narrower 
aspect to QOF CHD 7. 
    QOF CHD 11 (The 
percentage of patients 
with a history of 
myocardial infarction 
(diagnosed after 1 April 
2003) who are currently 
treated with an ACE 
inhibitor or Angiotensin II 
antagonist) 
    QOF HF 3 (The 
percentage of patients 
with a current diagnosis of 
heart failure due to LVD 
who are currently treated 
with an ACE inhibitor or  
Angiotensin Receptor 
Blocker, who can tolerate 
therapy and for whom 
there is no 
contraindication) Related 
to QOF HF 2 (same 
level) 
    CV48 (30 day mortality 
after first time Coronary 
Artery Bypass Graft) 
     
 212 
 
Screening 
and 
Prevention 
 
 
Diagnosis and 
prediagnosis 
management of 
patients 
 
 
Indications 
for use of 
surgical 
procedures 
 
Appropriate  
use of specific 
technologies and 
tests as part of 
clinical care 
 
Indicators for  
care of 
clinical 
conditions  
    CV49 (30 day mortality 
after first time aortic valve 
Replacement) 
    CV52 (30 day mortality 
following congenital heart 
disease surgery) 
    CV29 (Percentage of 
patients following 
myocardial infarction 
discharged on aspirin) 
Related to CV 30, 31, 32, 
33 (same level) 
Narrower than QOF HF 2 
    CV30 (Percentage of 
patients following 
myocardial infarction 
discharged on beta-
blockers) Related to CV 
29, 31, 32, 33 (same 
level) Narrower than 
QOF HF 2 
    CV31 (Percentage of 
patients following 
myocardial infarction 
discharged on statins) 
Related to CV 29, 30, 32, 
33 (same level) 
Narrower than QOF HF 2 
    CV32 (Percentage of 
patients following 
myocardial infarction 
discharged on ACE 
inhibitors) Related to CV 
29, 30, 31, 33 (same 
level) Narrower than 
QOF HF 2 
    CV33 (Percentage of 
patients following 
myocardial infarction 
discharged on 
theinopyridine 
(clopidogrel)) Related to 
CV 29, 30, 31, 32 (same 
level) Narrower than 
QOF HF 2 
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    QOF PP 2 (The 
percentage of people with 
hypertension 
diagnosed after 1 April 
2009 who are given 
lifestyle advice in the last 
15 months for: 
increasing physical 
activity, smoking 
cessation, safe alcohol 
consumption and healthy 
diet) Related to QOF PP1 
and QOF BP5 (same 
level). Narrower than 
QOF BP 4. 
    QOF HF 4 (The 
percentage of patients 
with a current 
diagnosis of heart failure 
due to LVD who are 
currently treated with an 
ACE inhibitor or  
Angiotensin Receptor 
Blocker, who are 
additionally treated with a 
beta-blocker licensed for 
heart failure, or recorded 
as intolerant to or having 
a contraindication to beta-
blockers. (9 
points; thresholds 40 – 
60%)) 
    QOF COPD 1 (The 
practice can produce a 
register of patients 
with COPD) 
Broader than QOF 
COPD 1, 8,13, and 11 
    QOF COPD 13 (The 
percentage of patients 
with COPD who have had 
a review, undertaken by a 
healthcare 
professional, including an 
assessment of 
breathlessness using the 
MRC dyspnoea score in 
the preceding 15 months) 
Narrower than QOF 
COPD 1. Related to 8,10, 
and 11 (same level) 
 
 
 
 
 
 
 
 
 
 
 214 
Screening 
and 
Prevention 
 
Diagnosis and 
prediagnosis 
management of 
patients 
 
Indications 
for use of 
surgical 
procedures 
Appropriate  
use of specific 
technologies and 
tests as part of 
clinical care 
Indicators for  
care of 
clinical 
conditions  
    QOF DM 15 (The 
percentage of patients 
with diabetes with a 
diagnosis of proteinuria or 
micro-albuminuria who 
are treated with ACE 
inhibitors (or A2 
antagonists)) Related to 
QOF DM 2, 5, 7, 9, 10, 
11, 12, 13, 16, 17, 18, 19, 
21, 22, 23, 24, 25 (same 
level? Expertise Issue) 
    QOF DM 23 (The 
percentage of patients 
with diabetes in whom 
the last HbA1c is 7 or less 
(or equivalent 
test/reference range 
depending on local 
laboratory) in the previous 
15 months) Middle 
Aspect of QOF DM 24, 
25, & 7 Related to QOF 
DM 2, 5, 7,  9, 10, 11, 12, 
13, 15, 16, 17, 18, 19, 21, 
22, 24, 25 (same level – 
Expertise Issue)) 
    QOF DM 24 (The 
percentage of patients 
with diabetes in whom 
the last HbA1c is 8 or less 
(or equivalent 
test/reference range 
depending on local 
laboratory) in the previous 
15 months) Middle 
Aspect of QOF DM 23, 
25, & 7 Related to QOF 
DM 2, 5, 7, 9, 10, 11, 12, 
13, 15, 16, 17, 18, 19, 21, 
22, 23, 25 (Same level) 
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    QOF DM 25 (The 
percentage of patients 
with diabetes in whom 
the last HbA1c is 9 or less 
(or equivalent 
test/reference range 
depending on local 
laboratory) in the previous 
15 months) Broadest 
Aspect of QOF DM 23, 
24, & 7 Related to QOF 
DM 2, 5,  9, 10, 11, 12, 
13, 15, 16, 17, 18, 19, 21, 
22. (same level ) 
    QOF DM 7 (patients 
with diabetes in whom the 
last HbA1c is 10 or less 
(or equivalent 
test/reference range 
depending on local 
laboratory) in the previous 
15 months) 
Narrower than QOF 
DM 25.  Broader than 
QOF DM 23, 24.  
Related to QOF DM 2, 
5, 9, 10, 11, 12, 13, 15, 
16, 17, 19, 18, 21, 22. 
    QOF ASTHMA 3 (The 
percentage of patients 
with asthma between the 
ages of 14 and 19 in 
whom there is a record of 
smoking status in the 
previous 15 months) 
Related to QOF 
ASTHMA 6, 8, 1 (same 
level) 
    QOF ASTHMA 6 (The 
percentage of patients 
with asthma who have 
had an asthma review in 
the previous 15 months) 
Related to QOF 
ASTHMA 1, 3, 8 (same 
level) 
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    QOF ASTHMA 1 (The 
practice can produce a 
register of patients with 
asthma, excluding 
patients with asthma who 
have been prescribed no 
asthma-related drugs in 
the previous twelve 
months) Related to QOF 
ASTHMA 6, 3, 8 (same 
level) 
    QOF EPILEPSY 6 
(The percentage of 
patients age 18 and over 
on drug treatment for 
epilepsy who have a 
record of 
seizure frequency in the 
previous 15 months) 
Narrower aspect of 
QOF EPILEPSY 5 
    QOF EPILEPSY 5 
(The practice can produce 
a register of patients aged 
18 and over receiving 
drug treatment for 
epilepsy) Broader aspect 
of QOF EPILEPSY 6, 
7 & 8   
    QOF EPILEPSY 7 
(The percentage of 
patients aged 18 and over 
on drug treatment for 
epilepsy who have a 
record of medication 
review involving the 
patient and/or carer in the 
previous 15 months) 
Narrower aspect of 
QOF EPILEPSY 5 
    QOF EPILEPSY 8 
(The percentage of 
patients aged 18 and over 
on drug treatment for 
epilepsy who have been  
seizure free for the last 12 
months recorded in the 
previous 15 months) 
Narrower aspect of 
QOF EPILEPSY 5 
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    QOF THYROID 1 
(The practice can produce 
a register of patients with 
hypothyroidism) Broader 
aspect of QOF THYROID 
2 
    MR30 (Mortality 
following a knee 
replacement) 
    MR31 (Mortality 
following a hip 
replacement) 
    TC03 (Diagnostics 
waiting times: percentage 
of patients 
waiting under 6 weeks) 
    QOF SH 1 (The 
practice can produce a 
register of women 
who have been prescribed 
any method of  
contraception at least 
once in the last year, or 
other appropriate interval 
e.g. 5 years for an IUS) 
Broader aspect of QOF 
SH 2 and 3 
    QOF SH 2 (The 
percentage of women 
prescribed an oral or 
patch contraceptive 
method who have also 
received information from 
the practice about long 
acting reversible methods 
of contraception in the 
previous 15 months) 
Narrower aspect of QOF 
SH 1. Related to SH 3 
(same level) 
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    QOF SH 3 (The 
percentage of women 
prescribed emergency 
hormonal contraception at 
least once in the year 
by the practice who have 
received information from 
the practice about long 
acting reversible methods 
of contraception at the 
time of, or within 
one month of, the 
prescription) Narrower 
aspect to QOF SH 1. 
Related to SH2 (same 
level). 
    HES 1 (Pressure ulcer 
incidence per 10,000 
patients) 
    HC22 (Surgical site 
infections - Knee 
prosthesis) Related to HC 
23 and 25 (same level) 
Narrower than HC21 
    HC23 (Surgical site 
infections - Hip 
prosthesis) Related to 
HC22 and 25 (same 
level). Narrower than 
HC21 
    HC25 (Surgical site 
infections - Hip 
hemiarthroplasty) Related 
to HC22 and 23 (same 
level) Narrower than 
HC21 
    QOF STROKE 8 (The 
percentage of patients 
with TIA or stroke whose 
last measured total 
cholesterol (measured 
in the previous 15 
months) is 5mmol/l or 
less) Related to QOF 
STROKE 5 and  6 (same 
level) Narrower aspect 
to QOF STROKE 1 
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    QOF STROKE 6 (The 
percentage of patients 
with a history of TIA or 
stroke in whom the last 
blood pressure reading 
(measured in the previous 
15 months) is 150/90 or 
less) Related to QOF 
STROKE 5 and 8 (same 
level) Narrower aspect 
to QOF STROKE 1 
    QOF STROKE 12 
(The percentage of 
patients with a stroke 
shown to be non-
haemorrhagic, or a history 
of TIA, who 
have a record that an anti-
platelet agent (aspirin, 
clopidogrel, dipyridamole 
or a combination), or an 
anti-coagulant is being 
taken (unless a 
contraindication or side 
effects are recorded)) 
Narrower aspect to QOF 
STROKE 1 
    CV08 (Proportion of 
sites with early supported 
discharge 
team attached to the 
stroke multidisciplinary 
team) 
    CV19 (Average waiting 
time for neurovascular 
clinics) 
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    QOF SMOKING 4 
(The percentage of 
patients with any (or any 
combination of) the 
following conditions: 
coronary 
heart disease, stroke or 
TIA, hypertension, 
diabetes, COPD, CKD, 
asthma, schizophrenia, 
bipolar affective disorder 
or other psychoses, who 
smoke and whose notes 
contain a record that 
smoking cessation advice 
or referral to a specialist 
service, where available, 
has been 
offered within the previous 
15 months) Narrower 
aspect to QOF 
SMOKING 3.  
    VSC11 (People who in 
last 6 months, have had 
enough support from local 
services or organisations 
to help manage long-term 
health condition(s)) 
Related to PEXIS 1,2 3, 
4, PE15 (same level). 
    ERIC1 (Total Backlog 
Cost per Occupied Floor 
Area) 
    PE49 (Score for patients 
who reported that the 
hospital room or ward was 
very or fairly clean) 
Related to PE 50, 53, 54 
(same level) 
    PE50 (Score for patients 
who reported that the 
toilets and bathrooms in 
hospital were very or fairly 
clean) Related to PE 49, 
53, 54 
    PE53 (Score for patients 
who reported that doctors 
always or sometimes 
washed or cleaned their 
hands between touching 
patients) Related to PE 
49, 50, 54 (same level) 
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    PE54 (Score for patients 
who reported that nurses 
always or sometimes 
washed or cleaned their 
hands between touching 
patients) Related to PE 
49, 50, 53 (same level) 
    PE41 (Score for patients 
who reported that they 
always or sometimes had 
confidence and trust in the 
doctors treating them) 
    PE42 (Score for patients 
who reported that when 
they had important 
questions to ask a nurse, 
they always or sometimes 
got answers they could 
understand) Related to 
PE43, PE18 and PE19 
(same level) 
    PE43 (Score for patients 
who reported that they 
always 
or sometimes had 
confidence and trust in the 
nurses treating them) 
Related to PE42 (same 
level) 
    PE36 (Score for patients 
who said they were given 
enough privacy when 
being examined or 
treated) Narrower than 
PE37. Broader than 
PE35 
    PE37 (Score for patients 
who overall felt they were 
treated with respect and 
dignity whilst in hospital) 
Broader aspect to PE 
33, 34, 36, 38, 39. 
Probably Redundant to 
PEXIS 8 and PEAT 3. 
    PE38 (Score for patients 
who reported that the 
doctors 
did not talk in front of 
them as if they were not 
there) Narrower aspect 
to PE 37 
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    PE39 (Score for patients 
who reported that the 
nurses did not talk in front 
of them as if they were not 
there) Narrower aspect 
to PE 37 
    PE56 (Score for whether 
given enough privacy 
when being examined or 
treated in the Emergency 
Department) Narrower 
aspect to PE37 
    PE48 (Score for patients 
who reported that they 
were not bothered by 
noise at night from 
hospital staff) Narrower 
aspect to PE37 
    PE51 (Score for patients 
who reported that the 
hospital food was very 
good or good) Related to 
PE52 (same level) 
Narrower than PEAT 2  
    PE52 (Score for patients 
who reported that they 
were offered a choice of 
food) Related to PE 51 
(same level) Narrower 
than PEAT 2 
    PEAT 1 (A yearly 
assessment of the Patient 
Environment for all sites 
with 10 or more in patient 
beds) Eg, Points for 
infection control and 
cleanliness. Related to 
PE49, 50 (same level)
 
    PEAT 2 (A yearly 
assessment of the Food 
and Food Service for all 
sites with 10 or more in 
patient beds) Broader 
than PE 51, 52, PE 06
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    PEAT 3 (A yearly 
assessment of Privacy & 
Dignity for all sites with 10 
or more in patient beds) 
Related to PE 33, 34, 36, 
37, 38, 39 (same level) 
Broader than PE 36, 38, 
39, 56. Probably 
Redundant to PE 37 and 
PEXIS 8
 
    
PEXIS 1 (Patient 
Experience Headline 
score for Access & 
Waiting) Broader than 
PE 04, 05, 11 
    
PEXIS 2 (Patient 
Experience Headline 
score for safe high quality 
coordinated care) 
Narrower than PE23 
    
PEXIS 3 (Patient 
Experience Headline 
score for Better 
Information, more choice) 
Broader than PE15 
    
PEXIS 4 (Patient 
Experience Headline 
score for Building Closer  
Relationships) 
    
PEXIS 5 (Patient 
Experience Headline 
score for Clean, 
comfortable, friendly place 
to be) Related to  PE 48, 
49, 50, 53, 54, PEAT 1 
    
PEXIS 6 (Patient 
Experience Headline 
score for Focus on 
the person) Vague 
    
PEXIS 7 (Patient 
Experience Headline 
score for organisation that 
learns from experience) 
Vague 
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PEXIS 8 (Patient 
Experience Headline 
score for Focus on 
Dignity and Respect) 
Related to PE 
36,37,38,39. Broader 
than PE 33, 34, 36, 38, 
39, 56. Probably 
Redundant to PE 37 and 
PEAT 3 
    
PE 58 (Score for staffing 
effectiveness - patient 
reported nursestaffing 
adequacy) 
    
CA25 (Quality of Patient 
Experience: percentage 
compliance with patient 
experience measures)  
    
PE07 (Score for patients 
who reported that their 
family or someone close 
had the opportunity to talk 
to a doctor if they wanted 
to) Broader than PE24. 
    
PE08 (Score for patients 
who said that they found a 
member of hospital staff 
to talk to about their 
worries and fears)  
    
PE15 (Score for patients 
who reported that the 
'right amount' of 
information was given 
about 
conditions/treatments by 
healthcare professionals) 
Narrower than PEXIS 3 
    
PE16 (Score for patients 
who reported that they 
were involved as much as 
they wanted to be in 
decisions about their care 
and treatment 
    
PE18 (Score for patients 
who reported that when 
leaving 
hospital they were given 
written or printed 
information about what 
they should or should not 
do) Narrower than PE15 
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PE19 (Score for patients 
who reported that staff 
explained the purpose of 
the medicines they were 
to take at home in a way 
they could understand) 
Related to PE 42, 21, 22 
(same level) 
    
PE21 (Score for patients 
who reported that staff 
told them how to take their 
medication in a way they 
could understand) 
Related to PE42, 19, 22 
(same level). Broader 
than PE 20. 
    
PE22 (Score for patients 
who reported they were 
given clear written or 
printed information about 
their 
medicines) Related to 
PE42, 19, 21. Broader 
than PE20. 
    
PE26 (Score for patients 
who reported that they 
received copies of letters 
sent between hospital 
doctors and their GP) 
    
PE29 (Score for patients 
who reported that whilst in 
hospital they saw posters 
or leaflets explaining how 
to complain about the 
care or treatment they 
received) Narrower than 
PE16 and PEXIS 4 
    
PE33 (Score for patient 
who reported that after 
moving 
wards they did not share a 
sleeping area with a 
member of the opposite 
sex) Narrower than 
PEAT 3 and PEXIS 8 
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PE34 (Score for patients 
who reported that they did 
not 
have to use the same 
bathroom or shower area 
as patients of the opposite 
sex) Narrower than 
PEAT 3, PE37 and 
PEXIS 8 
    
PE35 (Score for patients 
who said they were given 
enough privacy when 
discussing their condition 
or treatment) Narrower 
than PEAT 3, PE37 and 
PEXIS 8. Narrower than 
PE36 (discussion vs 
examination). 
    
PEAT 2 (Score for 
patients who reported that 
they always or sometimes 
got enough help from staff 
to eat their meals) 
Narrower than PE 02 
    PE 94 (Score for 
patients who reported that 
their admission date was 
not changed by the 
hospital) Narrower than 
PEXIS 1 
    
PE 05 (Score for patients 
who reported that on 
arrival at the hospital they 
did not have to wait a long 
time to get a bed on a 
ward) Narrower than 
PEXIS 1 
    
PE17 (Score for patients 
who reported that they 
were  involved in 
decisions about their 
discharge from hospital) 
    
PE09 (Score for patients 
who thought that the 
hospital 
staff did everything they 
could to help control their 
pain) 
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PE 28 (Score of [sic] for 
patients who reported that 
during 
their hospital stay they 
were asked to give their 
views on the quality of 
care) 
    
 
 
 
 
 
PE 27 (Percentage of 
staff who reported that in 
the last month they had 
seen any errors, near 
misses or  incidents that 
could have hurt 
patients/service) 
users 
    
PE 20 (Score for patients 
who reported that staff 
told them about 
medication side effects to 
watch out for when they 
went home) Narrower 
than PE 21, 23 
    
PE23 (Score for patients 
who reported that staff 
told 
them about any danger 
signals to watch out for 
after they went home) 
Broader than PE 20 
    
PE24 (Score for patients 
who reported that the 
doctors or nurses gave 
their family or someone 
close to them all the 
information they needed 
to help care 
for them) Narrower than 
PE07 
    
PE25 (Score for patients 
who reported they were 
told who to contact if they 
were worried about their 
condition or treatment 
after they left hospital) 
    
PE11 (Percentage of 
patients very or fairly 
satisfied with the time they 
had to wait from being 
referred by their GP to 
when they saw the 
hospital specialist) 
Narrower than PEXIS 1 
 228 
Screening 
and 
Prevention 
 
Diagnosis and 
prediagnosis 
management of 
patients 
 
Indications 
for use of 
surgical 
procedures 
Appropriate  
use of specific 
technologies and 
tests as part of 
clinical care 
Indicators for  
care of 
clinical 
conditions  
    
CV43 (Median waiting 
times (weeks) for 
echocardiogram) 
    
CA35a (Percentage of 
Bowel Cancer patients 
seeing a relevant 
specialist nurse) 
    
CA35b (Percentage of 
Lung Cancer patients 
seeing a relevant 
specialist nurse) 
    
PS39 (Incidence of 
MRSA bacteraemia) 
    
VS03 (Incidence of 
clostridium difficile) 
    
HC21 (Surgical site 
infections – orthopaedic) 
Broader than HC 22, 23, 
24, 25 
    
NRLS1 (Consistent 
reporting of patient safety 
events reported to the 
Reporting and Learning 
System 
(RLS)) Related to NRLS 
2 (same level) Narrower 
than NRLS 3. 
    
PS24 (Availability of hand 
washing facilities) 
    
PS37 
 (Sickness Absence Rate) 
    
NRLS 2 (Timely 
reporting of patient safety 
events reported 
to the Reporting and 
Learning System (RLS)) 
Related NRLS1 (same 
level) Narrower than 
NRLS 3. 
    
NRLS 3 (Rate of patient 
safety events occurring in 
trusts 
that were submitted to the 
Reporting and 
Learning System (RLS)) 
Broader than NRLS 1, 2 
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Screening 
and 
Prevention 
 
Diagnosis and 
prediagnosis 
management of 
patients 
 
Indications 
for use of 
surgical 
procedures 
Appropriate  
use of specific 
technologies and 
tests as part of 
clinical care 
Indicators for  
care of 
clinical 
conditions  
    
MH06 (The  proportion of 
those patients on Care 
programme approach 
(CPA) discharged from 
inpatient care who are 
followed up within 7 days) 
Related to MH 16, 17 
(same level) 
    
MH16 (NI 149: Adults 
receiving secondary 
mental health services on 
Care Programme 
Approach (CPA) in 
settled accommodation) 
Related to MH 06, 17 
(same level) 
    
MH17 (NI150: Adults 
receiving secondary 
mental health services on 
Care Programme 
Approach (CPA) in 
employment) Related to 
MH 06, 16 (same level) 
    
QOF CKD 1 (The 
practice can produce a 
register of patients 
aged 18 years and over 
with CKD (US National 
Kidney Foundation: Stage 
3 to 5 CKD)) Broader 
aspect to QOF CKD 2, 3, 
5 
    
PE04 (Score for 
patients who reported 
that their admission 
date was not changed 
by the hospital) 
Narrower than 
PEXIS1. 
 
    
PE06 (Score for 
patients who reported 
that they always or 
sometimes got enough 
help from staff to eat 
their meals)   Narrower 
than PEAT2. 
 
    
VSA03 (Incidence of 
clostridium difficile) 
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Appendix 5: Layers of Inclusion/Exclusion Criteria 
 
This appendix lists layers of inclusion and exclusion criteria.  Inclusion criteria 
are taken from the indicator Statement. Exclusion criteria are taken from any 
NHS HSCIC metadata field that mentions “excludes” or a similar word or 
phrase. 
 
Indicator Layers of Inclusion Criteria Layers of 
Exclusion 
Criteria 
CV35 1) ST-elevation myocardial infarction (STEMI) patients 
2) who received primary angioplasty 
3) within 120 minutes of call (call to 
balloon time) 
 
CV36 1) ST-elevation myocardial infarction (STEMI) patients 
2) who received thrombolytic treatment 
3) within 60 minutes of call (call to needle time) 
4) who [also] received primary angioplasty 
5) within 120 minutes of call (call to balloon time) 
 
CV34 1) ST-elevation myocardial infarction (STEMI) patients 
2) who received thrombolytic treatment 
3) within 60 minutes of call (call to needle time) 
 
RA18 1) fractured proximal femur 
2) Emergency readmissions to hospital 
3) within 28 days of discharge 
1) Day cases 
OR Spells with a 
discharge code 
of death 
(Denominator) 
RA17 1) hip replacement surgery 
2) Emergency readmissions to hospital 
3) within 28 days of discharge 
1) CIP spells 
with a discharge 
code of death 
(Denominator) 
RA20 1) stroke 
2) Emergency readmissions to hospital 
3) within 28 days of discharge 
 
RA24 1) hysterectomy 
2) Emergency readmissions to hospital 
3) within 28 days of discharge 
1) spells with a 
discharge coded 
as death 
[Denominator] 
RA25 1) gallbladder surgery 
2) Emergency readmissions to hospital 
 
RA26 1) abdominal aortic aneurysm surgery 
2) Elective Readmissions 
 
CV02 1) stroke patients 
2) given a brain scan 
3) within 24 hours of stroke 
1) Cases with 
subarachnoid 
haemorrhage, 
subdural and 
extradural 
haematoma 
CV06 1) stroke patients 
2) given a swallow screening 
3) within 24 hours of admission 
 
CV13 1) Acute [stroke] units with 5/6 key characteristics 
2) continuous physiological monitoring  
3) access to scanning 
    a) within 3 hours of admission 
4) 24 hour brain imaging  
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5) policy for direct admission from A&E  
6) specialist ward round  
    a) at least 5 times a week 
CV14 1) Acute [stroke] units 
2) access to scanning 
    a) within 3 hours of admission 
1) Rehabilitation 
sites 
CV01 1) stroke patients 
2) given Aspirin or alternative e.g. clopidogrel 
3) within 48 hours of stroke  
1) patient is 
receiving 
palliative care  
OR patient died  
OR patient has 
an intra-cerebral 
haemorrhage
 
CV10 1) stroke unit patients 
2) spending at least 90% of their time on a stroke unit 
 
CV20 1) Sites offering thrombolysis 
2) to stroke patients 
1) Excludes 
rehabilitation 
only sites 
RA01 1) 16+ years old only 
2) Emergency readmissions to hospital 
3) within 28 days of discharge 
 
HC24 1) long bone fracture  
2) Open reduction 
 
WCC 2.09 1) children, 2 years and under 
2) who complete MMR immunization 
 
WCC 2.10 1) children, 5 years and under 
2) who complete MMR immunisation (1st and 2nd dose) 
 
WCC 2.11 1) children, 5 years and under 
2) who complete DTP immunisation 
 
CF01 1) patients aged under 16 (on admission) 
2) under the care of a psychiatric specialist 
3) occupied bed days on adult psychiatric wards 
 
CF02 1) patients aged 16 or 17, on admission 
2) under the care of a psychiatric specialist 
3) occupied bed days on adult psychiatric wards 
 
QOF PC 2 1) multidisciplinary case review meetings 
2) where all patients on the palliative care register are 
discussed 
3) at least 3X monthly 
 
QOF PC 3 1) Register of all patients in need of palliative 
care/support 
 
WCC 3.24 1) all deaths  
2) that occur at home 
 
QOF LD 1 1) register of patients with learning disabilities  
QOF AF 4 1) patients with atrial fibrillation 
2) with ECG or specialist confirmed diagnosis 
3)  after 1 April 2009 
 
QOFAF 1 1) register of patients with atrial fibrillation  
 
QOF AF 3 1) patients with atrial fibrillation 
2) currently treated with anti-coagulation 
drug therapy or an anti-platelet therapy 
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Indicator 
 
Layers of Inclusion Criteria 
 
Layers of 
Exclusion 
Criteria 
QOF 
CANCER 3 
1) patients with cancer 
2) diagnosed within the last 18 months 
3) patient review recorded 
4) review recorded as occurring within 6 
months of the practice receiving confirmation of the 
diagnosis 
 
CWT 1 1) Patients urgently referred with suspected cancer 
2) first seen by a specialist within two weeks of referral 
 
QOF 
CANCER 1 
1) register of patients with a 
diagnosis of cancer 
1) non-
melanotic skin 
cancers from 1 
April 2003 
VSA09 1) women  
2) aged 53-70 
3) NHS Breast Screening Programme 
 
VSA10 1) men and women  
2) aged up to 75 
3) NHS Bowel Cancer Screening 
Programme 
 
VSA15 1) women 
2) receive results of cervical screening 
tests 
3) within 2 weeks 
 
WCC 2.23 1) women 
2) aged 25-49 and 50-64 
3) screened for cervical cancer 
 
VSA08 1) Breast Symptom 
2) 2 week wait 
1) urgent 
referrals for 
suspected 
breast cancer 
VSA11a 1) Cancer 
2) Surgery Treatments 
3) 31-Day Subsequent Treatments 
 
VSA12 1) Cancer 
2) Radiotherapy 
3) 31-Day Subsequent Treatments 
 
VSA13 1) Cancer 
2) Extended 62-Day Treatment  
 
WCC 2.25 1) Cancer Patients 
2) waiting no more than 31 days for cancer treatment 
 
QOF CHD 1 1) register of patients with coronary heart disease  
QOF CHD 2 1) newly diagnosed angina (diagnosed after 1 April 
2003) 
2) referred for exercise testing and/or specialist 
assessment 
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Indicator 
 
Layers of Inclusion Criteria 
 
Layers of 
Exclusion 
Criteria 
QOF CHD 5 1) patients with coronary heart disease 
2) whose notes have a record of blood 
pressure 
3) in the previous 15 months 
 
QOF CKD 2 1) patients on the CKD register 
2) whose notes have a record of blood pressure 
3) in the previous 15 months 
 
QOF CKD 1 1) register of patients with CKD (US National 
Kidney Foundation: Stage 3 to 5 CKD) 
2) who are aged 18 years and over 
 
QOF CKD 3 1) patients on the CKD register 
2) whom the last blood pressure reading, measured in 
the previous 15 months 
3) is 140/85 or less 
 
QOF CKD 5 1) patients on the CKD register 
2) with hypertension and proteinuria 
3) who are treated with an angiotensin converting 
enzyme inhibitor (ACE-I) or angiotensin receptor blocker 
(ARB) 
1) (unless a 
contraindication 
or side effects 
are recorded) 
QOF HF 1 1) register of patients with heart failure  
QOF BP 1 1) register of patients with established hypertension  
QOF 
STROKE 1 
1) register of patients with stroke or TIA  
CV47 1) acute coronary syndrome patients 
2) who are seen by a cardiologist 
3) during admission 
 
CV37 1) Heart Failure Audit participants  
CV38 1) Cardiac Rehabilitation Audit 1) Submission of 
less than 20 
cases per month 
OR less than 
70% case 
ascertainment 
CV16 1) continuing education programmes for Stroke Unit 
staff 
 
CV09 1) sites with a stroke multidisciplinary team 
2) with a community stroke team for longer term 
management 
 
CV21 1) sites with formal links to patient/carer groups  
CA36 1) bowel cancer cases 
 
 
CA40 1) surgical specimen 
2) Median number of lymph nodes examined 
 
CA41 1) Histological Confirmation Rate  
VSA11b 1) Cancer Drug Treatments 
2) 31-Day Subsequent Treatments Target 
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Indicator 
 
Layers of Inclusion Criteria 
 
Layers of 
Exclusion 
Criteria 
LT13 1) patients presenting to a nephrologist 
2) RRT initiation 
3) less than 90 days before RRT initiation 
1) centres in the 
years where 
10% or more of 
the patients 
were reported to 
have started 
RRT on the 
same date as 
the first 
presentation 
LT14a 1) prevalent haemodialysis (HD) patients 
2)  with haemoglobin between 10.5 - 12.5 
g/dl 
1) Less than 20 
patients with a 
haemoglobin 
measurement 
2) Less than 
50% of the 
relevant patients 
had an Hb 
measurement 
available 
LT14b 1) prevalent peritoneal dialysis (PD) patients 
2)  with haemoglobin between 10.5 - 12.5 
g/dl 
1) Less than 20 
patients with a 
haemoglobin 
measurement 
2) Less than 
50% of the 
relevant patients 
had an Hb 
measurement 
available 
LT15 1) prevalent haemodialysis (HD) patients 
2) with URR >65% 
1) Less than 20 
patients with a 
URR value 
2) Less than 
50% of the 
relevant patients 
had a URR 
value available 
LT17 1) prevalent haemodialysis patients 
2) with phosphate between 1.1 - 1.8 mmol/L 
1) Less than 
50% of the 
relevant patients 
had a URR 
value available 
2) Less than 20 
patients with a 
URR value 
LT18 1) prevalent peritoneal dialysis patients 
2) with phosphate between 1.1 - 1.8 mmol/L 
1) Less than 20 
patients with a 
phosphate value 
2) Less than 
50% of the 
relevant patients 
had a 
[phosphate] 
value available 
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LT20a 1) [peritoneal dialysis ] patients 
2)  with BP <130/80 mmHg:PD 
1) Less than 20 
patients with a 
[BP] value 
2) Less than 
50% of the 
relevant patients 
had a [BP] value 
available 
LT20b 1)  [peritoneal dialysis ] patients 
2) with BP <130/80 mmHg:Tx 
1) Less than 20 
patients with a 
[BP] value 
2) Less than 
50% of the 
relevant patients 
had a [BP]  
value available 
LT21 1) prevalent haemodialysis patients 
2) with bicarbonate between 20 - 26 mmol/L 
1) Less than 20 
patients with a 
[bicarbonate] 
value 
2) Less than 
50% of the 
relevant patients 
had a 
[bicarbonate] 
value available 
LT22 1) prevalent peritoneal dialysis patients 
2) with bicarbonate between 22 – 30 mmol/L 
1) Less than 20 
patients with a 
[bicarbonate] 
value 
2) Less than 
50% of the 
relevant patients 
had a 
[bicarbonate] 
value available 
VSB06 1) Pregnant women  
2) who have seen a midwife or a maternity healthcare  
professional  
3) for health and social care assessment of needs, risks 
and choices 
4) by 12 weeks and 6 days of pregnancy 
 
VSB11 1) Breastfeeding 
2) at 6-8 weeks 
 
WCC 2.06 1) pregnancy 
2) smoking 
 
QOF DEM 1 1) register of patients diagnosed with dementia  
QOF DEP 2 1) patients with a new diagnosis of depression 
2) recorded between the preceding 1 April to 31 March 
3) at the outset of treatment 
4) patients who have had an assessment of severity 
 
QOF DEP 1 1) patients on the diabetes register and/or the CHD 
register  
2) for whom case finding for depression has been 
undertaken 
3) using two standard screening questions 
4) on one occasion during the previous 15 months 
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QOF MH 9 1) patients with schizophrenia, bipolar affective disorder 
and other psychoses 
2) with a review recorded in the preceding 15 
months.  
3) In the review there should be evidence 
that the patient has been offered routine health 
promotion and prevention advice appropriate to their 
age, gender and health status 
 
QOF MH 4 1) patients on lithium therapy 
2) with a record of serum creatinine and TSH in the 
preceding 15 months 
 
QOF MH 6 1) [Mental Health] patients on the register 
2) who have a comprehensive care plan documented in 
the records agreed between individuals, their family 
and/or carers as appropriate 
 
QOF MH 7 1) patients with schizophrenia, bipolar affective disorder 
and other psychoses 
2) who do not attend the practice for their annual review 
who are identified 
3) and [are] followed up by the practice team 
4) within 14 days of non-attendance 
 
QOF MH 8 1) register of people with schizophrenia, bipolar disorder 
and other psychoses 
 
QOF MH 5 1) patients on lithium therapy 
2) with a record of lithium levels in the therapeutic range 
3) within the previous 6 months 
 
 
[QOF] MH 
12 
1) [Patients] who have completed a course of 
psychological treatment 
2) who are moving to recovery 
 
LT25 1) potential donors for whom solid organ donation 
2) was considered 
3) whose family were approached for consent to 
donation 
1) absolute 
contraindications 
LT26 1) potential donors for whom solid organ donation 
2) was considered 
3) whose family were approached for consent to 
donation 
4) who gave consent 
1) absolute 
contraindications 
LT27 1) potential [organ] donors 
2) who became actual donors 
1) absolute 
contraindications 
LT24 1) potential [organ] donors 
2) referred to a co-ordinator 
1) absolute 
contraindications 
CA27 1) Pathology services 
2) compliance with 3D measures 
 
CA28 1) Imaging services  
2) compliance with 3B measures 
 
CA29 1) Radiotherapy  
2) compliance with 3E measures 
 
CA51 1) chemotherapy services 
2) Compliance with 3C-100 to 3C-500 measures 
 
CA45 1) Cancer incident cases 
2) reviewed by Multi-Disciplinary Team (MDT) 
 
CA01 1) [Cancer] 
2) compliance with Peer Review by 
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team (breast, lung, colorectal, local and specialist 
gynaecology, local and specialist urology (including 
supranetwork testicular and penile, haematology  and 
head & neck 
CA42a 1) [Bowel Cancer] 
2) cases staged  
3) at presentation 
No longer in 
use. 
CA42b 1) [Head & Neck Cancer] 
2) cases staged  
3) at presentation 
 
CA42c 1) [Lung Cancer] 
2) cases staged  
3) at presentation 
No longer in use 
QOF CHD 6 1) patients with coronary heart disease 
2) in whom the last blood pressure reading 
(measured in the previous 15 months) 
3)  is 150/90 or less 
 
QOF CHD 7 1) patients with coronary heart disease  
2) whose notes have a record of total cholesterol  
3) in the previous 15 months 
 
QOF CHD 8 1) patients with coronary heart disease  
2) whose last measured total cholesterol 
(measured in the previous 15 months)  
3) is 5mmol/l or less 
 
QOF CHD 9 1) patients with coronary heart disease  
2) with a record in the previous 15 months 
3) that aspirin, an alternative anti-platelet therapy, or an 
anti-coagulant is being taken 
(unless a 
contraindication 
or side-effects 
are recorded) 
QOF CHD 
10 
1) patients with coronary heart disease  
2) who are currently treated with a beta 
blocker  
(unless a 
contraindication 
or side-effects 
are recorded) 
QOF CHD 
11 
1) patients with a history of myocardial infarction  
2) (diagnosed after 1 April 2003)  
3) who are currently treated with an ACE 
inhibitor or Angiotensin II antagonist 
 
QOF CHD 
12 
1) patients with coronary heart disease  
2) who have a record of influenza immunisation  
3) in the preceding 1 September to 31 March 
 
QOF HF 2 1) patients with a diagnosis of heart failure  
2) (diagnosed after 1 April 2006)  
3) which has been confirmed by an  echocardiogram or 
by specialist assessment 
 
QOF HF 3 1) patients with a current diagnosis of heart failure  
2) due to LVD  
3) who are currently treated with an ACE inhibitor or 
Angiotensin Receptor Blocker,  
4) who can tolerate therapy  
1) and for whom 
there is no 
contraindication 
QOF BP 4 1) patients with hypertension  
2) in whom there is a record of the blood pressure  
3) in the previous 9 months 
 
QOF BP 5 1) patients with hypertension  
2) in whom the last blood pressure (measured in the 
previous 9 months)  
3) is 150/90 or less 
 
CV48 1) first time CABG  
2) 30 day mortality after 
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3) first time Coronary Artery Bypass Graft 
CV49 1) first time aortic valve replacement 
2) 30 day mortality after 
 
CV52 1) congenital heart disease surgery 
2) 30 day mortality following 
1) patient has 
not had further 
procedures 
(reoperation)  
2) within 30 days 
or 1 year 
CV29 1) myocardial infarction patients  
2) discharged on aspirin 
1) Aspirin 
contraindicated 
OR Treatment 
declined OR 
transferred to 
another hospital 
CV30 1) myocardial infarction patients  
2) discharged on beta-blockers 
1) Beta-blockers 
contraindicated 
OR Declined 
treatment 
OR Transferred 
to another 
hospital 
CV31 1) myocardial infarction patients   
2) discharged on statins 
1) Died in 
hospital 
OR Transferred 
elsewhere 
CV32 1) myocardial infarction patients following  
2) discharged on ACE inhibitors 
1) ACE inhibitors 
contraindicated 
OR Declined 
treatment OR 
Transferred to 
another hospital 
CV33 1) myocardial infarction patients  
2) discharged on theinopyridine (clopidogrel) 
1) Clopidogrel 
contraindicated 
OR Treatment 
declined OR 
Transferred to 
another hospital 
QOF PP 1 1) patients with a new diagnosis of hypertension  
2) recorded between the preceding 1 April and 31 March 
3)  who have had a face to face cardiovascular risk 
assessment at the outset of diagnosis (within three 
months of the initial diagnosis)  
4) using an agreed risk assessment treatment tool 
(excluding those 
with pre-existing 
CHD, diabetes, 
stroke and/or 
TIA) 
QOF PP 2 1) people with hypertension 
2) diagnosed after 1 April 2009  
3) who are given lifestyle advice for: 
increasing physical activity, smoking cessation, 
safe alcohol consumption and healthy diet 
4) in the last 15 months  
 
QOF HF 4 1) patients with a current diagnosis of heart failure  
2) due to LVD  
3) who are currently treated with an ACE inhibitor or 
Angiotensin Receptor Blocker,  
4) who are additionally treated with a beta-blocker 
licensed for heart failure, or recorded as intolerant to or 
having a contraindication to beta-blockers. (9 points; 
thresholds 40 – 60%) 
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QOF COPD 
12 
1) patients with COPD 
2) diagnosed after 1st April 2009  
3) in whom the diagnosis has been confirmed by post 
bronchodilator spirometry 
 
QOF COPD 
10 
1) patients with COPD  
2) with a record of FeV1  
3) in the previous 15 months 
 
QOF COPD 
1 
1) register of patients with COPD  
QOF COPD 
8 
1) patients with COPD  
2) who have had influenza immunisation  
3) in the preceding 1 September to 31 March 
 
QOF COPD 
13 
1) patients with COPD  
2) who have had a review, undertaken by a healthcare 
professional 
3) including an assessment of breathlessness  
4) using the MRC dyspnoea score  
5) in the preceding 15 months 
 
QOF COPD 
11 
1) patients with COPD 
2) receiving inhaled treatment  
3) In whom there is a record that inhaler technique has 
been checked 
4) in the previous 15 months 
 
QOF DM 21 1) patients with diabetes  
2) who have a record of retinal screening 
3) in the previous 15 months 
 
QOF DM 9 1) patients with diabetes 
2)  with a record of the presence or absence of 
peripheral pulses  
3) in the previous 15 months 
 
QOF DM 10 1) patients with diabetes  
2) with a record of neuropathy testing  
3) in the previous 15 months 
 
QOF DM 11 1) patients with diabetes  
2) who have a record of the blood pressure  
3) in the previous 15 months 
 
QOF DM 13 1) patients with diabetes  
2) who have a record of micro-albuminuria testing  
3) in the previous 15 months (exception reporting for 
patients with proteinuria) 
 
QOF DM 22 1) patients with diabetes  
2) who have a record of estimated glomerular filtration 
rate (eGFR) or serum creatinine testing  
3) in the previous 15 months 
 
QOF DM 19 1) register of all patients with diabetes mellitus 
2) aged 17 years and over, 
3) which specifies whether the patient has Type 1 or 
Type 2 diabetes 
 
QOF DM 2 1) patients with diabetes  
2) whose notes record BMI  
3) in the previous 15 months 
 
QOF DM 5 1) patients with diabetes  
2) who have a record of HbA1c or equivalent  
3) in the previous 15 months 
 
QOF DM 12 1) patients with diabetes  
2) in whom the last blood pressure reading is 145/85 or 
less 
 
QOF DM 15 1) patients with diabetes   
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2) with a diagnosis of proteinuria or micro-albuminuria  
3) who are treated with ACE inhibitors (or A2 
antagonists) 
QOF DM 16 1) patients with diabetes  
2) who have a record of total cholesterol  
3) in the previous 15 months 
 
QOF DM 17 1) patients with diabetes  
2) whose last measured total cholesterol is 5mmol/l or 
less 
3) within the previous 15 months 
 
QOF DM 18 1) patients with diabetes  
2) who have had influenza immunisation  
3) in the preceding 1 September to 31 March 
 
QOF DM 23 1) patients with diabetes  
2) in whom the last HbA1c is 7 or less (or equivalent 
test/reference range depending on local laboratory)  
3) in the previous 15 months 
 
QOF DM 24 1) patients with diabetes  
2) in whom the last HbA1c is 8 or less (or equivalent 
test/reference range depending on local laboratory) 
3) in the previous 15 months 
 
QOF DM 25 1) percentage of patients with diabetes  
2) in whom the last HbA1c is 9 or less (or equivalent 
test/reference range depending on local laboratory)  
3) in the previous 15 months 
 
QOF DM 7 1) patients with diabetes  
2) in whom the last HbA1c is 10 or less (or equivalent 
test/reference range depending on local laboratory)  
3) in the previous 15 months 
 
QOF 
ASTHMA 8 
1) patients aged eight and over 
2) diagnosed as having asthma  
3) with measures of variability or reversibility 
4) from 1 April 2006 
 
QOF 
ASTHMA 3 
1) patients with asthma  
2) between the ages of 14 and 19  
3) in whom there is a record of smoking status  
4) in the previous 15 months 
 
QOF 
ASTHMA 6 
1) patients with asthma  
2) who have had an asthma review  
3) in the previous 15 months 
 
QOF 
ASTHMA 1 
1) register of patients with asthma 1) excluding 
patients with 
asthma who 
have been 
prescribed no 
asthma-related 
drugs  
2) in the 
previous twelve 
months 
QOF 
EPILEPSY 
6 
1) [epilepsy] patients  
2) age 18 and over  
3) on drug treatment for epilepsy  
4) who have a record of seizure frequency  
5) in the previous 15 months 
 
QOF 
EPILEPSY 
1) register of [epilepsy] patients 
2) aged 18 and over  
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5 3) receiving drug treatment for epilepsy 
QOF 
EPILEPSY 
7 
1) [epilepsy] patients  
2) aged 18 and over  
3) on drug treatment for epilepsy  
4) who have a record of medication review involving the 
patient and/or carer  
5) in the previous 15 months 
 
QOF 
EPILEPSY 
8 
1) [epilepsy] patients  
2) aged 18 and over  
3) on drug treatment for epilepsy  
4) who have been seizure free for the last 12 months  
5) recorded in the previous 15 months 
 
QOF 
THYROID 2 
1) patients with hypothyroidism 
2) with thyroid function tests recorded  
3) in the previous 15 months 
 
QOF 
THYROID 1 
1) register of patients with hypothyroidism 
 
TC05 1) BADS (British Association of Day 
Surgery) Directory of Procedures  
2) (including electronic assessment)  
3) carried out as a day case 
or within appropriate length of stay 
 
MR30 1) knee replacement 
2) Mortality following  
 
MR31 1) hip replacement 
2) Mortality following 
 
TC03 1) Diagnostics patients 
2) waiting under 6 weeks 
 
QOF DEP 3 1) patients with a new diagnosis of 
depression and assessment of severity  
2) recorded between the preceding 1 April to 31 March,  
3) the percentage of patients who have had a further 
assessment of severity  
4) 5-12 weeks (inclusive) after the initial recording of the 
assessment of severity.   
5) Both assessments should be completed using an 
assessment tool validated for use in primary care 
 
QOF CKD 6 1) patients on the CKD register 
2) whose notes have a record of an 
albumin:creatinine ratio (or protein:creatinine ratio) test  
3) in the previous 15 months 
 
QOF SH 1 1) register of women who have been prescribed any 
method of contraception  
2) at least once in the last year, or 
other appropriate interval e.g. 5 years for an IUS 
 
QOF SH 2 1) women prescribed an oral or patch contraceptive 
method  
2) who have also received information from the practice 
about long acting reversible methods of contraception  
3) in the previous 15 months 
 
QOF SH 3 1) women prescribed emergency 
hormonal contraception  
2) at least once in the year by the practice  
3) who have received information 
from the practice about long acting reversible methods of 
contraception  
4) at the time of, or within one month of, the prescription 
 
HES 1 1) 10,000 patients  
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2) Pressure ulcer incidence per 
HC22 1) Knee prosthesis 
2) Surgical site infections  
 
HC23 1) Hip prosthesis 
2) Surgical site infections  
 
HC25 1) Hip hemiarthroplasty 
2) Surgical site infections  
 
QOF 
STROKE 13 
1) new patients with a stroke or TIA  
2) who have been referred for further 
investigation 
 
QOF 
STROKE 5 
1) patients with TIA or stroke 
2) who have a record of blood pressure in the notes 
3) in the preceding 15 months 
 
QOF 
STROKE 7 
1) patients with TIA or stroke 
2) who have a record of total cholesterol  
3) in the last 15 months 
 
QOF 
STROKE 8 
1) patients with TIA or stroke 
2) whose last measured total cholesterol ) is 5mmol/l or 
less 
3) (measured in the previous 15 months) 
 
QOF 
STROKE 6 
1) patients with a history of TIA or stroke  
2) in whom the last blood pressure reading is 150/90 or 
less 
3) measured in the previous 15 months 
 
QOF 
STROKE 12 
1) patients with a stroke  
2) shown to be non-haemorrhagic,  
3) or a history of TIA,  
4) who have a record that an anti-platelet agent (aspirin, 
clopidogrel, dipyridamole or a combination), or an anti-
coagulant is being taken  
unless a 
contraindication 
or side effects 
are recorded 
QOF 
STROKE 10 
1) patients with TIA or stroke 
2) who have had influenza immunisation  
3) in the preceding 1 September to 31 March 
 
CV03 1) stroke patients  
2) given a mood assessment 
1) if patient 
unconscious 
throughout or 
patient died 
within 7 days 
CV08 1) sites with early supported discharge 
team  
2) attached to the stroke multidisciplinary team 
 
CV05 1) stroke patients  
2) who see Physiotherapist  
3) within 72 hours of admission 
 
CV11 1) higher risk TIA cases  
2) who are scanned  
3) and treated within 24 hours 
 
CV19 1) neurovascular clinics 
2) Average waiting time  
1) sites who do 
not provide any 
service for TIA 
(e.g. 
rehabilitation 
only sites) 
CV04 1) stroke patients  
2) who see occupational therapist  
3) within 4 working days 
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QOF OB 1 1) register of patients aged 16 and over  
2) with a Body Mass Index (BMI) greater than or equal to 
30  
3) in the previous 15 months 
 
QOF 
SMOKING 3 
1) patients with any (or any combination of) the 
following conditions: coronary 
heart disease, stroke or TIA, hypertension, 
diabetes, COPD, CKD, asthma, schizophrenia, bipolar 
affective disorder or other psychoses, 
2) whose notes record smoking status in the 
previous 15 months 
 
QOF 
SMOKING 4 
1) patients with any (or any combination of) the 
following conditions: coronary heart disease, stroke or 
TIA, hypertension, 
diabetes, COPD, CKD, asthma, schizophrenia, bipolar 
affective disorder or other psychoses,  
2) who smoke and  
3) whose notes contain a record that 
smoking cessation advice or referral to a 
specialist service, where available, has been 
offered  
4) within the previous 15 months 
 
VSC11 1) People with long-term health condition(s) 
2) who have had enough support from local services or 
organisations to help manage long-term health 
condition(s) 
3) in last 6 months 
 
ERIC1 1) Occupied Floor Area 
2) Total Backlog Cost  
1) leased-out 
and licensed-out 
areas OR areas 
which are not 
required for 
operational 
purposes (i.e. 
non-occupied 
areas 
PE49 1) patients who reported  
2) that the hospital room or ward  
3) was very or fairly clean 
 
PE50 1) patients who reported  
2) that the toilets and bathrooms in hospital  
3) were very or fairly clean 
 
PE53 1) patients who reported  
2) that doctors always or sometimes washed or cleaned 
their hands between touching patients 
 
PE54 1) patients who reported  
2) that nurses always or sometimes washed or cleaned 
their hands between touching patients 
 
PE41 1) patients who reported  
2) that they always or sometimes had confidence and 
trust in the doctors treating them 
 
PE42 1) patients who reported  
2) that when they had important questions to ask a 
nurse, they always or sometimes got answers they could 
understand 
 
PE43 1) patients who reported  
2) that they always or sometimes had confidence and 
trust in the nurses treating them 
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PE 36 1) patients who said  
2) they were given enough privacy when being 
examined or treated 
 
PE37 1) patients who overall  
2) felt they were treated with respect and dignity whilst in 
hospital 
 
PE38 1) patients who reported  
2) that the doctors did not talk in front of them as if they 
were not there 
 
PE39 1) patients who reported  
2) that the nurses did not talk in front of them as if they 
were not there 
 
PE56 1) Score for whether given enough privacy  
2) when being examined or treated  
3) in the Emergency Department 
 
PE48 1) patients who reported  
2) that they were not bothered by noise at night from 
hospital staff 
 
PE51 1) patients who reported  
2) that the hospital food was very good or good 
 
PE52 1) patients who reported 
2)  that they were offered a choice of food 
 
PEAT 1 1) Environment  
PEAT 2 1) Food and Food Service  
PEAT 3 1) Privacy and dignity  
PEXIS1 1) Patient Experience Headline score  
2) for Access & Waiting 
 
PEXIS2 1) Patient Experience Headline score  
2) for safe high quality coordinated care 
 
PEXIS3 1) Patient Experience Headline score  
2) for Better Information, more choice 
 
PEXIS4 1) Patient Experience Headline score 
2) for Building Closer Relationships 
 
PEXIS5 1) Patient Experience Headline score  
2) for Clean, comfortable, friendly place to be 
 
PEXIS6 1) Patient Experience Headline score  
2) for Focus on the person 
 
PEXIS7 1) Patient Experience Headline score  
2) for organisation that learns from experience 
 
PEXIS8 1) Patient Experience Headline score for Focus on 
Dignity and Respect 
 
PE58 1) patient reported  
2) nurse staffing adequacy 
 
CA25 1) compliance  
2) with patient experience measures. 
 
PE07 1) Score for patients who reported  
2) that their family or someone close had the opportunity 
to talk to a doctor if they wanted to 
 
PE08 1) Score for patients who said  
2) that they found a member of hospital staff to talk to 
about their worries and fears 
 
PE15 1) Score for patients who reported  
2) that the 'right amount' of information was given about 
conditions/treatments by healthcare professionals 
 
PE16 1) Score for patients who reported   
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2) that they were involved as much as they wanted to be 
in decisions about their care and treatment 
PE18 1) Score for patients who reported  
2) that when leaving hospital they were given written or 
printed information about what they should or should not 
do 
 
PE19 1) Score for patients who reported  
2) that staff explained the purpose of the medicines they 
were to take at home in a way they could understand 
 
PE21 1) Score for patients who reported  
2) that staff told them how to take their medication in a 
way they could understand 
 
PE22 1) Score for patients who reported  
2) they were given clear written or printed information 
about their medicines 
 
PE26 1) Score for patients who reported  
2) that they received copies of letters sent between 
hospital doctors and their GP 
 
PE29 1) Score for patients who reported  
2) that whilst in hospital they saw posters or leaflets 
explaining how to complain about the care or treatment 
they received 
 
PE33 1) Score for patients who reported  
2) that after moving wards they did not share a sleeping 
area with a member of the opposite sex 
 
PE34 1) Score for patients who reported  
2) that they did not have to use the same bathroom or 
shower area as patients of the opposite sex 
 
PE35 1) Score for patients who said  
2) they were given enough privacy when discussing their 
condition or treatment 
 
PE06 1) Score for patients who reported  
2) that they always or sometimes got enough help from 
staff to eat their meals 
 
PE04 1) Score for patients who reported  
2) that their admission date was not changed by the 
hospital 
 
PE05 1) Score for patients who reported  
2) that on arrival at the hospital they did not have to wait 
a long time to get a bed on a ward 
 
PE17 1) Score for patients who reported  
2) that they were involved in decisions about their 
discharge from hospital 
 
PE09 1) Score for patients who thought  
2) that the hospital staff did everything they could to help 
control their pain 
 
PE28 1) Score of for patients who reported  
2) that during their hospital stay they were asked to give 
their views on the quality of care 
 
PE27 1) Percentage of staff who reported  
2) that in the last month they had seen any errors, near 
misses or incidents that could have hurt patients/service 
users 
 
PE20 1) Score for patients who reported  
2) that staff told them about medication side effects to 
watch out for when they went home 
 
PE23 1) Score for patients who reported  
2) that staff told them about any danger signals to watch 
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out for after they went home 
PE24 1) Score for patients who reported  
2) that the doctors or nurses gave their family or 
someone close to them all the information they needed 
to help care for them 
 
PE25 1) Score for patients who reported  
2) they were told who to contact if they were worried 
about their condition or treatment after they left hospital 
 
PE11 1) Percentage of patients  
2) very or fairly satisfied with the time they had to wait 
from being referred by their GP to when they saw the 
hospital specialist 
 
CV43 1) echocardiogram 
2) Median waiting times (weeks) 
1) Less than 20 
waiters 
CA35a 1) [Bowel Cancer] patients  
2) seeing a relevant specialist nurse 
 
CA35b 1) [Lung Cancer] patients  
2) seeing a relevant specialist nurse 
 
PS39 1) Incidence of MRSA bacteraemia  
VSA03 1) Incidence of clostridium difficile  
HC21 1) orthopaedic 
2) Surgical site infections  
 
NRLS1 1) Consistent reporting of patient safety events reported 
to the Reporting and Learning System (RLS) 
 
PS24 1) Availability of hand washing facilities  
PS37 1) Sickness Absence Rate  
NRLS2 1) Timely reporting of patient safety events reported to 
the Reporting and Learning System (RLS) 
 
NRLS3 1) Rate of patient safety events occurring in trusts that 
were submitted to the Reporting and 
Learning System (RLS) 
 
MH06 1) The proportion of those [mental health] patients  
2) on Care programme approach (CPA)  
3) discharged from inpatient care  
4) who are followed up within 7 days 
 
MH16 1) Adults receiving secondary mental health services  
2) on Care Programme Approach (CPA)  
3) in settled accommodation 
 
MH17 1) Adults receiving secondary mental health services 
2) on Care Programme Approach (CPA)  
3) in employment 
1) Those who 
are detained 
under the Mental 
Health Act 
should be 
excluded 
[Definition] 
CV35 1) ST-elevation myocardial infarction (STEMI) patients 
2) who received primary angioplasty 
3) within 120 minutes of call (call to 
balloon time) 
 
CV36 1) ST-elevation myocardial infarction (STEMI) patients 
2) who received thrombolytic treatment 
3) within 60 minutes of call (call to needle time) 
4) who [also] received primary angioplasty 
5) within 120 minutes of call (call to balloon time) 
 
CV34 1) ST-elevation myocardial infarction (STEMI) patients 
2) who received thrombolytic treatment 
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3) within 60 minutes of call (call to needle time) 
RA18 1) fractured proximal femur 
2) Emergency readmissions to hospital 
3) within 28 days of discharge 
1) Day cases 
OR Spells with a 
discharge code 
of death 
(Denominator) 
RA17 1) hip replacement surgery 
2) Emergency readmissions to hospital 
3) within 28 days of discharge 
1) CIP spells 
with a discharge 
code of death 
(Denominator) 
RA20 1) stroke 
2) Emergency readmissions to hospital 
3) within 28 days of discharge 
 
RA24 1) hysterectomy 
2) Emergency readmissions to hospital 
3) within 28 days of discharge 
1) spells with a 
discharge coded 
as death 
[Denominator] 
RA25 1) gallbladder surgery 
2) Emergency readmissions to hospital 
 
RA26 1) abdominal aortic aneurysm surgery 
2) Elective Readmissions 
 
CV02 1) stroke patients 
2) given a brain scan 
3) within 24 hours of stroke 
1) Cases with 
subarachnoid 
haemorrhage, 
subdural and 
extradural 
haematoma 
CV06 1) stroke patients 
2) given a swallow screening 
3) within 24 hours of admission 
 
CV13 1) Acute [stroke] units with 5/6 key characteristics 
2) continuous physiological monitoring  
3) access to scanning 
    a) within 3 hours of admission 
4) 24 hour brain imaging  
5) policy for direct admission from A&E  
6) specialist ward round  
    a) at least 5 times a week 
 
CV14 1) Acute [stroke] units 
2) access to scanning 
    a) within 3 hours of admission 
1) Rehabilitation 
sites 
CV01 1) stroke patients 
2) given Aspirin or alternative e.g. clopidogrel 
3) within 48 hours of stroke  
1) patient is 
receiving 
palliative care  
OR patient died  
OR patient has 
an intra-cerebral 
haemorrhage
 
CV10 1) stroke unit patients 
2) spending at least 90% of their time on a stroke unit 
 
CV20 1) Sites offering thrombolysis 
2) to stroke patients 
1) Excludes 
rehabilitation 
only sites 
RA01 1) 16+ years old only 
2) Emergency readmissions to hospital 
3) within 28 days of discharge 
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HC24 1) long bone fracture  
2) Open reduction 
 
WCC 2.09 1) children, 2 years and under 
2) who complete MMR immunization 
 
WCC 2.10 1) children, 5 years and under 
2) who complete MMR immunisation (1st and 2nd dose) 
 
WCC 2.11 1) children, 5 years and under 
2) who complete DTP immunisation 
 
CF01 1) patients aged under 16 (on admission) 
2) under the care of a psychiatric specialist 
3) occupied bed days on adult psychiatric wards 
 
CF02 1) patients aged 16 or 17, on admission 
2) under the care of a psychiatric specialist 
3) occupied bed days on adult psychiatric wards 
 
QOF PC 2 1) multidisciplinary case review meetings 
2) where all patients on the palliative care register are 
discussed 
3) at least 3X monthly 
 
QOF PC 3 1) Register of all patients in need of palliative 
care/support 
 
WCC 3.24 1) all deaths  
2) that occur at home 
 
 
QOF LD 1 
 
1) register of patients with learning disabilities 
 
QOF AF 4 1) patients with atrial fibrillation 
2) with ECG or specialist confirmed diagnosis 
3)  after 1 April 2009 
 
QOFAF 1 1) register of patients with atrial fibrillation  
 
QOF AF 3 1) patients with atrial fibrillation 
2) currently treated with anti-coagulation 
drug therapy or an anti-platelet therapy 
 
QOF 
CANCER 3 
1) patients with cancer 
2) diagnosed within the last 18 months 
3) patient review recorded 
4) review recorded as occurring within 6 
months of the practice receiving confirmation of the 
diagnosis 
 
CWT 1 1) Patients urgently referred with suspected cancer 
2) first seen by a specialist within two weeks of referral 
 
QOF 
CANCER 1 
1) register of patients with a 
diagnosis of cancer 
1) non-
melanotic skin 
cancers from 1 
April 2003 
VSA09 1) women  
2) aged 53-70 
3) NHS Breast Screening Programme 
 
VSA10 1) men and women  
2) aged up to 75 
3) NHS Bowel Cancer Screening 
Programme 
 
VSA15 1) women 
2) receive results of cervical screening 
tests 
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3) within 2 weeks 
WCC 2.23 1) women 
2) aged 25-49 and 50-64 
3) screened for cervical cancer 
 
VSA08 1) Breast Symptom 
2) 2 week wait 
1) urgent 
referrals for 
suspected 
breast cancer 
VSA11a 1) Cancer 
2) Surgery Treatments 
3) 31-Day Subsequent Treatments 
 
VSA12 1) Cancer 
2) Radiotherapy 
3) 31-Day Subsequent Treatments 
 
VSA13 1) Cancer 
2) Extended 62-Day Treatment  
 
WCC 2.25 1) Cancer Patients 
2) waiting no more than 31 days for cancer treatment 
 
QOF CHD 1 1) register of patients with coronary heart disease  
QOF CHD 2 1) newly diagnosed angina (diagnosed after 1 April 
2003) 
2) referred for exercise testing and/or specialist 
assessment 
 
QOF CHD 5 1) patients with coronary heart disease 
2) whose notes have a record of blood 
pressure 
3) in the previous 15 months 
 
QOF CKD 2 1) patients on the CKD register 
2) whose notes have a record of blood pressure 
3) in the previous 15 months 
 
QOF CKD 1 1) register of patients with CKD (US National 
Kidney Foundation: Stage 3 to 5 CKD) 
2) who are aged 18 years and over 
 
QOF CKD 3 1) patients on the CKD register 
2) whom the last blood pressure reading, measured in 
the previous 15 months 
3) is 140/85 or less 
 
QOF CKD 5 1) patients on the CKD register 
2) with hypertension and proteinuria 
3) who are treated with an angiotensin converting 
enzyme inhibitor (ACE-I) or angiotensin receptor blocker 
(ARB) 
1) (unless a 
contraindication 
or side effects 
are recorded) 
QOF HF 1 1) register of patients with heart failure  
QOF BP 1 1) register of patients with established hypertension  
QOF 
STROKE 1 
1) register of patients with stroke or TIA  
CV47 1) acute coronary syndrome patients 
2) who are seen by a cardiologist 
3) during admission 
 
CV37 1) Heart Failure Audit participants  
CV38 1) Cardiac Rehabilitation Audit 1) Submission of 
less than 20 
cases per month 
OR less than 
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70% case 
ascertainment 
CV16 1) continuing education programmes for Stroke Unit 
staff 
 
CV09 1) sites with a stroke multidisciplinary team 
2) with a community stroke team for longer term 
management 
 
CV21 1) sites with formal links to patient/carer groups  
CA36 1) bowel cancer cases  
CA40 1) surgical specimen 
2) Median number of lymph nodes examined 
 
CA41 1) Histological Confirmation Rate  
VSA11b 1) Cancer Drug Treatments 
2) 31-Day Subsequent Treatments Target 
 
LT13 1) patients presenting to a nephrologist 
2) RRT initiation 
3) less than 90 days before RRT initiation 
1) centres in the 
years where 
10% or more of 
the patients 
were reported to 
have started 
RRT on the 
same date as 
the first 
presentation 
LT14a 1) prevalent haemodialysis (HD) patients 
2)  with haemoglobin between 10.5 - 12.5 
g/dl 
1) Less than 20 
patients with a 
haemoglobin 
measurement 
2) Less than 
50% of the 
relevant patients 
had an Hb 
measurement 
available 
LT14b 1) prevalent peritoneal dialysis (PD) patients 
2)  with haemoglobin between 10.5 - 12.5 
g/dl 
1) Less than 20 
patients with a 
haemoglobin 
measurement 
2) Less than 
50% of the 
relevant patients 
had an Hb 
measurement 
available 
LT15 1) prevalent haemodialysis (HD) patients 
2) with URR >65% 
1) Less than 20 
patients with a 
URR value 
2) Less than 
50% of the 
relevant patients 
had a URR 
value available 
LT17 1) prevalent haemodialysis patients 
2) with phosphate between 1.1 - 1.8 mmol/L 
1) Less than 
50% of the 
relevant patients 
had a URR 
value available 
2) Less than 20 
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patients with a 
URR value 
LT18 1) prevalent peritoneal dialysis patients 
2) with phosphate between 1.1 - 1.8 mmol/L 
1) Less than 20 
patients with a 
phosphate value 
2) Less than 
50% of the 
relevant patients 
had a 
[phosphate] 
value available 
LT20a 1) [peritoneal dialysis ] patients 
2)  with BP <130/80 mmHg:PD 
1) Less than 20 
patients with a 
[BP] value 
2) Less than 
50% of the 
relevant patients 
had a [BP] value 
available 
LT20b 1)  [peritoneal dialysis ] patients 
2) with BP <130/80 mmHg:Tx 
1) Less than 20 
patients with a 
[BP] value 
2) Less than 
50% of the 
relevant patients 
had a [BP]  
value available 
LT21 1) prevalent haemodialysis patients 
2) with bicarbonate between 20 - 26 mmol/L 
1) Less than 20 
patients with a 
[bicarbonate] 
value 
2) Less than 
50% of the 
relevant patients 
had a 
[bicarbonate] 
value available 
LT22 1) prevalent peritoneal dialysis patients 
2) with bicarbonate between 22 – 30 mmol/L 
1) Less than 20 
patients with a 
[bicarbonate] 
value 
2) Less than 
50% of the 
relevant patients 
had a 
[bicarbonate] 
value available 
VSB06 1) Pregnant women  
2) who have seen a midwife or a maternity healthcare  
professional  
3) for health and social care assessment of needs, risks 
and choices 
4) by 12 weeks and 6 days of pregnancy 
 
VSB11 1) Breastfeeding 
2) at 6-8 weeks 
 
WCC 2.06 1) pregnancy 
2) smoking 
 
QOF DEM 1 1) register of patients diagnosed with dementia  
QOF DEP 2 1) patients with a new diagnosis of depression  
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2) recorded between the preceding 1 April to 31 March 
3) at the outset of treatment 
4) patients who have had an assessment of severity 
QOF DEP 1 1) patients on the diabetes register and/or the CHD 
register  
2) for whom case finding for depression has been 
undertaken 
3) using two standard screening questions 
4) on one occasion during the previous 15 months 
 
QOF MH 9 1) patients with schizophrenia, bipolar affective disorder 
and other psychoses 
2) with a review recorded in the preceding 15 
months.  
3) In the review there should be evidence 
that the patient has been offered routine health 
promotion and prevention advice appropriate to their 
age, gender and health status 
 
QOF MH 4 1) patients on lithium therapy 
2) with a record of serum creatinine and TSH in the 
preceding 15 months 
 
QOF MH 6 1) [Mental Health] patients on the register 
2) who have a comprehensive care plan documented in 
the records agreed between individuals, their family 
and/or carers as appropriate 
 
QOF MH 7 1) patients with schizophrenia, bipolar affective disorder 
and other psychoses 
2) who do not attend the practice for their annual review 
who are identified 
3) and [are] followed up by the practice team 
4) within 14 days of non-attendance 
 
QOF MH 8 1) register of people with schizophrenia, bipolar disorder 
and other psychoses 
 
QOF MH 5 1) patients on lithium therapy 
2) with a record of lithium levels in the therapeutic range 
3) within the previous 6 months 
 
 
[QOF] MH 
12 
1) [Patients] who have completed a course of 
psychological treatment 
2) who are moving to recovery 
 
LT25 1) potential donors for whom solid organ donation 
2) was considered 
3) whose family were approached for consent to 
donation 
1) absolute 
contraindications 
LT26 1) potential donors for whom solid organ donation 
2) was considered 
3) whose family were approached for consent to 
donation 
4) who gave consent 
1) absolute 
contraindications 
LT27 1) potential [organ] donors 
2) who became actual donors 
1) absolute 
contraindications 
LT24 1) potential [organ] donors 
2) referred to a co-ordinator 
1) absolute 
contraindications 
CA27 1) Pathology services 
2) compliance with 3D measures 
 
CA28 1) Imaging services  
2) compliance with 3B measures 
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CA29 1) Radiotherapy  
2) compliance with 3E measures 
 
CA51 1) chemotherapy services 
2) Compliance with 3C-100 to 3C-500 measures 
 
CA45 1) Cancer incident cases 
2) reviewed by Multi-Disciplinary Team (MDT) 
 
CA01 1) [Cancer] 
2) compliance with Peer Review by 
team (breast, lung, colorectal, local and specialist 
gynaecology, local and specialist urology (including 
supranetwork testicular and penile, haematology  and 
head & neck 
 
CA42a 1) [Bowel Cancer] 
2) cases staged  
3) at presentation 
No longer in 
use. 
CA42b 1) [Head & Neck Cancer] 
2) cases staged  
3) at presentation 
 
CA42c 1) [Lung Cancer] 
2) cases staged  
3) at presentation 
No longer in use 
QOF CHD 6 1) patients with coronary heart disease 
2) in whom the last blood pressure reading 
(measured in the previous 15 months) 
3)  is 150/90 or less 
 
QOF CHD 7 1) patients with coronary heart disease  
2) whose notes have a record of total cholesterol  
3) in the previous 15 months 
 
QOF CHD 8 1) patients with coronary heart disease  
2) whose last measured total cholesterol 
(measured in the previous 15 months)  
3) is 5mmol/l or less 
 
QOF CHD 9 1) patients with coronary heart disease  
2) with a record in the previous 15 months 
3) that aspirin, an alternative anti-platelet therapy, or an 
anti-coagulant is being taken 
(unless a 
contraindication 
or side-effects 
are recorded) 
QOF CHD 
10 
1) patients with coronary heart disease  
2) who are currently treated with a beta 
blocker  
(unless a 
contraindication 
or side-effects 
are recorded) 
QOF CHD 
11 
1) patients with a history of myocardial infarction  
2) (diagnosed after 1 April 2003)  
3) who are currently treated with an ACE 
inhibitor or Angiotensin II antagonist 
 
QOF CHD 
12 
1) patients with coronary heart disease  
2) who have a record of influenza immunisation  
3) in the preceding 1 September to 31 March 
 
QOF HF 2 1) patients with a diagnosis of heart failure  
2) (diagnosed after 1 April 2006)  
3) which has been confirmed by an  echocardiogram or 
by specialist assessment 
 
QOF HF 3 1) patients with a current diagnosis of heart failure  
2) due to LVD  
3) who are currently treated with an ACE inhibitor or 
Angiotensin Receptor Blocker,  
4) who can tolerate therapy  
1) and for whom 
there is no 
contraindication 
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QOF BP 4 1) patients with hypertension  
2) in whom there is a record of the blood pressure  
3) in the previous 9 months 
 
QOF BP 5 1) patients with hypertension  
2) in whom the last blood pressure (measured in the 
previous 9 months)  
3) is 150/90 or less 
 
CV48 1) first time CABG  
2) 30 day mortality after 
3) first time Coronary Artery Bypass Graft 
 
CV49 1) first time aortic valve replacement 
2) 30 day mortality after 
 
CV52 1) congenital heart disease surgery 
2) 30 day mortality following 
1) patient has 
not had further 
procedures 
(reoperation)  
2) within 30 days 
or 1 year 
CV29 1) myocardial infarction patients  
2) discharged on aspirin 
1) Aspirin 
contraindicated 
OR Treatment 
declined OR 
transferred to 
another hospital 
CV30 1) myocardial infarction patients  
2) discharged on beta-blockers 
1) Beta-blockers 
contraindicated 
OR Declined 
treatment 
OR Transferred 
to another 
hospital 
CV31 1) myocardial infarction patients   
2) discharged on statins 
1) Died in 
hospital 
OR Transferred 
elsewhere 
CV32 1) myocardial infarction patients following  
2) discharged on ACE inhibitors 
1) ACE inhibitors 
contraindicated 
OR Declined 
treatment OR 
Transferred to 
another hospital 
CV33 1) myocardial infarction patients  
2) discharged on theinopyridine (clopidogrel) 
1) Clopidogrel 
contraindicated 
OR Treatment 
declined OR 
Transferred to 
another hospital 
QOF PP 1 1) patients with a new diagnosis of hypertension  
2) recorded between the preceding 1 April and 31 March 
3)  who have had a face to face cardiovascular risk 
assessment at the outset of diagnosis (within three 
months of the initial diagnosis)  
4) using an agreed risk assessment treatment tool 
(excluding those 
with pre-existing 
CHD, diabetes, 
stroke and/or 
TIA) 
QOF PP 2 1) people with hypertension 
2) diagnosed after 1 April 2009  
3) who are given lifestyle advice for: 
increasing physical activity, smoking cessation, 
safe alcohol consumption and healthy diet 
4) in the last 15 months  
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QOF HF 4 1) patients with a current diagnosis of heart failure  
2) due to LVD  
3) who are currently treated with an ACE inhibitor or 
Angiotensin Receptor Blocker,  
4) who are additionally treated with a beta-blocker 
licensed for heart failure, or recorded as intolerant to or 
having a contraindication to beta-blockers. (9 points; 
thresholds 40 – 60%) 
 
QOF COPD 
12 
1) patients with COPD 
2) diagnosed after 1st April 2009  
3) in whom the diagnosis has been confirmed by post 
bronchodilator spirometry 
 
QOF COPD 
10 
1) patients with COPD  
2) with a record of FeV1  
3) in the previous 15 months 
 
QOF COPD 
1 
1) register of patients with COPD  
QOF COPD 
8 
1) patients with COPD  
2) who have had influenza immunisation  
3) in the preceding 1 September to 31 March 
 
QOF COPD 
13 
1) patients with COPD  
2) who have had a review, undertaken by a healthcare 
professional 
3) including an assessment of breathlessness  
4) using the MRC dyspnoea score  
5) in the preceding 15 months 
 
QOF COPD 
11 
1) patients with COPD 
2) receiving inhaled treatment  
3) In whom there is a record that inhaler technique has 
been checked 
4) in the previous 15 months 
 
QOF DM 21 1) patients with diabetes  
2) who have a record of retinal screening 
3) in the previous 15 months 
 
QOF DM 9 1) patients with diabetes 
2)  with a record of the presence or absence of 
peripheral pulses  
3) in the previous 15 months 
 
QOF DM 10 1) patients with diabetes  
2) with a record of neuropathy testing  
3) in the previous 15 months 
 
QOF DM 11 1) patients with diabetes  
2) who have a record of the blood pressure  
3) in the previous 15 months 
 
QOF DM 13 1) patients with diabetes  
2) who have a record of micro-albuminuria testing  
3) in the previous 15 months (exception reporting for 
patients with proteinuria) 
 
QOF DM 22 1) patients with diabetes  
2) who have a record of estimated glomerular filtration 
rate (eGFR) or serum creatinine testing  
3) in the previous 15 months 
 
QOF DM 19 1) register of all patients with diabetes mellitus 
2) aged 17 years and over, 
3) which specifies whether the patient has Type 1 or 
Type 2 diabetes 
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QOF DM 2 1) patients with diabetes  
2) whose notes record BMI  
3) in the previous 15 months 
 
QOF DM 5 1) patients with diabetes  
2) who have a record of HbA1c or equivalent  
3) in the previous 15 months 
 
QOF DM 12 1) patients with diabetes  
2) in whom the last blood pressure reading is 145/85 or 
less 
 
QOF DM 15 1) patients with diabetes  
2) with a diagnosis of proteinuria or micro-albuminuria  
3) who are treated with ACE inhibitors (or A2 
antagonists) 
 
QOF DM 16 1) patients with diabetes  
2) who have a record of total cholesterol  
3) in the previous 15 months 
 
QOF DM 17 1) patients with diabetes  
2) whose last measured total cholesterol is 5mmol/l or 
less 
3) within the previous 15 months 
 
QOF DM 18 1) patients with diabetes  
2) who have had influenza immunisation  
3) in the preceding 1 September to 31 March 
 
QOF DM 23 1) patients with diabetes  
2) in whom the last HbA1c is 7 or less (or equivalent 
test/reference range depending on local laboratory)  
3) in the previous 15 months 
 
QOF DM 24 1) patients with diabetes  
2) in whom the last HbA1c is 8 or less (or equivalent 
test/reference range depending on local laboratory) 
3) in the previous 15 months 
 
QOF DM 25 1) percentage of patients with diabetes  
2) in whom the last HbA1c is 9 or less (or equivalent 
test/reference range depending on local laboratory)  
3) in the previous 15 months 
 
QOF DM 7 1) patients with diabetes  
2) in whom the last HbA1c is 10 or less (or equivalent 
test/reference range depending on local laboratory)  
3) in the previous 15 months 
 
QOF 
ASTHMA 8 
1) patients aged eight and over 
2) diagnosed as having asthma  
3) with measures of variability or reversibility 
4) from 1 April 2006 
 
QOF 
ASTHMA 3 
1) patients with asthma  
2) between the ages of 14 and 19  
3) in whom there is a record of smoking status  
4) in the previous 15 months 
 
QOF 
ASTHMA 6 
1) patients with asthma  
2) who have had an asthma review  
3) in the previous 15 months 
 
QOF 
ASTHMA 1 
1) register of patients with asthma 1) excluding 
patients with 
asthma who 
have been 
prescribed no 
asthma-related 
drugs  
2) in the 
 257 
previous twelve 
months 
QOF 
EPILEPSY 
6 
1) [epilepsy] patients  
2) age 18 and over  
3) on drug treatment for epilepsy  
4) who have a record of seizure frequency  
5) in the previous 15 months 
 
QOF 
EPILEPSY 
5 
1) register of [epilepsy] patients 
2) aged 18 and over  
3) receiving drug treatment for epilepsy 
 
QOF 
EPILEPSY 
7 
1) [epilepsy] patients  
2) aged 18 and over  
3) on drug treatment for epilepsy  
4) who have a record of medication review involving the 
patient and/or carer  
5) in the previous 15 months 
 
QOF 
EPILEPSY 
8 
1) [epilepsy] patients  
2) aged 18 and over  
3) on drug treatment for epilepsy  
4) who have been seizure free for the last 12 months  
5) recorded in the previous 15 months 
 
QOF 
THYROID 2 
1) patients with hypothyroidism 
2) with thyroid function tests recorded  
3) in the previous 15 months 
 
QOF 
THYROID 1 
1) register of patients with hypothyroidism 
 
TC05 1) BADS (British Association of Day 
Surgery) Directory of Procedures  
2) (including electronic assessment)  
3) carried out as a day case 
or within appropriate length of stay 
 
MR30 1) knee replacement 
2) Mortality following  
 
MR31 1) hip replacement 
2) Mortality following 
 
TC03 1) Diagnostics patients 
2) waiting under 6 weeks 
 
QOF DEP 3 1) patients with a new diagnosis of 
depression and assessment of severity  
2) recorded between the preceding 1 April to 31 March,  
3) the percentage of patients who have had a further 
assessment of severity  
4) 5-12 weeks (inclusive) after the initial recording of the 
assessment of severity.   
5) Both assessments should be completed using an 
assessment tool validated for use in primary care 
 
QOF CKD 6 1) patients on the CKD register 
2) whose notes have a record of an 
albumin:creatinine ratio (or protein:creatinine ratio) test  
3) in the previous 15 months 
 
QOF SH 1 1) register of women who have been prescribed any 
method of contraception  
2) at least once in the last year, or 
other appropriate interval e.g. 5 years for an IUS 
 
QOF SH 2 1) women prescribed an oral or patch contraceptive 
method  
2) who have also received information from the practice 
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about long acting reversible methods of contraception  
3) in the previous 15 months 
QOF SH 3 1) women prescribed emergency 
hormonal contraception  
2) at least once in the year by the practice  
3) who have received information 
from the practice about long acting reversible methods of 
contraception  
4) at the time of, or within one month of, the prescription 
 
HES 1 1) 10,000 patients 
2) Pressure ulcer incidence per 
 
HC22 1) Knee prosthesis 
2) Surgical site infections  
 
HC23 1) Hip prosthesis 
2) Surgical site infections  
 
HC25 1) Hip hemiarthroplasty 
2) Surgical site infections  
 
QOF 
STROKE 13 
1) new patients with a stroke or TIA  
2) who have been referred for further 
investigation 
 
QOF 
STROKE 5 
1) patients with TIA or stroke 
2) who have a record of blood pressure in the notes 
3) in the preceding 15 months 
 
QOF 
STROKE 7 
1) patients with TIA or stroke 
2) who have a record of total cholesterol  
3) in the last 15 months 
 
QOF 
STROKE 8 
1) patients with TIA or stroke 
2) whose last measured total cholesterol ) is 5mmol/l or 
less 
3) (measured in the previous 15 months) 
 
QOF 
STROKE 6 
1) patients with a history of TIA or stroke  
2) in whom the last blood pressure reading is 150/90 or 
less 
3) measured in the previous 15 months 
 
QOF 
STROKE 12 
1) patients with a stroke  
2) shown to be non-haemorrhagic,  
3) or a history of TIA,  
4) who have a record that an anti-platelet agent (aspirin, 
clopidogrel, dipyridamole or a combination), or an anti-
coagulant is being taken  
unless a 
contraindication 
or side effects 
are recorded 
QOF 
STROKE 10 
1) patients with TIA or stroke 
2) who have had influenza immunisation  
3) in the preceding 1 September to 31 March 
 
CV03 1) stroke patients  
2) given a mood assessment 
1) if patient 
unconscious 
throughout or 
patient died 
within 7 days 
CV08 1) sites with early supported discharge 
team  
2) attached to the stroke multidisciplinary team 
 
CV05 1) stroke patients  
2) who see Physiotherapist  
3) within 72 hours of admission 
 
CV11 1) higher risk TIA cases  
2) who are scanned  
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3) and treated within 24 hours 
CV19 1) neurovascular clinics 
2) Average waiting time  
1) sites who do 
not provide any 
service for TIA 
(e.g. 
rehabilitation 
only sites) 
CV04 1) stroke patients  
2) who see occupational therapist  
3) within 4 working days 
 
QOF OB 1 1) register of patients aged 16 and over  
2) with a Body Mass Index (BMI) greater than or equal to 
30  
3) in the previous 15 months 
 
QOF 
SMOKING 3 
1) patients with any (or any combination of) the 
following conditions: coronary 
heart disease, stroke or TIA, hypertension, 
diabetes, COPD, CKD, asthma, schizophrenia, bipolar 
affective disorder or other psychoses, 
2) whose notes record smoking status in the 
previous 15 months 
 
QOF 
SMOKING 4 
1) patients with any (or any combination of) the 
following conditions: coronary heart disease, stroke or 
TIA, hypertension,  
diabetes, COPD, CKD, asthma, schizophrenia, bipolar 
affective disorder or other psychoses,  
2) who smoke and  
3) whose notes contain a record that smoking cessation 
advice or referral to a specialist service, where available, 
has been offered 
4) within the previous 15 months 
 
VSC11 1) People with long-term health condition(s) 
2) who have had enough support from local services or 
organisations to help manage long-term health 
condition(s) 
3) in last 6 months 
 
ERIC1 1) Occupied Floor Area 
2) Total Backlog Cost  
1) leased-out 
and licensed-out 
areas OR areas 
which are not 
required for 
operational 
purposes (i.e. 
non-occupied 
areas 
PE49 1) patients who reported  
2) that the hospital room or ward  
3) was very or fairly clean 
 
PE50 1) patients who reported  
2) that the toilets and bathrooms in hospital  
3) were very or fairly clean 
 
PE53 1) patients who reported  
2) that doctors always or sometimes washed or cleaned 
their hands between touching patients 
 
PE54 1) patients who reported  
2) that nurses always or sometimes washed or cleaned 
their hands between touching patients 
 
PE41 1) patients who reported   
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2) that they always or sometimes had confidence and 
trust in the doctors treating them 
PE42 1) patients who reported  
2) that when they had important questions to ask a 
nurse, they always or sometimes got answers they could 
understand 
 
PE43 1) patients who reported  
2) that they always or sometimes had confidence and 
trust in the nurses treating them 
 
PE 36 1) patients who said  
2) they were given enough privacy when being 
examined or treated 
 
PE37 1) patients who overall  
2) felt they were treated with respect and dignity whilst in 
hospital 
 
PE38 1) patients who reported  
2) that the doctors did not talk in front of them as if they 
were not there 
 
PE39 1) patients who reported  
2) that the nurses did not talk in front of them as if they 
were not there 
 
PE56 1) Score for whether given enough privacy  
2) when being examined or treated  
3) in the Emergency Department 
 
PE48 1) patients who reported  
2) that they were not bothered by noise at night from 
hospital staff 
 
PE51 1) patients who reported  
2) that the hospital food was very good or good 
 
PE52 1) patients who reported 
2)  that they were offered a choice of food 
 
PEAT 1 1) Environment  
PEAT 2 1) Food and Food Service  
PEAT 3 1) Privacy and dignity  
PEXIS1 1) Patient Experience Headline score  
2) for Access & Waiting 
 
PEXIS2 1) Patient Experience Headline score  
2) for safe high quality coordinated care 
 
PEXIS3 1) Patient Experience Headline score  
2) for Better Information, more choice 
 
PEXIS4 1) Patient Experience Headline score 
2) for Building Closer Relationships 
 
PEXIS5 1) Patient Experience Headline score  
2) for Clean, comfortable, friendly place to be 
 
PEXIS6 1) Patient Experience Headline score  
2) for Focus on the person 
 
PEXIS7 1) Patient Experience Headline score  
2) for organisation that learns from experience 
 
PEXIS8 1) Patient Experience Headline score for Focus on 
Dignity and Respect 
 
PE58 1) patient reported  
2) nurse staffing adequacy 
 
CA25 1) compliance  
2) with patient experience measures. 
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PE07 1) Score for patients who reported  
2) that their family or someone close had the opportunity 
to talk to a doctor if they wanted to 
 
PE08 1) Score for patients who said  
2) that they found a member of hospital staff to talk to 
about their worries and fears 
 
PE15 1) Score for patients who reported  
2) that the 'right amount' of information was given about 
conditions/treatments by healthcare professionals 
 
PE16 1) Score for patients who reported  
2) that they were involved as much as they wanted to be 
in decisions about their care and treatment 
 
PE18 1) Score for patients who reported  
2) that when leaving hospital they were given written or 
printed information about what they should or should not 
do 
 
PE19 1) Score for patients who reported  
2) that staff explained the purpose of the medicines they 
were to take at home in a way they could understand 
 
PE21 1) Score for patients who reported  
2) that staff told them how to take their medication in a 
way they could understand 
 
PE22 1) Score for patients who reported  
2) they were given clear written or printed information 
about their medicines 
 
PE26 1) Score for patients who reported  
2) that they received copies of letters sent between 
hospital doctors and their GP 
 
PE29 1) Score for patients who reported  
2) that whilst in hospital they saw posters or leaflets 
explaining how to complain about the care or treatment 
they received 
 
PE33 1) Score for patients who reported  
2) that after moving wards they did not share a sleeping 
area with a member of the opposite sex 
 
PE34 1) Score for patients who reported  
2) that they did not have to use the same bathroom or 
shower area as patients of the opposite sex 
 
PE35 1) Score for patients who said  
2) they were given enough privacy when discussing their 
condition or treatment 
 
PE06 1) Score for patients who reported  
2) that they always or sometimes got enough help from 
staff to eat their meals 
 
PE04 1) Score for patients who reported  
2) that their admission date was not changed by the 
hospital 
 
PE05 1) Score for patients who reported  
2) that on arrival at the hospital they did not have to wait 
a long time to get a bed on a ward 
 
PE17 1) Score for patients who reported  
2) that they were involved in decisions about their 
discharge from hospital 
 
PE09 1) Score for patients who thought  
2) that the hospital staff did everything they could to help 
control their pain 
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PE28 1) Score of for patients who reported  
2) that during their hospital stay they were asked to give 
their views on the quality of care 
 
PE27 1) Percentage of staff who reported  
2) that in the last month they had seen any errors, near 
misses or incidents that could have hurt patients/service 
users 
 
PE20 1) Score for patients who reported  
2) that staff told them about medication side effects to 
watch out for when they went home 
 
PE23 1) Score for patients who reported  
2) that staff told them about any danger signals to watch 
out for after they went home 
 
PE24 1) Score for patients who reported  
2) that the doctors or nurses gave their family or 
someone close to them all the information they needed 
to help care for them 
 
PE25 1) Score for patients who reported  
2) they were told who to contact if they were worried 
about their condition or treatment after they left hospital 
 
PE11 1) Percentage of patients  
2) very or fairly satisfied with the time they had to wait 
from being referred by their GP to when they saw the 
hospital specialist 
 
CV43 1) echocardiogram 
2) Median waiting times (weeks) 
1) Less than 20 
waiters 
CA35a 1) [Bowel Cancer] patients  
2) seeing a relevant specialist nurse 
 
CA35b 1) [Lung Cancer] patients  
2) seeing a relevant specialist nurse 
 
PS39 1) Incidence of MRSA bacteraemia  
VSA03 1) Incidence of clostridium difficile  
HC21 1) orthopaedic 
2) Surgical site infections  
 
NRLS1 1) Consistent reporting of patient safety events reported 
to the Reporting and Learning System (RLS) 
 
PS24 1) Availability of hand washing facilities  
PS37 1) Sickness Absence Rate  
NRLS2 1) Timely reporting of patient safety events reported to 
the Reporting and Learning System (RLS) 
 
NRLS3 1) Rate of patient safety events occurring in trusts that 
were submitted to the Reporting and 
Learning System (RLS) 
 
MH06 1) The proportion of those [mental health] patients  
2) on Care programme approach (CPA)  
3) discharged from inpatient care  
4) who are followed up within 7 days 
 
MH16 1) Adults receiving secondary mental health services  
2) on Care Programme Approach (CPA)  
3) in settled accommodation 
 
MH17 1) Adults receiving secondary mental health services 
2) on Care Programme Approach (CPA)  
3) in employment 
1) Those who 
are detained 
under the Mental 
Health Act 
should be 
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excluded 
[Definition] 
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Appendix 6: Issues Log  
 
This log was established to track issues encountered during the ontology 
development process. Resolution is recorded in the ‘How’ column. 
 
Date Issue Date 
Resolved 
How 
4/3/
13 
Need to figure out how to 
delete Indicators as a 
subclass of Indicators 
(shows up in Relations 
mode) 
 
 Can’t even find Relations 
mode now, so may not be a 
problem. 
4/3/
13 
Need to delete subclasses 
of Indicators that I have 
now entered as Slots 
5/3/13 Done 
5/3/
13 
Need to change Defaults 
for Topic slot in Planned 
Care subclass of NSR to 
subslots or find alternative 
solution. 
18/3/13 Added has_topic_of as a 
slot for Indicators and NSR 
pathway 
18/3
/13 
Determine whether 
redundant classes and 
slots for Topic/topic are a 
problem 
22/5/13 Get rid of Topic altogether 
(They are assigned 
inconsistently by IC 
anyway). Done 
5/3/
13 
Consider changing 
subclasses of Dimension 
and NSR Pathway to 
instances or can they also 
be properties of Indicator? 
6/3/13 Added as properties 
5/3/
13 
Need expert to check 
overall framework.  
22/4/13 Professor John Chelsom 
advised Protégé 3.4.1 was 
poor choice. 
6/3/
13 
Order of properties need to 
be organised in logical 
manner in Forms. 
15/3/13 Done 
7/3/
13 
Troubleshoot Purpose slot 
in a similar manner to 
Topic.  Values may need to 
be recorded differently. 
22/5/13 
[decision 
made] 
No action taken as slots can 
also be classes. Purpose is 
a major component of this 
research. 
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Date Issue Date 
Resolved 
How 
17/3
/13 
Inclusion/Exclusion Criteria 
need to be layered from full 
to minimum instead of 1st 
layer, 2nd layer, etc. 
(because slots and 
subslots include content of 
narrower slots) 
Done 
3/13 
Consider additional slot for 
Number of Inclusion Criteria 
and Number of Exclusion 
Criteria to handle queries 
based on 
Inclusion/Exclusion criteria.  
This could compensate for 
backward nature of layers of 
criteria and enable queries 
for related indicators to be 
structured from common and 
initial criteria inwards.. 
18/3
/13 
Have not created slot for 
NHS IC –assigned 
Category or Subject.  This 
is because these terms 
appear arbitrary.  A stable 
clinical terminology should 
accomplish the same 
purpose.  May be able to 
delete Topic/topic 
redundancies using same 
analogy. 
 No action needed 
18/3
/13 
Redundant detail in IC 
categories means I am not 
always including exact 
statements. 
 No action needed. 
19/3
/13 
Just because Exclusion 
criteria is not stated does 
not mean there are no 
exclusion criteria.  Does 
this matter if the criteria are 
essentially covered in 
Inclusion criteria? 
 No action needed. 
19/3
/13 
Future work should 
consider authority records 
for associated creators, 
publishers, etc. 
 Include in Discussion 
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Date Issue Date 
Resolved 
How 
19/3
//13 
 
 
 
 
 
25/3
/13 
Doublecheck Statement vs 
Formula (have been taking 
Formula from Definition or 
Detailed Descriptor and 
Statement from Title) back 
to RA20 
For the purposes of this 
ontology, the formula is 
taken from the Definition or 
Detailed Descriptor section 
of the NHS IC metadata.  
The Formula/Calculation 
methodology appears 
inconsistent, sometimes 
with just a referring URL 
and sometimes with 
extensive detail.  Some of 
this detail would be better 
included as a note. For this 
PhD project, the primary 
objectives are to attempt to 
distinguish inclusion and 
exclusion criteria and to 
assess types of indicator 
purpose.  Stopped this 
after VSA08.  This NHS IC 
spreadsheet shows how 
extensive the number of 
fields would potentially 
need to be, along with 
creating relationships 
between them, to enter 
complex formulae: 
http://www.ic.nhs.uk/CHttp
Handler.ashx?id=10397&p
=0  This seems beyond the 
scope of this project. 
 Include in Discussion 
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Date Issue Date 
Resolved 
How 
19/3
/13 
Detailed Descriptor 
[sometimes entered as 
Notes, though this may be 
unnecessary, due to 
inclusion of URL for 
complete methodology] for 
RA24 is so complex and 
disorganised that 
alternative fields may be 
necessary.  Detailed 
descriptor sometimes 
includes information for 
specific years of data-
gathering, making it 
potentially unwieldy.  Other 
times, it is very minimal 
and mainly a referring URL. 
 Include in Discussion. 
20/3
/13 
Need to record HC24 as 
Narrower than HC21 (after 
entering Instance of HC 21) 
.  Nd. To record QOF 
STROKE 1 as Broader aspect 
to QOF STROKE 5, 7, 8, 13, 
CV03, CV05. 
NK Done 
22/3
/13 
Consider whether to fix 
inconsistent slot values for 
Related to vs 
Broader/Narrower Than. 
23/3/13 Slot value for Related 
changed to Instance. 
25/3
/13 
VSA10 is an example of 
why I am not being 
consistent with selection of 
NHS IC – supplied field for 
Formula.  The 
Formula/Methodology field 
includes justification, which 
is more than just a formula 
or methodology.  WCC 
2.23 is an example where 
the Formula/Methodology 
field includes only a 
referring URL. 
 Include in Discussion 
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Date Issue Date 
Resolved 
How 
26/3
/13 
Inconsistencies in Source 
information for LT13-22 are 
an example of why 
authority records are 
needed.  Sometimes 
Source is listed as UK 
Renal Registry.  Sometime 
it is listed as National 
Renal Dataset. 
 Include in Discussion 
26/3
/13 
LT13-22 (try LT20a) show 
more examples of Formula 
vs Detailed Descriptor 
issue. 
 Include in Discussion 
2/4/
13 
Need to enter for [QOF] 
MH12 - PSA 18 Indicator 5 
: Improve Access to 
Psychological Therapies 
13/4/13 Done 
2/4/
13 
Need to enter for LT25  - 
Broader aspect to LT2. 
13/4/13 There is no LT2.  Thesis 
corrected. 
3/4/
13 
QOF DM 7 has been 
recorded inconsistently.  
Needs to be added to 
Indicators by Purpose 
Table (Screening) and 
relationships entered in 
table and ontology. 
13/4/13 Done  
4/4/
13 
The Query, Common 
Criteria for CV35 and CV36 
(who received primary 
angioplasty), may need 
revising as the word ‘also’ 
had to be removed from 
CV36 in order to make it 
work.  Need to check 
whether this interferes with 
logic.  Also need to 
consider whether number 
of layers is a necessary 
slot. 
4/4/13 Done.  Reduced key words 
to ‘received primary 
angioplasty’ and restored 
[also]. 
5/4/
13 
Need to record that CV11 is 
related to VSA14 
12/4/13 Not Done.  VSA14 is not 
part of this set. 
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Date Issue Date 
Resolved 
How 
7/4/
13 
Have not included PE49, 
PE50, PE53, PE54, PE41, 
PE42, PE43, PE36, PE37, 
PE38, PE39, PE56, PE48, 
PE51, PE52 due to status 
uncertainty and lack of 
metadata. 
CF01, CF02: Nd to decide 
whether to enter [Not 
entered] 
Started entering some of 
these due to relationships. 
May go back and delete. 
Also review RA25. 
15/4/13 . Have now deleted those 
that were dropped, no 
longer in use, or status 
unknown at the time of 
indicator analysis. 
7/4/
13 
Need to enter Related info 
for Patient Experience 
indicators 
11/4/13 Done 
8/4/
13 
Need to add PE06, PE04 
and VSA03 to Indicators by 
Type table in thesis 
13/4/13 Done 
8/4/
13 
Create rule for status issue 
(eg, Dropped at the time I 
entered data vs Dropped 
after I entered data, 
Replaced by) 
 Include in Discussion 
10/4
/13 
Does the order in which the 
full inclusion criteria appear 
matter? (Different issue - 
Order for some levels of 
criteria sometimes matter 
more than others.) 
 Include in Discussion 
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Date Issue Date 
Resolved 
How 
10/4
/13 
Boolean logic may be an 
issue for 
inclusion/exclusion criteria.  
Eg, OR = same level, but 
should it be a single 
statement or 2 entries?  
Also, dependencies are 
recorded at same level (eg, 
access to scanning within 3 
hours of admission: 2 
concepts, but recorded at 
same level because within 
3 hours of admission must 
apply to scanning).  
Temporal issues are 
recorded inconsistently in 
this pilot, due to semantics 
(eg, 1) patients with 
coronary heart disease  
2) with a record in the 
previous 15 months. 
Compare the semantics of 
the next 2 rows: 
 Include in Discussion 
QOF 
BP 4 
1) patients with 
hypertension  
2) in whom there is a 
record of the blood 
pressure  
3) in the previous 9 months 
 Include in Discussion 
QOF 
BP 5 
1) patients with 
hypertension  
2) in whom the last blood 
pressure (measured in the 
previous 9 months)  
3) is 150/90 or less 
 
11/4
/13 
PS37, MH06, MH16 and 
MH17 need to be entered 
in 1st table and in ontology 
12/4/13 Done 
11/4
/13 
Because 
Inclusion/Exclusion criteria 
is taken from Statement, 
rather than Formula (which 
is not always possible), the 
criteria are sometimes 
vague/weak.  EG, PS37: 
Sickness Absence Rate = single 
layer 
 Include in Discussion 
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Date Issue Date 
Resolved 
How 
15/4
/13 
Clinical Terminology Code 
Version needs to be 
deleted, as its status as a 
subslot does not 
accomplish the task 
intended.  It inherits the 
superslot, but does not 
allow you to attach a 
version. 
15/4/13 Done 
16/4
/13 
Some slots/widgets are 
primitive, as they allow (this 
is sometimes considered 
necessary to accurately 
identify the information and 
make it both searchable 
and linked as the ability to 
define Relationships is not 
as flexible in Protégé as is 
sometimes needed) you to 
enter more than one data 
type.  Eg, Clinical 
Terminology entries include 
both code and term(s).  
The complete terminology 
itself would need to be 
integrated into the 
ontology, with a look-up 
feature. 
 Include in Discussion 
17/4
/13 
Nd to add Related 
Indicators for CA25 
(Quality of Patient 
Experience: percentage 
compliance with [Cancer] 
patient experience 
measures)  
22/5/13 Done. Created query for 
Patient Experience 
Dimension  
24/4
/13 
UMLS same gives 
separate codes for 
concepts that are 
essentially the same (eg, 
C0514823 Provide for 
privacy and confidentiality, 
C0515043  Provide privacy 
and ensure confidentiality).  
Key word searching of 
UMLS is cumbersome, 
requiring entry of 
synonyms and different 
versions of same concept. 
 Include in Discussion 
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Date Issue Date 
Resolved 
How 
25/4
/13 
Need to replace Patient 
and Coronary Heart 
Disease codes with 
C0451606   CHD 
monitoring   for most QOF 
CHD entries (already have 
in QOF CHD 9). 
22/5/13 Done 
26/4
/13 
Cite Clinical Quality 
eMeasure Logic and 
Implementation Guidance 
v1.3, 
http://cms.gov/Regulations-
and-
Guidance/Legislation/EHRI
ncentivePrograms/ 
Downloads/2014_eCQM_
Measure_Logic_Guidancev
13_April2013.pdf,  
https://vsac.nlm.nih.gov/# 
(Value Set Authority 
Center), 
http://www.qualityforum.org
/QualityDataModel.aspx 
(“The Quality Data Model 
(QDM) is an “information 
model” that clearly defines 
concepts used in quality 
measures and clinical care 
and is intended to enable 
automation of electronic 
health record (EHR) use.” – 
Saved model to HD, 
including preference rules, 
p 7) 
 and other links from 
http://www.nlm.nih.gov/new
s/nlm_vsac_publishes_ann
ual_update.html 
 in Discussion 
5/13 Done 
26/4
/13 
Look at slides and watch 
video, 
http://www.qualityforum.org
/Calendar/2012/09/Knowle
dge_ 
Infrastructure_Behind_the_
Measure_Authoring_Tool_(
MAT).aspx 
26/4/13 Looked at slides. Not v 
useful. 
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Date Issue Date 
Resolved 
How 
26/4
/13 
Difficulties with coding 
include lack of medical 
expertise.  Can’t remember 
norms for clinical 
conditions (eg, blood 
pressure and cholesterol).  
This makes it difficult to 
select relevant codes for 
measurements. 
Also, some indicator text is 
non-specific.  Eg, QOF DM 
23 (or equivalent 
test/reference range 
depending on local 
laboratory) 
Some ranges specified in 
indicators do not show as 
an option in UMLS, 
requiring general codes 
that result in the same 
coding for different 
indicators (Eg, aged 53-70 
- VSA09) 
 Include in Discussion 
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Appendix 7 Classes and Subclasses 
 
A class is “ concept in the domain of the ontology (Musen et al. 2012). 
Classes may have subclasses, which inherit the properties or attributes of 
their parent versions. 
 
Class Subclass Definition 
Dimension  Aspect of quality; identified from 
(Darzi 2008) UK Department of 
Health report, collating vision from 
10 UK Strategic Health Authorities. 
 Effectiveness This dimension relates to 
understanding success rates from 
different treatments for different 
conditions.  It may also extend to 
people’s well-being and ability to 
live independent lives. 
 Patient Experience "Quality of care includes quality of 
caring. This means how personal 
care is – the compassion, dignity 
and respect with which patients are 
treated. It can only be improved by 
analysing and understanding patient 
satisfaction with their own 
experiences." (Darzi 2008) 
 
Safety 
This dimension of quality is that we 
do no harm to patients. "This means 
ensuring the environment is safe 
and clean, reducing avoidable harm 
such as excessive drug errors or 
rates of healthcare associated 
infections."  (Darzi 2008). 
Next Stage 
Review 
Pathway 
 Clinical pathway, identified from 
2008 Darzi DoH report collating 
vision from 10 UK Strategic Health 
Authorities 
 
Acute Care 
One of eight clinical areas assigned 
to NHS Strategic Health Authorities 
for needs assessment exercise. 
Darzi 2008 DoH report.     
 Children and Young 
People 
One of eight clinical areas assigned 
to NHS Strategic Health Authorities 
for needs assessment exercise. 
Darzi 2008 DoH report. 
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Class Subclass Definition 
Next Stage 
Review 
Pathway 
End of Life Care 
One of eight clinical areas assigned 
to NHS Strategic Health Authorities 
for needs assessment exercise. 
Darzi 2008 DoH report. 
 
Long Term Conditions 
One of eight clinical areas assigned 
to NHS Strategic Health Authorities 
for needs assessment exercise. 
Darzi 2008 DoH report. 
 Maternity and Newborn 
Care 
One of eight clinical areas assigned 
to NHS Strategic Health Authorities 
for needs assessment exercise. 
Darzi 2008 DoH report. 
 
Mental Health 
One of eight clinical areas assigned 
to NHS Strategic Health Authorities 
for needs assessment exercise. 
Darzi 2008 DoH report. 
Indicator 
 Measures healthcare outcomes. 
 
Formula 
Calculation methodology for 
determining indicator data result 
 Inclusion/Exclusion 
Criteria (subclass to 
Formula) 
The inclusion and exclusion criteria 
are generally taken from the 
indicator Statement, due to 
metadata inconsistencies. 
Purpose 
 Intended application (From Institute 
of Medicine 1992 classic CPG 
report (Field and Lohr 1992), 
referred to as "Guidelines by 
Purpose"; in this case 'Indicators' 
substitutes for 'Guidelines'). 
 Appropriate Use of 
Specific Technologies 
and Tests as part of 
Clinical Care 
Eg, Use of autologous or donor 
blood for transfusions. 
 Diagnosis and 
Prediagnosis 
Management of 
Patients 
Eg, Management of patients 
following coronary-artery bypass 
graft 
 
 Indications for Use of 
Surgical Procedures 
Eg, Indications for carotid 
endarterectomy. 
 Screening and 
Prevention 
Eg, Vaccination for pregnant women 
who are planning international travel 
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Appendix 8 Slots and Subslots 
 
Properties of classes and subclasses in the ontology are specified as ‘slots’. 
Slots may have subslots, which inherit the properties or attributes of their 
parent versions. 
 
Class/Subclass Slot Subslot Definition 
Indicators Access Point  Location(s) of results of indicator 
assessment 
Indicators Clinical 
Terminology 
Code 
 The code(s) and clinical term or 
terms used to source data to 
calculate the indicator 
Indicators Creator  Developer(s) or author(s) of the 
indicator content 
Indicators Formula  Calculation methodology for 
determining indicator data result 
Indicators Formula Inclusion/
Exclusion 
Criteria 
This is the parent layer for subslots of 
inclusion or exclusion criteria. 
Indicators Formula Exclusion  
Criteria 
Full 
(subslot 
to 
Inclusion/
Exclusion 
Criteria) 
Eg, in the previous twelve months 
Indicators Formula Exclusion 
Criteria 
Minus 
One 
Layer 
Eg, congenital heart disease surgery 
Indicators Formula Inclusion 
Criteria 
Full 
Eg, ST-elevation myocardial 
infarction (STEMI) patients 
Indicators Formula Inclusion 
Criteria 
Minus 
One 
Layer 
Eg, who received thrombolytic 
treatment 
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Class/Subclass Slot Subslot Definition 
Indicators  Formula Inclusion 
Criteria 
Minus 
Two 
Layers 
Eg, within 60 minutes of call (call to 
needle time) 
Indicators Formula Inclusion 
Criteria 
Minus 
Three 
Layers 
Eg, who received primary angioplasty 
Indicators Formula Inclusion 
Criteria 
Minus 
Four 
Layers 
Eg, within 120 minutes of call (call to 
balloon time) 
Indicators Formula Inclusion 
Criteria 
Minus 
Five 
Layers 
Similar to other inclusion layers. 
Indicators Indicator 
Statement 
 A sentence or paragraph clearly 
describing what is being measured 
[referred to as “Detailed Descriptor” 
by NHS Information Centre]. The 
statement is sometimes taken from 
sources other than Detailed 
Descriptor, due to issues of 
consistency and clarity. 
Indicators Is Broader 
Than 
 Shows indicator is broader than 
(an)other indicator(s) 
Indicators Is Narrower 
Than 
 Shows indicator is narrower than 
(an)other indicator(s) 
Indicators Is Related 
To 
 Shows indicators can be related at 
the same level (neither broader nor 
narrower 
Indicators Next Stage 
Review 
Pathway 
 Complex value type per AMIA 2003 
Protege tutorial slide, Common 
Facets: Value Type, where a slot 
may be an instance of another class.  
Indicators may be categorised by 
Next Stage Review pathways, 
Purpose, and Dimensions. 
Indicators Notes  Miscellaneous information to support 
the organisation and referencing of 
quality indicators. 
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Class/Subclass Slot Subslot Definition 
Indicators Number of 
Layers of 
Exclusion 
Criteria 
 This is to support development of 
queries for specific layers of 
exclusion criteria. 
Indicators Number of 
Layers of 
Inclusion 
Criteria 
 This is to support development of 
queries for specific layers of inclusion 
criteria. 
Indicators Publisher  Party responsible for making 
indicator available 
Indicators Purpose  from Institute of Medicine 1992 
classic CPG report (Field and Lohr 
1992), referred to as "Guidelines by 
Purpose"; in this case 'Indicators' 
substitutes for 'Guidelines' 
Screening and prevention: Eg, 
Vaccination for pregnant women who 
are planning international travel. [3rd 
Broadest, 3-way tie] 
Diagnosis and prediagnosis 
management of patients: Eg, 
Evaluation of chest pain in the 
emergency room. [3rd Broadest, 3-
way tie] Tends to be paired with 
Appropriate use of technologies 
Indications for use of surgical 
procedures: Eg, Indications for 
carotid endarterectomy. [3rd 
Broadest, 3-way tie] 
Appropriate use of specific 
technologies and tests as part of 
clinical care: Eg, Use of autologous 
or donor blood for transfusions. [2nd 
Broadest] Tends to be paired with 
Diagnoses and prediagnosis 
management 
Guidelines for care of clinical 
conditions: Eg, Management of 
patients following coronary-artery 
bypass graft [Broadest]” 
Indicators Reference  The source(s) from which the 
indicator has been derived; normally 
the dataset applied (eg, National 
Audit dataset) 
Indicators Unique 
Identifier 
 Unambiguous reference number or 
string of letters and/or numbers 
Indicators URL  URL with most detail about 
methodology 
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Class/Subclass Slot Subslot Definition 
Indicators Version 
History 
 Record of revisions to the indicator 
Dimension/ 
Effectiveness 
Complication 
Rates 
 Intended to show success of 
treatments for different conditions. 
Darzi 2008 DoH report.  
http://www.official-
documents.gov.uk/document/cm74/7
432/7432.pdf 
Dimension/ 
Effectiveness 
Mortality 
Rates 
 Intended to show success of 
treatments for different conditions. 
Darzi 2008 DoH report.  
http://www.official-
documents.gov.uk/document/cm74/7
432/7432.pdf 
 
Class/Subclass 
 
Slot 
 
Subslot 
 
Definition 
Dimension/ 
Effectiveness 
Proms  Patient-Reported Outcomes 
Measures.  
Examples include improvement in 
pain-free movement after a joint 
replacement, or returning to work 
after treatment for depression. 
Darzi 2008 DoH report.  
http://www.official-
documents.gov.uk/document/cm74/7
432/7432.pdf 
Dimension/ 
Effectiveness 
Survival 
Rates 
 Intended to show success of 
treatments for different conditions. 
Darzi 2008 DoH report.  
http://www.official-
documents.gov.uk/document/cm74/7
432/7432.pdf 
Dimension/ 
Patient 
Experience 
Compassion  Patient satisfaction with how 
personal care is. Darzi 2008 DoH 
report.  http://www.official-
documents.gov.uk/document/cm74/7
432/7432.pdf 
Dimension/ 
Patient 
Experience 
Dignity  Patient satisfaction with how 
personal care is. Darzi 2008 DoH 
report.  http://www.official-
documents.gov.uk/document/cm74/7
432/7432.pdf 
Dimension/ 
Patient 
Experience 
Respect  Patient satisfaction with how 
personal care is. Darzi 2008 DoH 
report.  http://www.official-
documents.gov.uk/document/cm74/7
432/7432.pdf 
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Class/Subclass Slot Subslot Definition 
Dimension/ 
Safety 
Cleanliness  The first dimension of quality must be 
that we do no harm to patients. Darzi 
2008 DoH report.  http://www.official-
documents.gov.uk/document/cm74/7
432/7432.pdf 
Dimension/ 
Safety 
Drug Errors  The first dimension of quality must be 
that we do no harm to patients. Darzi 
2008 DoH report.  http://www.official-
documents.gov.uk/document/cm74/7
432/7432.pdf 
Dimension/ 
Safety 
Healthcare- 
Related 
Infections 
 The first dimension of quality must be 
that we do no harm to patients. Darzi 
2008 DoH report.  http://www.official-
documents.gov.uk/document/cm74/7
432/7432.pdf 
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Appendix 9 The Ontology 
 
The ontology can be found in the CD attached to the back of this thesis. You 
will need to install Protégé Frames 3.4.1 (Stanford Center for Biomedical 
Informatics Research 2014b). 
 
After you have installed Protégé 3.4.1, you can ask it to open a project.  You 
will need to have inserted the attached CD into your computer. Select Open 
Other, then the Pilot Ontology folder and the Protégé 3.4.1 folder. Then select 
the NHS Quality Indicators Ontology pprj file. 
 
Once you have opened the ontology, click cancel on the pop-up window that 
asks you to Choose an associated ChAO. Then click Close on the pop-up 
window that says No ChAO. The default screen shows the classes in the left 
frame. Click the triangle next to each class to view subclasses. There are tabs 
towards the top of the screen, above the frames, to view Slots, Forms, 
Instances and Queries. Subslots can be viewed if a triangle is to the left  
 
Instances have been entered for the Indicators class. Click on Indicator in the 
left frame and an Instance Browser frame will appear in the middle of the 
screen, showing unique identifiers for all 222 indicators. Click on one of the 
unique identifiers and its properties (slots) will appear in the right-hand frame.  
 
Queries to find Instances of the indicators with common criteria may be 
entered by clicking the Queries tab. Click on the rectangles with + signs above 
the text boxes for Classes and Slots to select criteria. Enter free text in the 
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String text box to specify additional criteria. You may also select a sample 
query from the Query Library in the frame at the bottom of the screen. To 
execute a sample query, click on the middle button at the top of that frame, on 
the right side. Then click the Find button in the bottom right corner of the 
Query frame. Search results will appear on the right side of the screen. 
 
 
